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General introduction

General introduction
1.1 Introduction
Cleft lip with or without cleft palate is the most frequently occurring 
congenital craniofacial birth defect in humans and occurs in about 1 in 
700 live births.1 The incidence varies among ethnic groups, with the 
highest rates for native American and Asian populations. Caucasian and
1 9African populations have the lowest incidence. ’ In the Netherlands, 
approximately 370 children with some type o f cleft lip and palate are
-5
born each year. Although cleft lip and palate occurs in various types, 
three main categories can be distinguished: isolated cleft lip and/or 
alveolus (CL), isolated cleft palate (CP), and combined cleft lip, alveolus, 
and palate (CLP). The distribution between the clefts show that CLP is 
the largest group, followed by CP and CL.1,4 CLP is more frequent in 
males, but CP is twice as common in females.4 Approximately 70% of 
CLP cases occur as an isolated disorder, thus are non-syndromic. The 
remaining 30% are associated with other congenital malformations, and 
therefore are syndromic.5
Patients with orofacial clefts encounter several problems. They often 
have functional impairments and aesthetic deviations, which may also 
have psychological and social implications. Functions such as sucking, 
swallowing, speech, and hearing may be impaired, while facial deformity 
and dental malocclusion are usually present.6 To overcome these 
problems, these children require extensive interdisciplinary treatment into 
adulthood. These treatments are costly, both financially and in terms of 
burden o f care for the patient. Patients may be subjected to multiple 
procedures, and they and their families may experience a variety of 
psychosocial problems.
Many different surgical techniques have been used to repair 
orofacial clefts. However, side effects are associated with cleft palate 
repair such as growth disturbances of the midface caused by wound 
contraction and scar tissue formation. In order to prevent these side 
effects, a tissue engineering strategy may be employed to supplement 
tissue shortage during the repair of a cleft palate. The field of tissue 
engineering aims to replace damaged or diseased tissue or restore 
function through the use o f constructed artificial tissue and organ
11
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replacements. The overall aim o f this study is to develop a substitute for 
oral mucosa, which can prevent the iatrogenic effects o f surgical cleft 
palate closure. First, a general overview of normal and pathological 
palatogenesis, and the side effects associated with cleft palate repair will 
be presented. In the subsequent sections strategies o f tissue engineering 
in cleft palate surgery are reviewed, and the aims of this study are 
highlighted.
1.2 Palatogenesis and cleft palate
The palate consists of the primary and the secondary palate. The primary 
palate is anterior to the incisal foramen, and the secondary palate is 
posterior to it. The palate consists clinically of two distinct regions, the 
bony and immobile hard palate, and the mobile posterior fibro-muscular 
part, known as the soft palate. The palatine processes o f the maxillae and 
the horizontal plates o f the palatine bones form the hard palate. There are 
no muscles in the hard palate, but it is covered by keratinized oral 
mucosa that is continuous with the periosteum, and therefore called a 
mucoperiosteum. There are numerous minor salivary glands in its 
posterior portion.9 The formation o f mesenchymal structures of the head 
and neck, including the palate, can be attributed to the migration and 
proliferation o f the cranial neural crest cells.10 During craniofacial 
development, cranial neural crest cells migrate ventrolaterally as they 
populate the branchial arches. The human palate, as well as the palates of 
other mammals, is formed by the union o f three elements: the primary 
palate which is the inferior most extension o f the frontonasal process, 
and the two lateral maxillary palatal shelves that together will form the 
secondary palate. Development o f the palate starts at about the fourth 
week after conception, and is a sequential process that involves palatal 
shelf growth, shelf elevation, midline fusion o f the palatal shelves, and 
the disappearance o f the midline epithelial seam.10 The primary palate 
develops from fusion of the medial nasal prominences. This consists of 
the prolabium that forms the philtrum of the upper lip and the premaxilla 
that houses the four maxillary incisors. The latter segment represents a
12
General introduction
small but critical part o f the hard palate where the most visible part o f the 
CLP deformity arises.
A cleft palate occurs when the palatal shelves fail to fuse properly. 
In theory, clefts can be classified according to the pathology, etiology, 
pathomorphology, topographic anatomy, and the time at which they have 
developed. However, as the exact cause of a cleft is still not clear, and the 
deformity is very complex, many different classifications have been 
used.11 There is general agreement upon the multifactoral etiology of 
clefts; both genetic and environmental factors contribute to the formation 
of orofacial clefts. Specific genes such as MSX-1, and TGF-ß3 have all 
been linked to clefts.12-14 The general agreement from these studies is that 
there is not a simple single gene that is associated with CLP. In fact,
1 9different genes may be involved in different populations. It is estimated 
that more than 200 syndromes include some form of cleft palate, and a 
syndrome is diagnosed in more than one third of all isolated cleft palate 
patients.15
Epidemiological studies have demonstrated associations between 
environmental factors during pregnancy and a higher risk of having a 
child with a cleft. These include maternal alcohol use, cigarette smoking, 
and intake o f some specific medicines such as anti-epileptic drugs.16-19 
Nutrition also seems to play a role in developing cleft lip or cleft palate. 
It has been recommended that pregnant women and those women 
planning on having a baby should take folic acid (>400 microgram/day)
9 nas a daily dietary supplement. In conclusion, both genetic and 
environmental factors contribute to the etiology o f orofacial clefts.
1.3 Cleft palate surgery and facial growth
Patients with an orofacial cleft require multidisciplinary care, which 
should be provided by a team of specialists working in this field. 
Following the standards o f the American Cleft Palate-Craniofacial 
Association the cleft palate team should consists of an operating surgeon, 
orthodontist, speech-language pathologist, and at least one additional 
specialist from otolaryngology, audiology, pediatrics, genetics, social
13
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work, psychology, and general pediatric or prosthetic dentistry (American 
Cleft Palate-Craniofacial Association, 2007). The multidisciplinary 
treatment of these children starts soon after birth and extends until the 
end o f growth (17-20 years old). The treatment of patients with orofacial 
clefts includes many orthopaedic, surgical and orthodontic interventions 
that all by itself may have an impact on dento-maxillary growth. A strong 
indication for these iatrogenic effects is the near normal growth and
9 1dental development in non-operated CLP patients. Therefore, CLP 
repair by itself is considered to be the main cause of growth inhibition of  
the maxillofacial complex since it is impossible to describe all the 
various interventions that might influence maxillofacial growth in cleft 
lip and palate patients; we will only discuss palatal repair which is
9 9probably most significant effect on the maxillofacial growth pattern. In 
general, all contemporary surgical techniques give similar results with 
respect to dental arch form, speech outcome, feeding, or any other 
functional variable,23,24 and they all cause serious disturbances in 
maxillofacial growth.
Experimental studies on animals have been carried out to investigate 
the effects of cleft palate repair on maxillary growth and development. 
Since the breeding of animals with standardized palatal clefts is not yet 
possible, most studies use a soft tissue cleft in the middle of the palate as
9 C
a model. - Most authors conclude that the manipulation o f the palatal 
mucoperiosteum during surgery is the critical variable responsible for 
alveolar growth disturbance.
The palatal wound healing process in the dog has been investigated 
extensively.26,28,29 The results not only showed similar effects on growth 
as can be seen clinically but also that the extent was related to the age at 
which the surgery was performed. Especially when surgery was 
performed before or during the transition o f the posterior teeth, 
deviations in maxillary arch dimensions were found. This is caused by 
impaired growth of the maxilla as well as by palatal tipping of the teeth 
in the lateral areas. These effects were explained by wound contraction 
and scar tissue formation in the denuded bone areas.27,28 Wound 
contraction in the dog model is restricted to the first week after the
™ ■j'y
operation. - This is associated with the appearance o f myofibroblasts
14
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which are responsible for wound contraction. , - These cells also 
contribute to collagen accumulation and therefore to scar tissue in 
formation. In the later phases o f wound healing, the myofibroblasts 
disappear, presumably through apoptosis, and wound contraction
-5 c
ceases. The wound tissue is then slowly remodeled into a mature scar.
The composition of the palatal scar tissue in dogs differs from that 
of the normal mucoperiosteum. The scar tissue lacks elastic fibers, and is 
attached to the underlying bone by means of Sharpey’s fibers. 
Furthermore, most of the collagen fibers are orientated in a transverse 
direction, but many fibers also showed a vertical orientation. These fibers 
are continuous with the cervical periodontal ligament, thus forming a 
mechanical connection between the teeth and the palatal bone.28,36 This 
connection presumably causes traction on the erupting permanent teeth 
alongside the scar tissue. These findings have led to the hypothesis that 
the iatrogenic effects o f palatal surgery are initially caused by wound 
contraction, but scar formation and the accompanying attachment o f the 
scar tissue tot the palatal bone and the teeth, are probably the most 
important features. This leads to a restriction of maxillary growth and 
palatal tipping of erupting teeth in that region. Therefore, reducing the 
number o f myofibroblasts during wound healing, and preventing scar 
tissue attachment to the palatal bone might decrease the impairment of 
maxillary growth.
Studies have been performed to prevent the attachment o f scar tissue 
to the palatal bone.37,38 Surgical techniques that reduce the denudation of 
the palatal bone show some beneficial effects,39,40 but other attempts 
using Low level laser therapy, biodegradable poly-(L-lactic) acid 
membranes, or tissue expansion did not show any significant long term 
improvements.41-43 In the partially-split flap technique described by 
Leenstra, the palatal mucoperiosteum is split parallel to the bony surface. 
Subsequently, the oral part o f the mucoperiosteum is closed over the 
cleft. The periosteal layer o f the mucoperiosteum remains on the bone. 
This technique induces less scar formation and the growth pattern o f the
-5 Q
maxilla was more normal. However, this technique is hampered by the 
risk of avulsion o f the major palatine artery leading to necrosis o f the 
palatal flaps. In spite o f all efforts, most authors agree that scar tissue
15
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formation after palatal repair is still one of the main causes of maxillary 
growth inhibition. In the era of regenerative medicine, an alternative 
approach might be to supplement the tissue shortage after palatal repair 
with a constructed mucosal substitute using tissue engineering.
1.4 The structure of skin and oral mucosa
The basic structure of human skin and oral mucosa is similar. They both 
are composed of three functional layers: a covering epithelium, an 
underlying connective tissue (dermis) and a hypodermis or subcutis. A 
basement membrane separates the epithelium from the dermis. The 
epithelium acts as a barrier against exogenous substances and pathogens, 
and the skin also prevents loss of moisture.45,46 The epithelium of skin 
(epidermis) can vary in thickness depending on the location, but in 
general it is about 0.2 mm thick. It consists of distinct layers: from deep 
to super ficial the stratum basale, the stratum spinosum, the stratum 
granulosum, and the stratum corneum. The stratum basale contains 
slowly dividing cells providing new keratinocytes that migrate upwards 
and terminally differentiate. The mature keratinocytes are finally lost 
from the stratum corneum in a process called desquamation. This pattern 
of maturation is called orthokeratinization. In addition to keratinocytes, 
skin also contains non-keratinocyte clear cells: melanocytes, Langerhans 
cells, and Merkel cells. The function of the melanocytes is to produce 
melanin, which gives the skin its color, and to transfer it to the 
surrounding keratinocytes by means of cytoplasmic processes. Like the 
melanocytes, Langerhans cells are dendritic cells. The function of these 
cells is to detect antigens which have penetrated the epidermis. The 
Merkel cells serve as mechanoreceptors and are involved in the sense of 
touch. The dermis is divided into a thin superficial layer known as the 
papillary dermis containing the epidermal rete pegs, and the thicker 
deeper portion known as the reticular dermis. The primary cell type is the 
fibroblast which produces the structural extracellular matrix proteins
47collagen and elastin among others.
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The dermal tissue provides mechanical strength and elasticity. The 
papillary layer and the epidermis are connected by the basement 
membrane.45 The major proteins of the basement membrane are collagen 
IV, nidogen and heparan sulphate proteoglycans. The basement 
membrane is synthesized by both the basal keratinocytes and the dermal 
fibroblasts.48
The oral mucosa has some distinct differences compared to skin. 
Oral mucosa consists of two layers, the epithelium and the lamina 
propria, the underlying fibrous connective tissue layer. In some regions 
of the mouth, the oral mucosa is attached to underlying structures by a 
loose connective tissue, the submucosa. These three layers are analogous 
to the epidermis, dermis and subcutis of the skin. In contrast to skin 
keratinization, there are three different patterns of differentiation of oral 
keratinocytes. In regions of the oral cavity subjected to mechanical forces 
such as mastication, there is a keratinized epithelium of the 
orthokeratinized type closely resembling that of the skin. Large parts o f 
this keratinized regions show a variation known as parakeratinization. In 
this type of keratinization, pycknotic nuclei are retained within the 
cornified layer. In the areas of the mouth that require flexibility to 
accommodate chewing, speech, or swallowing such as the floor of the 
mouth and the buccal regions, the epithelium is of the nonkeratinized 
type.46,49
Similar to the dermis of the skin, the lamina propria of the oral 
mucosa is composed of a network of collagen and elastin fibers, and 
provides mechanical strength and elasticity. The submucosa of the buccal 
oral mucosa is a loose fatty connective tissue. In contrast to buccal 
mucosa, the palatal mucosa is a mucoperiosteum, in which the mucosa 
and periosteum are merged, and attached directly to the palatal bone. The 
palatal mucoperiosteum contains also less elastin fibers compared to the 
buccal mucosa.50 Therefore, the palatal mucoperiosteum is much stiffer 
than buccal mucosa. In the field of tissue engineering, techniques have 
been developed to culture an epithelium, with or without a dermal 
component. These structures can be used for repair of tissue defects.
17
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1.5 Tissue engineering of oral mucosa
Tissue engineering or regenerative medicine has been defined as „an 
interdisciplinary field that applies the principles of engineering and life 
sciences toward the development of biological substitutes for the repair 
or regeneration of tissue or organ function.44 Tissue engineering 
strategies might also be useful to improve cleft palate repair by the 
implantation of mucosal substitutes.
In full-thickness skin wounds, both the epithelium and the dermis 
are lost. These wounds heal by second intention, which is characterized 
by extensive granulation tissue formation followed by wound contraction
-5 -5
and scar formation. In exposed areas of the body, scar tissue causes 
aesthetic problems, and around the joints it may impair function.51 The 
mechanical effects of scar tissue in children can result in growth 
restriction. In cleft palate repair, autologous oral grafts are generally not 
used because of the limited availability of oral mucosa. To overcome this 
problem, several skin transplantation techniques in oral surgery have 
been described using autologous grafts from donor sites elsewhere in the 
body.53,54 These grafts frequently give rise to additional problems because 
the donor wound site contributes significantly to the morbidity of the 
treatment.55 Further, the donor tissue may cause additional problems 
because it maintains its original characteristics. Hair growth after 
transplantation of skin within the oral cavity has been shown in an animal 
experiment and in clinical studies.56,57 To solve the problem of the lack of 
autologous skin or oral mucosa for reconstructive surgery, and to 
minimize scar formation, several tissue regeneration techniques have 
been developed. Firstly, biocompatible membranes have been used to 
prevent attachment of the scar tissue to the palatal bone or to reduce 
contraction and scar formation (Figure 1E). A second approach is the 
engineering of mucosal substitutes to fill the tissue defects. To this end 
thin cell sheets have been cultured that can be used as epithelial grafts 
(Figure 1A). Thirdly, keratinocytes have been cultured on top of a dermal 
matrix to produce a bilayered or composite graft, which is a substitute for 
the entire mucosa (Figure 1B+C).
18
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Figure 1 Schematic drawing o f different tissue engineering techniques for skin and 
oral mucosa.
1.5.1 Biocompatible membranes
Firstly, biocompatible membranes have been used for tissue regeneration. 
These membranes can be divided into synthetic membranes, skin-derived 
substrates, and collagen-based membranes. Initially, the principles of 
guided tissue regeneration were used by inserting synthetic membranes
c o
such as poly-(L-lactic) acid membranes. These membranes were used to 
cover the bone thereby preventing the formation of Sharpey’s fibers, but 
yielded unsatisfactory results due to uncontrollable degradation and 
exfoliation of the membrane or incomplete coverage of the bone.59
19
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Next to these synthetic membranes, the use of skin-derived 
substrates have been described. The two most studied skin-derived 
dermal substrates are DED, and commercially available human DED, 
called AlloDerm™. De-epidermized dermis (DED) has often been 
described for epidermal and oral keratinocytes-dermal substrates 
cultures.60-62 DED is prepared from cadaveric split-thickness skin by the 
removal of the epidermis and the dermal cells from the dermis. The 
advantages of DED are its durability and its stable structural properties, 
even after being frozen, lyophilized or preserved in glycerol.63,64 
AlloDerm is a commercially available human dermis (DED) which was 
described for the first time by Wainwright in 1995.62,65 It is made from 
pathogen-screened cadaveric skin and freeze-dried through a patented 
process that does not damage the crucial elements of the tissue structure. 
It is described as a suitable dermal substrate for the culture of epidermal 
and oral keratinocytes.66-68 After implantation, these skin-derived 
substrates seem to support fibroblast infiltration and neovascularisation. 
These materials also may shorten the healing time and reduce wound 
contraction.69-71
In the past decades, collagen-based substrates have been used widely 
in tissue engineering for skin and oral mucosa.72,44 Their unlimited 
availability and biocompatibility are strong advantages of these
*7-5
materials. Collagen has been used in the form of gels, sponges, meshes, 
and membranes. However, the high degradation rate and the low strength 
of untreated collagen limits its use. Cross linking of a collagen matrix is 
an effective way to slow down the degradation and to improve the
HAmechanical property of the material. However, cross linking of collagen 
may also negatively influence cell growth into the substrate.74,75 
Collagen-based substrates can be supplemented with other extracellular 
matrix components to further improve their function. These extracellular 
matrix components include: collagen type IV, elastin, or 
glycosaminoglycans.74,76-79 Integra® is an example of a collagen
on
chondroitin-6-sulfatematrix.80
Chondroitin-6-sulfate is a glycosaminoglycan, it is hydrophilic, and 
therefore allows water-soluble molecules to diffuse rapidly into the 
matrix. On top of the Integra matrix a silicon membrane is present, which
20
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functions as a temporary epithelial covering. The matrix is grafted onto 
the wound and the silicon membrane is removed after 14 days, when 
granulation tissue and blood vessels are formed. Long-term follow-up 
studies showed improved wound healing in terms of reduced scarring. 
However, the main disadvantage is the varying „take rate’ and the risk of 
infection.81-85
1.5.2 Epithelial sheets
In 1975, Rheinwald and Green introduced a method to culture epidermal 
human keratinocytes in vitro using a feeder layer composed of lethally 
irradiated 3T3 mouse fibroblasts and a specific medium called Green’s 
medium.86 This method was modified many times but is still used for the 
preparation of epithelial sheets. If allogeneic keratinocytes are used, the 
graft behaves as a temporary wound dressing that only accelerates
o7
reepithelisation. Oral keratinocytes, obtained from a mucosal biopsy, 
can be also be cultured to form an epithelial sheet, and have been
oo
cultured successfully without a feeder layer. These thin sheets of 
cultured autologous keratinocytes have been utilized for resurfacing burn 
injuries89 and intra-oral grafting.90,91 However, they are fragile, difficult
Q9to handle and can result in early loss, blistering and scarring. In 
addition, 2-3 weeks are required to obtain sufficient quantities of 
keratinocytes from a biopsy. Nowadays, these sheets are used for 
biocompatibility tests and oral biology research, such as disease 
modeling and wound healing. For example, to study the effects of 
mercury release from fillings to an oral mucosa equivalent and to 
investigate the effect of human immunodeficiency virus type 1 (HIV-1)
93,94to the oral mucosa. ,
1.5.3 Bilayered or composite graft
Sheets of cultured autologous keratinocytes provide little resistance to 
woundcontraction and scarring in the absence of a dermal 
component.47,95-97 Thus, the development of a three dimensional 
multilayered culture was of major importance in epithelial biology and 
tissue engineering. The chances for successful „take’ of cultured grafts 
are improved when a dermis or a dermal component is present.95,98 The
21
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presence of a dermal substrate is also supposed to diminish contraction 
scar formation.99 Therefore, the combination of cultured keratinocytes 
with a dermal substrate seems to limit wound contraction and scarring.
These full-thickness engineered oral mucosa equivalents have been 
used for clinical application in periodontology and maxillo-facial 
reconstructions. Sauerbier et al. (2006) showed that a normal oral 
epithelium with rete pegs and a basement membrane was present six 
months after implantation of a full-thickness engineered oral mucosa 
equivalent.100 Another study showed that an implanted mucosal 
equivalent composed of keratinocytes and AlloDerm had a 100% take 
rate at 28 days post-grafting.101 One clinical study showed that an 
implanted mucosal equivalent required a shorter time for re- 
epithelialisation, and showed only slight scar tissue formation compared
1 09to a skin-derived substrate alone. The post-operative healing period of
1 mtissue-engineered mucosa is even shorter than that of split-skin grafts. 
Another advantage of tissue-engineered mucosa in either pre-prosthetic 
or reconstructive surgery is the convenience for the patient.
In summary, full-thickness engineered oral mucosa equivalents can 
be constructed that provide an epithelial and a dermal component. When 
allogeneic keratinocytes are used, the equivalent is directly available but 
it only functions as a temporary coverage and has a risk of disease 
transmission. The “ideal” oral mucosal equivalent contains autologous 
cells and provides a permanent tissue replacement. However, the culture 
period of several weeks to obtain enough autologous cells may not be 
clinically acceptable. Therefore, an acellular substrate added with 
suitable growth factors to promote angiogenesis and regeneration of the 
submucosa might also be a better approach. In general, long-term results 
of grafted skin and oral mucosal equivalents are not yet available. It can 
be concluded that prior to the study of the effects of an implanted 
substitute on the development of the dento-maxillary complex, the 
construction of such a substitute needs to be investigated.
22
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1.6 Aims of this study
The ultimate scope of our research is to improve the treatment of children 
with an orofacial cleft. Therefore, the aim of the present study is to 
develop a substitute which is suitable for cleft palate repair, and can 
reduce wound contraction and scar tissue formation to achieve a normal 
facial and maxillary development. In the first part, a substitute is 
developed composed of dog keratinocytes cultured on several dermal 
substrates. These substitutes are histologically evaluated and the degree 
of differentiation of the epithelium and the expression of characteristic 
basal proteins are determined. In the second part, substitutes containing 
autologous keratinocytes are evaluated in vivo after implantation on 
experimental wounds in the palate of beagle dogs. In the third part the 
effect of a substitute on the development of the dento-maxillary complex 
is analyzed in a simulated cleft palate repair in beagle dogs.
The specific aims of this study are:
• To compare the epithelial differentiation of keratinocytes of oral 
and dermal origin on two skin-derived and three collagen-based 
dermal substrates (Chapter 2).
• To evaluate the tissue response to two skin-derived and three 
collagen-based dermal substrates after implantation in palatal 
wounds in the beagle dog (Chapter 3).
• To evaluate the performance of cultured autologous mucosal 
substitute after implantation in palatal wounds (Chapter 4).
• To investigate the intra-oral tissue response to Integra® with and 
without the silicon top layer (Chapter 5).
• To investigate the dento-alveolar development in beagle dogs after 
palatal repair according to the Von Langenbeck technique with and 
without the implantation of the dermal substitute Integra® (Chapter 
6).
23
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Oral keratinocytes cultured on dermal matrices form a m ucosa-like tissue
Summary
Introduction: Oral reconstructions for cleft palate repair are often 
complicated by a shortage of mucosal tissue. This shortage causes scar 
tissue formation leading to impaired growth of the dento-maxillary 
complex. The overall aim of our research is to develop a substitute, 
which limits the iatrogenic effects of cleft palate surgery.
Methods: This study describes the culture and characterization of 
mucosal substitutes containing keratinocytes. Epidermal and oral 
keratinocytes from a beagle dog were cultured on several skin-derived 
and collagenbased substrates.
Results: Oral keratinocytes cultured on the skin-derived substrates 
closely resembled normal oral epithelium of the dog. A multi-layered 
epithelium was formed showing parakeratosis, expression of cytokeratin 
16 and the formation of a basement membrane. Epidermal keratinocytes 
cultured on the skin-derived substrates formed an epithelium which was 
similar to dog epidermis. In contrast, keratinocytes cultured on the 
collagen-based substrates invaded the substrate without the formation of 
a multi-layered epithelium.
Conclusion: This study shows that oral canine keratinocytes cultured 
on skin-derived substrates exhibit a tissue organization that resembles 
normal oral mucosa. This type of mucosal substitute will therefore be 
used in further studies for implantation on the palate of beagle dogs. 
These studies might eventually lead to an improvement of cleft palate 
surgery in humans.
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2.1 Introduction
Surgical reconstructions of skin or oral mucosa are often complicated by 
a shortage of tissue. To overcome this problem, several transplantation 
techniques have been described using autologous grafts from donor sites
1 9elsewhere in the body. ’ These grafts frequently give rise to additional 
problems because the donor wound site contributes significantly to the
-5
morbidity of the treatment. Further, the donor tissue may cause 
additional problems because it maintains its original characteristics. The 
surgical closure of a palatal cleft is also complicated by a shortage of 
mucosal tissue. Generally no autologous grafts are used in cleft palate 
repair. Therefore, large open wounds exposing the palatal bone remain 
after surgery. These wounds heal by secondary intention, which causes 
wound contraction and the formation of scar tissue, resulting in an 
impaired development of the dento-maxillary complex.4-6
Advances in tissue engineering permit the growth of autologous 
keratinocyte sheets from a small skin biopsy, which can be grafted on a
7 ofull-thickness wound. , However, wound contraction and scarring are not 
prevented by this procedure.9 In contrast, the combination of cultured 
keratinocytes with a dermal substrate seems to limit wound contraction 
and scarring.10,11 The most widely used types of dermal substrates are 
skin-derived or collagen-based materials. The former type is prepared 
from cadaveric donor skin.12 The latter ones generally consist of a 
collagen type-I substrate sometimes supplemented with extracellular 
matrix components such as collagen type-IV, elastin, or 
glycosaminoglycans.13-19
Several techniques for the reconstruction of skin and mucosa have
1 1 9  n _'s 's
been developed using keratinocytes cultured on a dermal substrate. , 
These techniques include the transplantation of collagen gels seeded with
9 "2cultured keratinocytes and fibroblasts, the transplantation of a collagen
9zlsubstrate containing chondroitin-6-sulphate with cultured keratinocytes,24 
and the transplantation of de-epidermized donor skin combined with
9 Scultured keratinocytes. These types of cultured substitutes have been 
successfully applied in a variety of in vivo testing protocols.
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The overall aim of this research is to construct an oral mucosal 
substitute, which can limit the iatrogenic effects of cleft palate surgery 
caused by wound contraction and scar tissue formation. If suitable, the 
use of epidermal keratinocytes instead of oral keratinocytes would be 
preferable because a skin biopsy causes less discomfort to the patient 
than an intra-oral biopsy. Therefore, the specific aim of this study was to 
compare the epithelial differentiation of keratinocytes of oral and 
epidermal origin cultured on two skin-derived, and three collagenbased 
substrates.
In this in vitro study, all keratinocytes are of canine origin because 
the mucosal substitutes will be used for implantation studies in our dog 
model for cleft palate surgery.26,27
2.2 Methods
2.2.1 Dermal substrates
In this study five different dermal substrates were used; de-epidermized 
dog skin (DED), commercially available human donor dermis 
(AlloDerm®, LifeCell Corporation, Branchburg, NJ, USA), collagen type­
I substrate (Kindly provided by Dr. A. van Kuppevelt, Department of 
Biochemistry, University Medical Center, University of Nijmegen, The 
Netherlands), a collagen type-I substrate coated with 3% w/w a-elastin 
hydrolysate (Kindly donated by Dr. E. Middelkoop, Burn Center, 
Department of Surgery, Red Cross Hospital, Beverwijk, The
9 »Netherlands), and a collagen type-I substrate with chondroitin-6- 
sulphate (Integra™, Medeco B.V., Oud-Beijerland, The Netherlands).29
DED was produced from full-thickness skin explants, as described 
previously.30,31 The explants were obtained from the groin of beagle dogs, 
which is the least hairy region of the animal. Briefly, the skin was 
subjected to at least three freeze-thaw cycles using liquid nitrogen. 
Subsequently, the skin was placed in phosphate-buffered saline (PBS) 
supplemented with 100 ^g/ml penicillin G and 100 mg/ml streptomycin 
(Life Technologies, Breda, The Netherlands) at 37°C for two weeks to 
detach the epithelium. The DED was stored in PBS with antibiotics at
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-20°C. Before each experiment, the DED was thawed and washed three 
times in DMEM (Biowhittaker Europe, Verviers, Belgium). A sample 
was placed in keratinocyte medium (described in detail below) for 48 h at 
37°C in a humidified incubator containing 5% CO2 in air to confirm 
sterility.
The silicon sheet covering the collagen type-I chondroitin-6-sulphate
9 Qsubstrate was removed prior to the experiment. Before every 
experiment, all substrates were washed three times in PBS and incubated 
overnight at 37°C in keratinocyte medium.
2.2.2 Primary keratinocyte cultures
Keratinocyte culture methods were similar to those described 
previously.32,33 In short, biopsies from skin and palatal mucosa were 
obtained from a beagle dog. The biopsies were incubated at 37°C in a 
0.25% trypsin solution (Gibco, Grand Island, NY, USA) to detach the 
epithelium. Subsequently, the tissue was washed in keratinocyte medium 
and the epithelial layer was removed with a forceps. Keratinocyte 
medium contained DMEM and HAM-F12 (Biowhittaker Europe, 
Verviers, Belgium) in a volume ratio of 3:1 supplemented with 5% 
newborn calf serum (Biowhittaker Europe, Verviers, Belgium), 100 U/ml 
penicillin G, 100 ^g/ml streptomycin, 0.4 ^g/ml hydrocortisone, 10 mm 
isoproterenol, and 5 ^g/ml insulin.
A single-cell suspension was obtained by vigorously pipeting the 
epidermal fragments. The cell suspension was seeded onto a preplated 
feeder layer of lethally irradiated 3T3 fibroblasts in keratinocyte medium
'S
in a 75 cm culture flask (Nunc®, Nalge Nunc International, Taastrup,
-5 1
Denmark). The cells were incubated at 37°C in a humidified incubator 
containing 5% CO2 in air, and the medium was changed every two to 
three days. When the cultures were nearly confluent, the keratinocytes 
were washed in PBS and detached in a 0.25% trypsin solution. The cell 
suspension was transferred to new culture flasks to establish secondary 
cultures. The expanded keratinocytes were stored in liquid nitrogen in 
keratinocyte freezing medium containing 10% dimethyl sulphoxide until 
use.
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Before every experiment, the cryopreserved cells were quickly 
thawed by gentle agitation in a 37°C water bath. For the culture of the 
substitutes, third-passage cells were used always. All cultures were 
checked for mycoplasma contamination using a mycoplasma kit (Gen 
probe, Biomierieux Inc, St Louis, MO, USA).
2.2.3 Composite cultures
Culture methods for the production of the composite substitutes have 
been described previously.34,35 Briefly, the dermal substrates were placed 
on stainless steel grids in keratinocyte medium. Subsequently, 
approximately 2.105 cells third-passage keratinocytes were seeded on the 
dermal substrates in a stainless-steel ring with an inner diameter of 10 
mm. The cells were cultured submerged in keratinocyte medium for three 
days and then air-exposed for another 4-18 days. The medium used for 
air-exposed culture was supplemented with 10 ng/ml epidermal growth 
factor (Sigma Chemical Co, St. Louis, MO, USA). The medium was 
changed every two to three days. All experiments were performed in 
triplicate. Additionally, dermal substrates were cultured for 21 days 
without keratinocytes to confirm the absence of living cells and to ensure 
the stability of the substrates in culture medium. All dermal substrates 
without keratinocytes lacked vital cells and showed good stability.
2.2.4 Histology
Samples for histological analyses were fixed for 4 h in 4% 
paraformaldehyde in 0.1 m phosphate buffer at room temperature. 
Subsequently, the samples were processed for embedding in paraffin. 
Sections (4 ^m) were made and mounted onto superfrost (Menzel-Gläser, 
Braunschweig, Germany) slides. Skin and palatal mucosa samples 
obtained from a beagle dog served as normal controls. The sections were 
stained with haematoxilin and eosin (HE). The HE staining was used to 
assess keratinocyte morphology, the number of cell layers, and the 
thickness of the keratinized layer. The quantitative analyses were 
performed on 12 randomly chosen points in each section.
Immunohistochemical analyses were performed to detect the 
presence of the cytokeratins 10 and 16 and the basal membrane
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component heparan sulphate. Cytokeratin 10 was detected with a 
monoclonal mouse antihuman cytokeratin 10 antibody (Euro-Diagnostica, 
Arnhem, The Netherlands). Although this antibody was raised against 
human cytokeratin 10, it strongly cross-reacts with canine cytokeratin 10. 
Before staining, the slides were rinsed in PBS for 10 min. The sections 
were pre-incubated with 0.1% trypsin (Sigma Chemical Co, St. Louis, 
MO, USA) in 0.1% CaCl2 at pH 7.8 for 15 min at 37°C. Subsequently, 
the sections were washed in PBS and incubated in 1% bovine serum 
albumin (BSA, Sigma Chemical Co, St. Louis, MO, USA) in PBS for 20 
minutes. After removal of the BSA, the sections were incubated with 
mouse anti-human cytokeratin 10. Antibody binding was visualized with 
an anti-mouse IgG biotinylated antibody (Vector Laboratories, 
Burlingame, CA, USA) and a standard DAB technique (Sigma). The 
sections were counterstained with Mayer’s haematoxilin.
Cytokeratin 16 was detected by means of a monoclonal mouse anti­
human cytokeratin 16 (Novo Casta, Newcastle upon Tyne, UK), which 
also cross-reacts strongly with canine cytokeratin 16. The procedure was 
the same as for cytokeratin 10 except that the preincubation with trypsin 
was replaced by an antigen retrieval method.36
The anti-heparan sulphate JM 403 antibody (mouse anti-human 
heparan sulphate, IgM) was a kind gift of Prof. Dr. J. Berden 
(Department of Nephrology, UMC St. Radboud, Nijmegen, The
-5'7
Netherlands). The staining method was the same as that described for 
cytokeratin 10, except for the secondary antibody which was a 
biotinylated rabbit anti-mouse IgM antibody (Vector Laboratories, 
Burlingame, CA, USA). Representative sections were photographed on a 
Leitz DMRD Microscope (Leica, Wetzlar, Germany).
2.3. Results
2.3.1 General histology
Oral mucosa of the palate of the dog showed an epithelium with a basal 
layer and a regular stratification (Figure 1A). The basal layer was 
composed of cuboidal and columnar shaped cells. Above the basal layer,
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on average 15 layers (Table I) of spherical to flattened cells are present. 
The keratinized layer with a mean thickness of 31.3 ^m was composed of 
very flat cells. In many of the squames, pyknotic nuclei were retained.
Figure 1 Histological sections o f the experimental samples stained with HE. Palatal 
mucosa (A), Oral keratinocytes cultured on DED (B) and collagen type-I (C) 
for 21 days. Skin (D), Epidermal keratinocytes cultured on DED (E) and 
collagen type-I (F) for 21 days. Bars represent 50 ¡m.
Oral keratinocytes cultured on DED and AlloDerm® already formed 
a continuous layer of 5 -6  cells after 7 days of culture (Table I). The cells 
were round and showed little signs of differentiation. After 14 days, six 
to eight cell layers were present on these skin-derived substrates (Table 
I). In addition, rete pegs had formed in all cultures, and many vacuoles 
were present within the middle epithelial layers. After 21 days, the 
cultures showed approximately ten cell layers (Table I). The epithelium 
was composed of a basal cell layer with cuboidal cells, some intermediate 
layers with vacuoles within the flattened cells, and a superficial cornified 
layer of the parakeratinized type (Figure 1B). These cultures were thinner 
and contained less cell layers than normal palatal mucosa of the dog 
(Table I and Figure 1A). In contrast, the cornified layer of the cultured 
substitutes was thicker compared to the oral mucosa (Table I). The
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underlying dermal substrates showed no signs of cellular infiltration by 
the keratinocytes.
Table I  Morphological analysis o f keratinocytes cultured on dermal matrices. The 
quantitative analyses were performed on 12 randomly chosen locations o f 
each sample. Data are reported as average and (SD)
Controls
Oral mucosa cell layers 15 (3.4)
cornified layer (um) 31.3 (6.3)
Epidermis cell layers 2 (0.9)
cornified layer (um) 3.1 (0.8)
Experiment Days in culture
Keratinocytes substrate 7 14 21
Oral origin DED cell layers 5 (1.3) 8 (1.9) 9 (1.8)
cornified layer (um) 31.2 (1.6) 37.4 (11.1) 76.4 (18.2)
AlloDerm® cell layers 6 (1.0) 6 (1.5) 10 (1.6)
cornified layer (um) 6.3 (0.6) 50.5 (13.7) 99.9 (18.8)
Epidermal origin DED cell layers 1 (0.9) 2 (1.7) 3 (1.6)
cornified layer (um) ND ND 11.8 (3.8)
AlloDerm® cell layers 1 (0.8) 2 (1.5) 3 (0.8)
cornified layer (um) ND ND 24.7 (10.6)
ND: not determined
Oral keratinocytes cultured on the collagen-based substrates did not 
form epithelial cell layers. These substrates exhibited only cell ingrowth 
into the substrate (Figure 1C). After 21 days, local cornification was 
present within cell clusters in the collagen substrates.
Epidermal epithelium of the beagle dog demonstrates an epithelium 
of the orthokeratinized type (Figure 1D). The epithelium is composed of 
two cell layers with rounded cells (Table I). These cells show little 
evidence of differentiation from the basal to the superficial layer. The
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cornified layer with a mean thickness of 3.1 ^m is composed of very flat 
squames and does not contain any nuclei.
Epidermal keratinocytes cultured on top of both types of skin- 
derived substrates formed a discontinuous layer after two weeks of 
culture (not shown). The cell patches present on top of the substrates 
contained approximately one layer after 1 week and two layers after 2 
weeks with some signs of keratinization (Table I). After 21 days, the 
cultures contained stratified epithelial layers in coalescent keratinocyte 
colonies (Figure 1E). The subcornified part of the epithelium contained 
up to three cell layers and the cornified layer exhibited spots of 
orthokeratinization (Table I). At this stage, a very thin epidermal layer 
was present (Figure 1E).
The epidermal keratinocytes cultured on the collagenbased 
substrates showed similar characteristics as the oral keratinocyte cultured 
on these substrates. In all sections, ingrowth of keratinocytes into the 
collagen substrates was found with the appearance of keratinisation spots 
within cell clusters (Figure 1F).
2.3.2 Immunohistochemical analyses
Cytokeratin 10 expression was not detected in any of the sections of 
cultured oral keratinocytes (Figure 2G, J, M) or in the normal palatal 
mucosa (Figure 2D). In contrast, cytokeratin 10 expression was found in 
the supra-basal layer of the normal epidermis (Figure 2A) and in the 
sections of epidermal keratinocytes on top of both types of skin-derived 
substrates after 21 days of culture (not shown).
Cytokeratin 16 was expressed in the oral palatal mucosa of the 
beagle dog except in the basal layer (Figure 2E), and throughout the 
cultures composed of oral keratinocytes from day seven on (Figure 2H, 
K, N). In the epidermis of the skin, cytokeratin 16 was not expressed 
(Figure 2B). However, the supra-basal layers of the cultures with 
epidermal keratinocytes were locally stained for cytokeratin 16 (not 
shown).
The basement membrane component heparan sulphate was not 
detected in the DED preparations before culture or in the collagen-based 
substrates. In contrast, it was still present on the uncultured AlloDerm®.
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Continuous staining for heparan sulphate was observed at the epithelial­
dermal border of the normal epidermis (Figure 2C) and the oral mucosa 
(Figure 2F), and in all cultures composed of oral keratinocytes and 
AlloDerm®. In the DED specimen, however, expression of heparin 
sulphate was only detected on days 14 and 21 (Figure 2L and O).
E___
C
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Figure 2 Immunohistochemical staining for cytokeratin 10 on sections o f skin (A), 
oral mucosa (D) and oral keratinocytes cultured on DED for 7 (G), 14 (J), 
and 21 days (M), staining for cytokeratin 16 on skin (B), oral mucosa (E) 
and oral keratinocytes cultured on DED for 7 (H), 14 (K), and 21 days (N), 
staining for heparan sulphate on skin (C), oral mucosa (F) and oral 
keratinocytes cultured on DED for 7 (I), 14 (L), and 21 days (O). Bars 
represent 50 ¡ m.
2.4 Discussion
The general aim of these studies is to develop a substitute for oral 
mucosa, which can limit the iatrogenic effects of cleft palate surgery. In 
this in vitro study, we evaluated substitutes composed of oral and 
epidermal keratinocytes of a beagle dog cultured on several dermal 
substrates. The morphology and differentiation of the cultured substitutes 
were compared to normal palatal mucosa and skin.
The results show that canine oral keratinocytes cultured on a skin- 
derived substrate at the air-liquid interface form an approximately ten 
cell layers thick parakeratinized epithelium closely resembling normal 
palatal epithelium of the beagle dog. We have further shown that oral 
keratinocytes and epidermal keratinocytes in culture are strikingly 
different. Epidermal keratinocytes cultured on topof the skin-derived 
substrates form only upto three cell layers and an orthokeratinized 
stratum corneum. However, this is similar to the histological 
characteristics of normal canine epidermis. This study clearly 
demonstrates that canine keratinocytes from palatal mucosa and skin are 
capable to form an epithelium in culture. In both cases, the histological 
characteristics of the original tissue were reproduced. This is in 
agreement with the result of others using human keratinocytes.38,39 
Therefore, keratinocytes of oral origin appear to be suitable for culturing 
a mucosa-like tissue.
Oral keratinocytes cultured on skin-derived substrates undergo 
stratification and keratinization from day 7 on. This is in agreement with
-5 C
the results of others using human keratinocytes. However, all cultures 
showed a large increase of stratum corneum thickness and only a limited 
increase in the number of suprabasal cell layers with increasing culture
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time. The increase in thickness of the stratum corneum might be 
explained by the absence of shedding in culture that normally occurs in 
vivo due to mechanical abrasion. However, others suggest that this might 
be dependent on the presence of EGF in the culture medium.40
Regeneration of rete pegs was observed from day 14 on in the 
dermal substitute containing a skin-derived substrate and oral 
keratinocytes. Medalie41 suggested that a skin-derived substrate retains 
the undulating papillary surface of normal dermis. The invaginations of 
this skin-derived surface will be filled by keratinocytes to form rete pegs. 
However, our skin-derived substrates originally do not posses a papillary 
surface. An alternative, more suitable, explanation might be that 
keratinocytes are able to contract the substrate forming a papillary 
surface. It has been shown before that keratinocytes are able to contract 
skin-derived substrates and collagen gels in vitro.42,43 The exact nature of 
this mechanism is still unclear.
None of the collagen-based substrates seeded with oral or epidermal 
keratinocytes induced the formation of a stratified epithelium. These 
cultures exhibited only cell ingrowth into the substrate. This is not in 
agreement with others, who observed the formation of a stratified and 
partially keratinized epithelium upon a collagen gel.44 This difference 
might be explained by the presence of fibroblasts in the collagen gel.41,45 
In addition, the large pore size of the collagen substrates could explain 
the ingrowth of keratinocytes. All substrates used in the present study had 
a pore size of over 100 ^m. In the future, adding a surface layer of a 
smaller pore size or incorporating fibroblasts into the matrix may 
improve the collagen-based substrates.
The skin-derived substrates containing oral keratinocytes were 
characterized by the presence of cytokeratin 16 and the absence of 
cytokeratin 10. Cytokeratin 16 expression was found in the suprabasal 
layers. This cytokeratin is specifically found in mucosal epithelia, and in 
hyperproliferative skin.46 This indicates that the cytokeratin expression of 
oral keratinocytes in these cultures is similar to that of oral mucosa. 
However, EGF, a component of the culture medium, can also induce the
47expression of cytokeratin 16. This might also explain the local staining 
of cytokeratin 16 in our cultures with epidermal keratinocytes.
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Cytokeratin 10 expression was only observed in the cultures containing 
epidermal keratinocytes at day 21. Cytokeratin 10 expression in 
keratinocytes on a collagen-based substrate or a nylon mesh was also 
observed by others.48,49
A difference between the two skin-derived substrates was the 
presence of the basement membrane component heparan sulphate on the 
human donor dermis. Heparan sulphate was not present in the DED since 
we used trypsin treatment to prepare the substrate. However, heparan 
sulphate was expressed in the cultures composed of oral keratinocytes 
and DED from day 14 on. This is in agreement with others who also 
show that a structural basement membrane is not a prerequisite for 
epidermal morphogenesis and differentiation.50
In conclusion, we have shown that the oral mucosal substitutes 
composed of oral keratinocytes cultured on skin-derived substrates (DED 
or AlloDerm®) showed histological and immunohistochemical 
characteristics close to normal oral mucosa. In addition, epidermal 
keratinocytes cultured on a skin-derived substrate revealed a more skin­
like tissue. Therefore, we hypothesize that oral keratinocytes cultured on 
a skin-derived substrate are suitable to prevent the iatrogenic effects of 
cleft palate repair. In future studies, such a mucosal substitute will be 
implanted on the palate of a beagle dog in a simulated cleft palate repair. 
This may ultimately lead to the improvement of cleft palate surgery in 
humans.
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Histologic evaluation o f implanted skin-derived and collagen-based substrates
Summary
Introduction: Tissue shortage complicates the surgery of cleft lip and 
palate anomalies and the healing of defects on the palate impairs growth 
of the dento-alveolar complex due to scar tissue formation. Implantation 
of substitutes into the wound area might overcome this adverse effect.
Methods: The aim of this study was to compare the tissue response 
to three collagen-based (collagen type I substrate alone, or collagen 
coated with elastin or chondroitin-6-sulfate) and two skin-derived 
substrates (unprocessed dermis and AlloDerm) after implantation into 12 
dogs. Histology was performed at 3, 10, and 20 days postsurgery.
Results: We showed that all substrates were well tolerated. However, 
it is unclear whether AlloDerm was rapidly degraded or if it was 
sequestrated. There was no elastin or collagen present in these wounds. 
All collagen-based substrates showed good epithelial regeneration, 
although heparan sulfate (JM 403) was absent. Wounds treated with the 
collagen-based substrates contained fewer myofibroblasts at 20 days 
postsurgery and the type III collagen fibers in the immature scar tissue 
were more randomly oriented than in an untreated wound.
Conclusion: Palatal wounds with a dermal substrate heal with fewer 
indications of scar tissue formation and evoke only a mild inflammatory 
reaction, which is preferred over the tissue reaction in an untreated 
wound.
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3.1 Introduction
Oral mucosa defects are often an inevitable consequence of 
maxillofacial surgery. The surface area of these wounds is reduced by the 
proliferation and migration of cells as well as by wound contraction and 
scarring. When wound contraction and scar tissue formation occur during 
skeletal growth, it is proposed that it counteracts normal development of 
the facial skeleton. This occurs in cleft palate repair when primary 
surgery is performed on a growing child. During closure of the cleft, 
mucosal defects are produced on the lateral areas of the palate. 
Immediately after surgery, maxillary development is inhibited by wound 
contraction. Later on, extensive scar tissue is formed, which is firmly 
anchored to the palatal bone. It has been strongly suggested that this scar 
tissue is a major factor in the impairment of skeletal growth and 
development of the dentition in both cleft palate patients and animal
1  -5
models.
Myofibroblasts are probably involved in wound contraction.4,5 These 
contractile fibroblasts are numerous in many types of contracting 
wounds. Subsequently, the myofibroblasts disappear, probably through 
apoptosis, and wound contraction ceases.5 Therefore, reducing the 
number of myofibroblasts during palatal wound healing after closure of 
the cleft might decrease wound contraction.
Histologic studies have shown that the tissue that develops by 
wound healing on the palatal bone after palatal repair in animal models is 
different from normal palatal mucosa. It lacks elastic fibers, the collagen 
fibers are oriented in a transverse direction, and the tissue is attached to 
the underlining bone by Sharpey’s fibers.1,6 Therefore, this tissue is true 
scar tissue. It has been suggested that prevention of the attachment of 
scar tissue to the palatal bone might lead to a more favorable maxillary 
growth.1
Contraction by myofibroblasts and scarring could possibly be 
reduced by the use of some graft material. Literature describes the 
transplantation of tissue from the radial forearm, pectoralis major, or free 
tissue flaps with microvascular anastomoses to reconstruct large
n_i a
defects. Although these techniques may be used successfully,
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additional problems may arise when the graft becomes necrotic or
1 1   1-5
dysplastic. Other problems may occur when the graft tissue maintains 
its original characteristics. Hair growth after transplantation of skin 
within the oral cavity has been shown in animal and clinical studies.14,15 
To overcome these problems, the use of oral mucosal grafts from the 
buccal mucosa or the hard palate is described for the reconstruction of 
small defects in the oral cavity.16 However, it is difficult to obtain enough 
oral mucosa for the reconstruction of large defects.
To increase the availability of epithelium, in vitro culture techniques
1 7for keratinocytes have been used. However, an epithelium composed of 
cultured keratinocytes without a dermal substrate is very fragile, difficult 
to handle, and when grafted on a full-thickness skin wound, contraction 
of the connective tissue can still occur.18,19 When cultured keratinocytes 
are used in combination with a dermal substrate, re-epithelialization 
might be faster, wound contraction might be limited, and the formation of 
scar tissue might also be minimized.20,21 The most widely used types of 
dermal substrates are collagen-based and skin-derived materials. The 
collagen-based substrates generally consist of a type I collagen matrix 
sometimes supplemented with other extracellular matrix components 
such as elastin or glycosaminoglycans.22,23 The skin-derived substrates 
are prepared from glycerol-preserved cadaveric skin or processed to
OAremove cellular components.
Dermal substrates consisting of type I collagen have been widely 
studied for the treatment of partial or full-thickness skin wounds. These 
substrates with or without autologous human keratinocytes and/or 
fibroblasts may have positive effects in the treatment of skin wounds in 
human and animal models.25,26 Collagen is biodegradable and exhibits 
little antigenicity.27,28 The formation of new dermis has been reported 
using a type I collagen substrate supplemented with chondroitin-6-sulfate
9 Qglycosaminoglycans. Dermal substrates derived from glycerol- 
preserved skin seem to have only limited value in treating full-thickness 
skin wounds because of rejection and the risk of viral transmission. These 
substrates may induce a stronger inflammatory response than the 
processed cadaveric skin substrates because of remaining cellular 
components. Specifically, the processed skin-derived substrates were
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shown to be only weakly immunogenic or even nonimmunogenic and 
allowed host fibroblast infiltration, neovascularization, and keratinocyte 
migration.30,31 Processed skin-derived dermal substrates, like AlloDerm® 
(LifeCell Corporation, Branchburg, NJ) have been used in clinical trials 
for burn wound management and soft tissue augmentation.32,33 They seem 
to function as a permanent dermal substitute and enhance wound 
healing.34,35
In order to study the iatrogenic effects of palatal repair on skeletal 
growth and dental development, we conducted several experiments in 
which soft tissue palatal repair was performed in a beagle dog model.1 In 
this study, it was suggested that the prevention of scar tissue attachment 
to the palatal bone leads to a more favorable skeletal growth. In follow- 
up studies, attempts were made to prevent the attachment of scar tissue 
by modifying the surgical techniques or by the use of biodegradable 
membranes. However, both approaches did not produce optimal long­
term results.36,37
The overall aim of our current studies is to develop a cultured 
substitute for oral mucosa containing autologous keratinocytes and a 
dermal substrate and to reduce the problem of contraction and scarring 
after cleft palate surgery. The specific aim of the present study was to 
evaluate the tissue response to several collagen-based and skin-derived 
substrates after implantation in palatal wounds in beagle dogs. Therefore, 
we have evaluated the inflammatory response, the presence of 
myofibroblasts, re-epithelialization, and the formation of a basement 
membrane. In addition, we evaluated the formation of scar tissue in the 
palatal mucosa. In a follow-up study, the most promising materials will 
be used as a substrate for keratinocyte culture and subsequent 
implantation in experimental wounds on the palate of beagle dogs.
3.2 M aterials and methods
In this experiment, defects in the palatal mucosa beagle dogs were filled 
with collagen-based substrates, skin-derived substrates, autologous 
mucosal implants or they were left open as a control. To evaluate the
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tissue response to the substrates, histology was performed at 3, 10, and 
20 days postsurgery.
A total of 12 beagle dogs (age 2.5-3 years) were used in this study. 
All animals were kept under normal laboratory conditions and were fed 
standard dog chow and water ad libitum. The experiment was approved 
by the Board for Animal Experiments of the University of Nijmegen.
3.2.1 Dermal substrates
Five different dermal substrates were used; unprocessed de-epidermized 
dog dermis (DED), commercially available processed human donor
-5 O
dermis (AlloDerm, LifeCell Corporation), type I collagen substrate 
(kindly provided by Dr A. van Kuppevelt, Department of Biochemistry,
-5 Q
University Medical Center Nijmegen, The Netherlands), a type I 
collagen substrate coated with 3 percent w/w a-elastin hydrolysate 
(kindly donated by Dr E. Middelkoop, Burn Center, Department of 
Surgery, Red Cross Hospital, Beverwijk, The Netherlands),40 and a type I 
collagen substrate with chondroitin-6-sulfate (Integra™, Medeco B.V., 
Oud-Beijerland, The Netherlands).41
DED was produced from full-thickness skin explants, as described 
previously for human skin.42 The explants were obtained from the groin 
of beagle dogs, which is the least hairy region of the animal. Briefly, the 
skin was subjected to at least three freezethaw cycles using liquid 
nitrogen. Subsequently, the skin was placed in phosphate-buffered saline 
solution (PBS) supplemented with 100 U/ml penicillin G and 100 ^g/ml 
streptomycin (Life Technologies, Breda, The Netherlands) at 37 °C for 
two weeks to detach the epithelium. The DED was stored in PBS with 
antibiotics at - 20 °C. Before each experiment, the DED was thawed and 
washed three times in PBS. The silicon sheet covering the type I 
collagen/chondroitin-6-sulfate substrate was removed before the 
experiment. All substrates were washed three times in PBS before every 
experiment.
3.2.2 Surgical procedure
Prior to surgery, the animals were premedicated with 0.5 ml Thalamonal 
(0.05 mg fentanyl +2.5 mg/ml droperidol; Janssen Pharmacuetica,
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Beersen, Belgium) and 0.5 ml atropine i.m. (0.5 mg/ml atropine sulfate). 
Subsequently, they were anesthetized with an intravenous injection of 30 
mg/kg Narcovet (60 mg/ml sodium pentobarbital; Apharmo, Arnhem, 
The Netherlands). After intubation, anesthesia was maintained with 
Ethrane (15 mg/mg enflurane; Abott, Amstelveen, The Netherlands). The 
palatal mucosa was cleaned with Betadine solution (povidoniodine 
Dagra-Pharma, Diemen, The Netherlands). In addition, approximately
2 ml Xylocaine (0.4 mg/ml lidocaine-hydrocloride +0.0125 mg/ml 
epinephrine; Astra Chemicals, Rijswijk, The Netherlands) was injected 
into the palatal mucosa to avoid excessive bleeding during the procedure.
The 12 dogs were randomly assigned to three groups before surgery. 
The three groups of four dogs were evaluated at 3, 10, and 20 days 
postsurgery. In all dogs, four to six standardized full-thickness wounds 
were created on the palate with a 4-mm biopsy punch. The circular soft 
tissue defects were made between the rugae at both sides of the palate. 
One randomly chosen wound served as a control and was left open. A 
second randomly chosen wound was filled with an autologous mucosal 
punch biopsy from one of the other wounds. The other biopsy wounds 
were randomly filled with one of the five experimental dermal substrates. 
To prevent loss of the substrate, every substrate was fixed gently in place 
using two sutures (4-0 Vicryl, Ethicon; Johnson & Johnson Company, 
Amersfoort, The Netherlands). All five substrates, the control wound, and 
the autologous implant were evaluated in triplicate at each time point. All 
animals received a normal diet after surgery.
3.2.3 Histologic procedures
At the time of euthanasia, the animals were brought under general 
anesthesia using 30 mg/kg Narcovet. After several minutes, a lethal dose 
of Narcovet was injected intravenously. The maxillae were dissected and 
immersed in 4 percent paraformaldehyde in 0.1M phosphate buffer at 
room temperature. After fixation, the maxillae were sawn into six smaller 
blocks, each containing a biopsy wound. The tissue blocks were 
decalcified in 20 percent formic acid and 5 percent sodium citrate. 
Decalcification was checked radiographically. Palatal mucosa samples 
taken outside the wounded areas served as normal controls. Next, the
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tissue was dehydrated through a graded series of ethanol solutions and 
embedded in paraffin. Serial paraffin sections of ^ mm were made 
through the entire wound. Each tenth section was mounted onto a 
superfrost (Menzel-Gläser, Braunschweig, Germany) slide and stained 
with hematoxylin & eosin (H&E) for general tissue survey. For further 
histologic analyses, six consecutive sections from the center of each 
wound were taken. Elastin was detected with the Weigert-Van Gieson 
staining and Sirius red staining was used to visualize the collagen 
fibers.43,44 The presence or absence of the substrate in each specimen was 
determined on sections stained with Weigert-Van Gieson. When elastic 
fibers were found in the wound area, we concluded that the substrate was 
present because those fibers are found in all skin-derived substrates and 
the type I collagen substrate coated with three percent w/w a-elastin 
hydrolysate and are not present in control wound tissue. The wound area 
of each specimen was blindly evaluated by one of the authors (RO) for 
the degree of inflammation and epithelial regeneration using H&E stained 
sections and the orientation and amount of elastic fibers (Weigert-Van 
Gieson staining). The scoring system used for degree of inflammation 
and the amount of the elastic fibers was on a scale of 0 (none) to 4 
(abundant). Epithelial regeneration was given a score from 0 to 4 (0 = no 
cell layers; 1 = closed with some cell layers (<10); 2 = closed with many 
cell layers and no rete peg formation; 3 = closed with many cell layers 
and some rete peg formation; 4 = closed with many cell layers and 
normal rete peg formation). A mean value of the three sections of each 
time point was used.
3.2.4 Immunohistochemical procedures
Immunohistochemical analysis was performed on native palatal mucosal 
tissue and the 3, 10, and 20 days postsurgical sections to detect heparan 
sulfate, type III collagen, and a-smooth muscle actin. The paraffin 
sections were collected on Superfrost Plus slides (Menzel-Gläser), 
deparaffinated, and rehydrated again. Before staining, the slides were 
treated with 0.1 percent trypsin 250 (DIFCO Laboratories, Detroit, MI) 
for 10 minutes and rinsed with PBS. Thereafter, the slides were treated
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with with 3 percent H2O2 in PBS for 30 minutes to block endogenous 
peroxidase and rinsed in PBS.
The anti-heparan sulfate JM 403 antibody (mouse antihuman 
heparan sulfate, IgM) was a kind gift of Prof. Dr J. Berden (Department 
of Nephrology, University Medical Center, Nijmegen, The 
Netherlands).45 The sections were preincubated with 5 percent bovine 
serum albumin in PBS buffer (BSA, Sigma-Aldrich, St. Louis, MO). 
After pretreatment, the sections were incubated with mouse anti-heparan 
sulfate IgM for one night at 4 °C. After washing with PBS, the sections 
were incubated with a biotinylated goat anti-mouse antibody 1 : 400 
(Vector Laboratories, Burlingame, CA) for 60 minutes at room 
temperature. After washing with PBS, the sections were treated with 
ABC-peroxidase (Vector Laboratories). Peroxidase activity was 
visualized with a standard diaminobenzidine technique (Sigma-Aldrich). 
The sections were counterstained with Dellafields hematoxylin.
Type III collagen was detected with a rabbit anticollagen III 
antibody (Chemicon, Temecula, CA). The staining method was the same 
as described for heparin sulfate except the secondary antibody was a 
biotinylated goat anti-mouse antibody (Chemicon).
a-smooth muscle actin was detected by a mouse anti-smooth muscle 
actin antibody (1 : 1600) (Sigma-Aldrich). The staining method was the 
same as described for heparan sulfate. Only the secondary antibody was a 
biotinylated donkey anti-mouse antibody (1 : 500; Jackson Laboratories, 
West Grove, PA).
The presence or absence of heparan sulfate in each specimen was 
determined. The scoring system used for the presence of type III collagen 
and a-smooth muscle actin was on a scale of 0 (none) to 4 (abundant). 
Mean values of the three sections of each time point were used. 
Representative sections were photographed on a Leitz DMRD microscope 
(Leica, Wetzlar, Germany).
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3.3 Results
The palatal mucoperiosteum of a beagle dog consists of four layers: the 
epithelium, the lamina propria, the submucosa, and the periosteum 
(Figure 1A). The palatal epithelium contains a basal layer with cubical 
and columnar cells. Superficial to the basal layer, on average 15 layers of 
spherical to flattened cells are present with normal epithelial 
stratification. The parakeratinized layer is composed of flat cells in which 
often pyknotic nuclei are retained. The lamina propria contains a 
relatively loose network of collagen fibers while in the deeper layers 
more densely packed collagen fibers are found. The submucosa contains 
the major arteries, veins, and nerves of the palate. Elastin is found in the 
submucosa and in the walls of the blood vessels of normal palatal 
mucosa. The periostial part of the mucoperiosteum consists of two layers, 
a fibrous layer and a thin layer with some osteoblasts. Only a few fibers 
connect the fibrous layer of the periosteum to the palatal bone.
3.3.1 Histology o f  experimental wounds
At three days postsurgery, a blood clot and many polymorphonuclear 
leukocytes were present in the untreated wounds (Figure 1B). The 
epithelium had already started to proliferate and had migrated from the 
wound edges under the blood clot. None of the untreated wounds was 
closed at this time. The wounds were filled with granulation tissue that 
was rich in fibroblasts, granulocytes, and an extracellular matrix without 
a clear organization. Neither elastin nor collagen fibers were observed in 
the wounds.
The implants could easily be recognized in the wounds filled with an 
autologous implant (not shown). Remaining keratinocytes with large 
vacuoles were present at three days postsurgery. Below the implant, the 
tissue organization was similar to that of the untreated wounds at three 
days. Elastin and collagen staining was clearly observed in the 
autologous mucosal implants. The collagen fibers were thick and 
resembled that of normal palatal mucosa. A noncollagenous tissue was 
surrounding the implant.
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Figure 1 Histology o f normal palatal mucosa and experimental wounds at three days 
postsurgery. (A) Normal palatal mucosa o f a beagle dog, (B) untreated 
wound at three days postsurgery, (C) skin-derived substrate DED at three 
days postsurgery, (D) skin-derived substrate DED at three days postsurgery 
(Sirius RED), (E) skin-derived substrate AlloDerm at three days postsurgery, 
(F) collagen-based substrate Integra at three days postsurgery. All sections 
are H&E stained except i f  noted. S = substrate, e = epithelium, l = lamina 
propria, s = submucosa, p  = periosteum, b = bone and f  is wound margin. 
The bar represents 50 ¡m. (Original magnification 50x).
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The wounds filled with the skin-derived substrates showed 
histologic characteristics different from the autologous ones. DED was 
easily detectable in the wounds (Figure 1C), except for one sample. 
Elastin staining was always present in the DED and thick collagen fibers 
were detected with Sirius Red staining (Figure 1D). A noncollagenous 
tissue surrounded the substrate. In contrast, in all wounds filled with 
AlloDerm, there was no evidence that the substrate was still present in 
the wound area (Figure 1E). This finding was supported by the fact that 
no elastin or collagen was present in the wound area.
The collagen-based substrates were easily recognized in the wounds, 
especially Integra because of its characteristic structure (Figure 1F). The 
inflammatory response and the epithelial regeneration for both 
skinderived substrates and the collagen-based substrates were comparable 
to that of the untreated wounds (Table I).
Table I  Histologic changes in the experimental wounds*
Treatment group-parameter 3
Time (d)
10 20
Untreated wounds
epithelial regeneration 0 1 2
inflammation 3 2 1
elastic fib re s 0 0 0
A utologous m ucosal grafts
epithelial regeneration 0 1 2
inflammation 3 2 1
elastic fib re s 2 1 1
Skin-derived substrate A lloD erm  9
epithelial regeneration 0 1 2
inflammation 3 3 1
elastic fib re s 0 1 0
Skin-derived substrate D E D
epithelial regeneration 0 1 3
inflammation 3 2 1
elastic fib re s 2 1 1
C ollagen-based substrates
epithelial regeneration 0 1 3
inflammation 3 2 1
elastic fib re s 0 0 0
*Epithelial regeneration was given a mean absolute score from  0 to 4 (0=no cell layers;1 =closed with 
some cell layers [< 10]; 2=closed with many cell layers no rete peg formation; 3=closed with many 
cell layers and signs o f  rete peg  formation; 4=closed with many cell layers and rete peg  formation). 
The mean absolute values fo r  inflammation and elastic fibers represent 0=none to 4=abundant.
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Figure 2 Histology o f experimental wounds at 10 and 20 days postsurgery. (A ) 
Untreated wound at 10 days postsurgery, (B) autologous implant at 10 days 
postsurgery, (C) collagen-based substrate Integra at 10 days postsurgery, 
(D) untreated wound at 20 days postsurgery, (E) skin-derived substrate DED 
at 20 days postsurgery (elastin staining), (F) skin-derived substrate DED at 
20 days postsurgery. All sections are H&E except i f  noted. S=substrate and 
I is woundmargin.The bar represents 50 ¡m. (Originalmagnification 50x).
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At 10 days postsurgery, the untreated wounds were covered with up 
to five epithelial cell layers but rete pegs had not yet formed (Figure 2A). 
The wound was completely filled with granulation tissue that was rich in 
fibroblasts, granulocytes, some blood vessels, and thin collagen fibers. 
The inflammatory infiltrate was still present, although it was reduced 
compared to three days postsurgery. The collagen fibers had a mainly 
transverse orientation. Superficial osteoclastic bone resorption was found 
in all samples.
The histologic findings of the autologous implants (Figure 2B) and 
both skin-derived substrates were comparable to the untreated wounds. 
However, the epithelium covering both skin-derived substrates contained 
more cell layers than the untreated wounds and some signs of rete peg 
formation were already visible. The skin-derived substrates AlloDerm 
and DED were difficult to identify in four of the six samples because of 
severe degradation. In the remaining samples, no AlloDerm or DED was 
found within the wound area. These samples also failed to show elastin 
staining which indicates the absence of these substrates. The 
inflammatory response was predominantly chronic in all of the wounds 
except for one of the wounds filled with AlloDerm in which an acute 
inflammatory reaction with many polymorphonuclear leukocytes was still 
visible. Thick collagenous bundles with a random orientation were 
observed in the autologous implants and the DED remaining in the 
wounds. In all wounds, thin collagen fibers with a parallel orientation 
were enclosing the substrates if present. In the wounds filled with the 
autologous mucosal implants and the skinderived substrates, elastin 
staining was present in remaining patches of the substrate.
The collagen-based substrates could still be easily recognized, 
especially Integra, because of its characteristic structure. Thin collagen 
fibers were aligned in transverse direction and seemed to enclose these 
substrates (Figure 2C). The inflammatory infiltrate outside the implant 
was comparable to the untreated wounds although in some samples there 
were signs of a somewhat patchy infiltrate of inflammatory cells within 
the substrate (Table I).
At 20 days postsurgery, the epithelium had become thicker in the 
untreated wounds and a cornified layer had formed, although rete pegs
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had not yet developed (Figure 2D). The inflammatory infiltrate had 
decreased but some inflammatory cells were still present in the wounds 
(Table I). The number of fibroblasts had also decreased. Bone apposition 
was found at some sites where the bone probably has been damaged by 
the biopsy punch.
The tissue organization of the wounds filled with an autologous 
implant was in general comparable to that of the untreated wounds at 20 
days (not shown). However, the epithelium contained more cell layers 
and the thick collagenous bundles of the original implant were still 
present as shown by the elastin staining.
The wounds filled with skin-derived substrate Allo-Derm were 
different than the wounds filled with DED. AlloDerm could not be 
detected in two of the three samples, and in these two samples, there was 
also no elastin staining present within the wound area. In contrast, elastin 
staining was always present in the wounds filled with DED (Figure 2E) 
and the histologic findings were comparable to that of the wounds with 
an autologous implant. However, the epithelium covering the wounds 
filled with DED consisted of more cell layers than the wounds with the 
autologous implants, and more pronounced rete pegs were present 
(Figure 2F). The orientation of the collagenous bundles in the superficial 
layer of the dermis was more random with less transverse thick bundles. 
However, in the deeper layers of the wound, they were oriented in a 
transverse direction with more dense collagenous bundles. These parallel 
collagen fibers were surrounding an area containing collagen fibers with 
a random orientation.
The number of cell layers in the epithelium covering the collagen- 
based substrates was not increased compared to 10 days postsurgery, but 
rete peg formation was visible (not shown). The substrates contained 
many fibroblasts. Collagenous bundles with a transverse orientation had 
become thicker and had enclosed the substrate. There were still no signs 
of substrate degradation, which was comparable to three days postsurgery 
(not shown). In some samples, there was a mild inflammatory infiltrate 
still present at some spots within the substrate (Table I). However, in 
these samples, the inflammatory response outside the substrate was 
comparable to an untreated wound.
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3.3.2 Immunohistochemical findings
Heparan sulfate staining was used to evaluate the formation of a 
basement membrane. Continuous staining for heparan sulfate was always 
observed at the epithelial-dermal border of the normal mucosa and only a 
few patches in the autologous mucosal grafts at three days postsurgery 
(not shown). Although in the end, all wounds were closed with a newly 
formed epithelium and some rete peg formation was also present in the 
wounds filled with the skin-derived DED and collagenbased substrates, 
there was no sign of heparan sulfate in any of the wounds at any time 
point (Figures 3A and Table II). However, continuous staining for 
heparan sulfate was always present in all the samples away from the 
wound areas.
Table II  Immunohistochemical changes in the experimental wounds*
Treatment group-antigen
Time (d)
3 10 20
Untreated wounds
heparan sulphate 0 0 0
collagen type III 0 2 1
a-Smooth muscle actin 0 2 1
Autologous mucosal grafts
heparan sulphate 1 0
collagen type III 0 2 1
a-Smooth muscle actin 0 2 1
Skin-derived substrates
heparan sulphate 0 0
collagen type III 0 2 1
a-Smooth muscle actin 0 2 1
Collagen-based su bstrates
heparan sulphate 0 0
collagen type III 0 3 1
a-Smooth muscle actin 0 2 1
* The value for heparan sulfate represents 0=absent and 1= easily distinguishable. The 
scorings system used for the presence o f type III collagen and a-smooth muscle actin was 
on a scale o f 0 (none) to 4 (abundant).
In the unwounded palatal mucosa, an intensely stained network of 
loose type III collagen fibers was present in the papillary layer of the
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submucosa, and around blood sinuses. The staining in the other regions 
of the submucosa was very weak.
Figure 3 Immunohistochemistry o f experimental wounds at 10 and 20 days 
postsurgery. (A) Heparan sulfate in a wound with DED at 20 days 
postsurgery,(B) type III collagen in an untreated wound at 10 days
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postsurgery,(C) type III collagen in a wound with Integra at 20 days 
postsurgery, (D) a-smooth muscle actin in an untreated wound at 10 days 
postsurgery,(E) a-smooth muscle actin in a wound with DED at 20 days 
postsurgery,(F) a-smooth muscle actin in a wound with Integra at 20 days 
postsurgery. S=substrate and fis wound margin. The bar represents 50 ¡m. 
(Original magnification 50x).
Type III collagen was not present in any of the wounds at three days 
postsurgery. At 10 days postsurgery, all groups showed type III collagen 
staining which was more intense closer to the epithelium than deeper in 
the wounds (Figure 3B). The wounds filled with the collagen-based 
substrates also showed collagen III staining within the substrate and in 
the deeper layers of the submucosa between the substrate and the bone. 
Twenty days after surgery, the intensity o f the type III collagen staining 
was reduced in all wounds. In the center of the collagen-based substrates, 
staining for type III collagen was also reduced compared to 10 days 
postsurgery (Figure 3C).
a-smooth muscle actin staining was used to detect myofibroblasts. 
In normal unwounded palatal mucosa, a-smooth muscle actin staining 
was only found around the blood vessels.
In none of the wounds a-smooth muscle actin staining was found at 
three days postsurgery (not shown). Positive cells were found in all 
wounds at day 10 in considerable numbers (Figures 3D and Table II). In 
general, there were more a-smooth muscle actin positive cells directly 
below the epithelium than in the deeper layers of the submucosa. There 
was a less intense staining in the wounds with the skin-derived substrates 
compared to the open wounds. Within the collagen-based substrates, the 
staining was more intense in the deeper layer of the substrate and in the 
area between the substrate and the bone compared to all other wounds 
(not shown). The a-smooth muscle actin staining in some samples was 
locally more intense. However, the general distribution of positive cells 
was equal to the other wounds (Table II).
At day 20, the amount of a-smooth muscle actin positive fibroblasts 
in all wounds had decreased compared to 10 days postsurgery (Table II). 
However, some positive cells were still present in the granulation tissue. 
In the wounds with an autologous implant or filled with DED, some spots
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with an intense staining for a-smooth muscle actin were found. This area 
was surrounded with a layer of parallel collagen fibers without any a -  
smooth muscle actin positive fibroblasts (Figure 3E). Within the 
collagen-based substrates, myofibroblasts had disappeared at 20 days, but 
in a few samples, some positive cells were still present around the 
substrate (Figure 3F).
3.4 Discussion
The overall aim of our research is to develop a cultured mucosal 
substitute for implantation on the palate after cleft palate surgery. The 
implantation of some graft material into an open wound might reduce 
wound contraction and scarring.34 The aim of this specific study was to 
investigate the in vivo behavior of several dermal substrates after 
implantation in open palatal wounds in the beagle dog. Subsequently, in a 
follow-up study, the most promising dermal substrate will be used for 
keratinocyte culture and implantation in experimental wounds on the 
palate of beagle dogs.
In the histologic evaluation, the general tissue response of the palatal 
mucosa was studied and more specifically the substrate degradation, 
inflammation, epithelial regeneration, basement membrane formation, 
and collagen orientation.
The present study has shown that most of the substrates were hard to 
detect in the specimens, except for the collagen-based substrate Integra 
because of its characteristic structure. We used elastin staining as an aid 
to identify the substrates in the wound areas. The samples with an 
autologous implant or DED always showed the presence of elastic fibers. 
Because elastic fibers are not present in control wound tissue, we 
concluded that both substrates were still present in the wounds. On the 
other hand, none of the samples with the collagen-based substrates and 
only few with AlloDerm showed elastin fibers. Stricklin and Nanney46 
reported that in the early stages of wound healing degradative processes
47within the wound bed take place. Lamme et al. also showed that elastic 
fibers remained undetectable up to three weeks after implantation,
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although they implanted a collagen type I substrate coated with elastin. 
Therefore, it might be possible that the elastin present in those substrates 
was rapidly degraded after implantation. Another possibility might be 
that the collagen-based substrates and AlloDerm were sequestrated by the 
epithelium that grew under it.
All substrates showed severe degradation starting 10 days 
postsurgery except for Integra that did not show any signs of degradation 
up to 20 days postsurgery. Kremer et al.41 also reported that Integra 
grafted in an athymic mouse showed only fibroblast and endothelial cell 
ingrowth without any signs of substrate degradation up to 15 days 
postsurgery. At eight weeks postsurgery, they found that the Integra was 
completely replaced by native connective tissue. These findings indicate 
that Integra might have been replaced if a longer follow-up period was 
included in our study.
The present study has further shown that all substrates were well 
tolerated by the oral mucosa except for AlloDerm. Others48,49 have shown 
that the rejection of such a dermal substrate is due to a specific immune 
response to its cellular components. As AlloDerm is supposed to be cell- 
free, it is unlikely that the low survival of the AlloDerm is due to a 
specific immune response. The findings of our study are not in agreement 
with those of Owens and Yukna50 who also implanted AlloDerm in the 
palate of beagle dogs. They showed a slight to moderate degradation of 
the substrate without signs of inflammation at one month after 
implantation, and a severe to complete degradation of the substrate at 
four months after surgery. However, they used AlloDerm as a 
subcutaneous implant, and not, like in our study, in an open wound. It 
would be reasonable to assume that the tissue reaction to the substrate is 
different when there is a mucosal coverage. Turnbull and Stross51 
reported that their porcine skin-derived substrate showed no 
incorporation or vascularization after implantation in an open wound in 
the hamster cheek pouch within 28 days postsurgery. Although the 
animal model and the implantation site are different from ours, their 
findings support ours. This could be explained by the use of open wounds 
and subsequent wound healing by secondary intention in both models. In
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general, it might be concluded that all substrates were well tolerated by 
the oral mucosa, but it seems that AlloDerm is not incorporated well.
In none of the wounds with DED or the collagen-based substrates 
heparan sulfate was detected, although these samples exhibited the most 
complete epithelial regeneration. Heparan sulfate remained undetectable 
during the entire experimental period, which indicates that in spite of an 
intact epithelium, the basement membrane was not yet completely 
restored. Andriessen et al., using the same antibody, reported that in 
wounded human skin, heparan sulfate was absent for up to two weeks. 
They speculated that in that time range the expression of this specific 
epitope was still below the detection level in paraffinembedded tissue.
The untreated wounds in our study showed parallel collagen fibers 
and considerable numbers of myofibroblasts at 10 days postsurgery, 
which is in agreement with others. It has been shown that the collagen 
fibers in a healing wound tend to run in the direction of the contraction 
forces.53 Squier and Kremenak4 have shown that myofibroblasts are 
present in healing palatal wounds of the beagle dog from 7 days 
postsurgery, and are most numerous between 10 and 15 days. The 
wounds filled with a skin-derived substrate showed less myofibroblasts 
than an untreated wound at 10 days postsurgery. Furthermore, the 
collagen fibers in the wounds with DED no longer contained 
myofibroblasts at 20 days postsurgery. Also in the collagen fibers 
surrounding the collagen-based substrates, myofibroblasts were not 
encountered. Myofibroblasts had disappeared within these substrates 
from 20 days postsurgery. Hence, it seems clear that the collagen-based 
substrates showed fewer myofibroblasts than the untreated wounds. 
These findings indicate that both the skin-derived and the collagen-based 
substrates induce less wound contraction than occurs in an untreated 
wound.
Our results show that palatal wounds with an implant heal with 
fewer indications of scar tissue formation and evoke only a mild 
inflammatory reaction, which is preferred over the tissue reaction in an 
untreated wound. The collagen fibers in the immature scar tissue are 
more randomly oriented than in an untreated wound. The wounds filled 
with a skin-derived substrate, DED, or collagen-based substrates showed
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the best epithelial regeneration. In general, the wounds treated with these 
substrates showed less myofibroblasts compared to the untreated wounds. 
It is not completely clear whether the skin-derived substrate AlloDerm 
was rapidly degraded or that it was sequestrated by the epithelium that 
grew under it. Based on the findings of this study, all substrates will be 
used for further studies on keratinocyte culture. Subsequently, the 
keratinocyte-seeded substrate with the best histologic characteristics will 
be implanted in experimental wounds on the palate of beagle dog. This 
may ultimately lead to the improvement of cleft palate surgery in 
humans.
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Implantation o f tissue-engineered mucosal substitutes in the dog palate
Summary
Introduction: Tissue shortage complicates the surgery of cleft palate 
anomalies. The healing of defects on the palate impairs growth of the 
dento-maxillary complex due to scar tissue formation. Implantation of 
grafts into the wound area might reduce this adverse effect of surgery. 
The aim of this study was to evaluate a cultured autologous mucosal 
substitute, which can be used as such a graft material.
Methods: Two different types of cultured mucosal substitutes 
composed of skin-derived substrates (unprocessed dermis and 
AlloDerm®) and autologous oral keratinocytes were implanted in palatal 
wounds in six beagle dogs (1-1.5 years of age). The cultured substitutes 
were compared with a sham and a control group. The animals were 
sacrificed in pairs 1, 3, and 12 weeks after surgery. Epithelial 
regeneration, inflammatory response (leucocyte protein L1), ingrowth of 
(myo-)fibroblasts, collagen type III, and formation of a basal membrane 
(JM 403) were evaluated.
Results: The results demonstrated that all cultured substitutes 
possessed a multilayered epithelium, closely resembling normal palatal 
epithelium. After implantation however, the epithelium was lost and an 
inflammatory response was observed in the first week. After 3 and 12 
weeks, the implanted substitutes had completely disappeared and 
epithelial migration occurred from the wound margins.
Conclusion: It is possible to culture an autologous epithelium on a 
skin-derived substrate, and implant it as an oral mucosal substitute in 
palatal wounds. However, these substitutes do not improve the healing of 
palatal wounds. It is suggested that the revascularisation of the wound 
area is too slow to allow survival and integration of the substitutes.
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4.1 Introduction
Oral mucosal defects in the lateral areas of the palate are often an 
inevitable consequence of cleft palate (CP) surgery. These wounds heal 
by secondary intention involving wound contraction and scarring. 
Extensive scar tissue is formed that is firmly anchored to the palatal 
bone. Although CP surgery has advanced, the scar tissue is still a major
factor in the impairment of maxillary growth and development of the
1 ^dentition in CP patients. -
Animal studies have shown that manipulation of the 
mucoperiosteum leads to dento-alveolar growth inhibition.4 The collagen 
fibres of the scar tissue were orientated in a transverse direction and were 
attached to the underlying bone by Sharpey’s fibres. It was suggested that 
prevention of scar tissue attachment to the palatal bone might lead to a 
more favourable maxillary growth.5 In beagle dogs, wound contraction 
occurred during the first weeks after wounding, and was associated with 
the appearance of myofibroblasts which are involved in wound
c n
contraction. - These cells contribute to collagen accumulation and 
therefore to scar tissue formation. In the later phases of wound healing, 
the myofibroblasts disappear, presumably through apoptosis, and wound 
contraction ceases. The wound tissue is then slowly remodelled into a 
mature scar. Therefore, reducing the number of myofibroblasts during 
wound healing, and prevention of the tissue attachment to the palatal 
bone after cleft closure might decrease impairment of maxillary growth 
and development of the dentition.
Studies in a full-thickness skin wound in animal models on the of
o
use grafts show a reduction in the number of myofibroblasts, which may 
result in decreased wound contraction and scar tissue formation. For the 
reconstruction of small defects in the oral cavity the use of palatal or 
buccal mucosal autografts has been described,9 but for larger oral defects, 
it is impossible to obtain sufficient mucosa.10 Autologous skin grafts have 
also been employed in animal and human studies, but they seem to
11 19maintain their original characteristics such as hair growth. , 
Furthermore, autologous grafts are associated with donor site morbidity.
84
Implantation o f tissue-engineered mucosal substitutes in the dog palate
In vitro culture techniques have been used to increase the
1 ^availability of oral keratinocytes. However, grafts composed of only 
cultured keratinocytes are fragile, difficult to handle, and when grafted on 
a full-thickness intra-oral wound, undesirable wound contraction still
14occurs.
Two types of dermal substrates, collagen-based and skin-derived 
materials, have been used for intra-oral grafting. The collagen-based 
substrates generally consist of a type I collagen matrix, sometimes 
supplemented with other extracellular matrix components such as elastin,
i c  i  n
or glycosaminoglycans. - The skin-derived substrates consist of
glycerol-preserved cadaveric skin, or skin that is processed to remove
1 8cellular components. The latter technique leads to a relatively 
immunologically inert allograft. Skin-derived substrates, such as 
AlloDerm®, have been used for intra-oral applications.19,20 These dermal 
substrates diminish the impairment of maxillary growth if applied to the 
denuded bone surfaces following CP repair.
Full-thickness grafts composed of cultured keratinocytes and a 
dermal component grafted in skin defects showed faster re
91 9^epithelialisation, less wound contraction, and less scar tissue. - Both 
the cultured epithelium and the dermal substrate seems to contribute to
9zlthese effects. However, the intra-oral implantation of a full-thickness 
substitute in an open wound has not yet been investigated. Therefore, the 
overall aim of the present study is to develop a full-thickness substitute 
composed of a dermal substrate and oral keratinocytes for CP repair, in 
order, to minimize contraction and subsequent scarring.
Recently, it has been shown that substitutes composed of oral 
keratinocytes cultured on skin-derived dermal substrates possess 
histological and immunohistochemical characteristics close to normal
9 Soral mucosa. In the present study, two types of skin-derived substitutes 
were implanted in full-thickness wounds in the palatal mucosa of dogs. 
Histology and immunohistochemistry were performed to evaluate the 
tissue response and the wound healing process at 1 (inflammatory phase), 
3 (granulation tissue and contraction phase), and 12 (remodelling phase) 
weeks post-surgery. Inflammatory response, ingrowth of fibroblasts, re- 
epithelialisation, and the formation of a basal membrane were evaluated.
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4.2 M aterial and methods
4.2.1 Animals
Six beagle dogs (1-1.5 years of age) were used. All animals were kept 
under normal laboratory conditions and were fed standard dog chow and 
water ad libitum. The experiment was approved by the Board for Animal 
Experiments of the University of Nijmegen, The Netherlands.
4.2.2 Primary keratinocyte cultures
Dog oral keratinocytes were cultured as described previously. In short, 
3 mm biopsies from the palatal mucosa were obtained from each beagle 
dog. The biopsies were incubated in 0.25 percent trypsin solution (Gibco, 
Grand Island, New York, USA) to detach the epithelium. A single-cell 
suspension was seeded onto a pre-plated feeder layer of lethally 
irradiated 3T3 fibroblasts in keratinocyte medium. When the cultures 
were nearly confluent, the keratinocytes were harvested and stored in 
liquid nitrogen in keratinocyte medium with 10 percent dimethyl 
sulphoxide until use. Before every experiment, the cryopreserved 
autologous cells were quickly thawed at 37°C under gentle agitation. For 
culture of the substitutes, third-passage cells were used. Mycoplasma 
contamination is one of the main problems in cell cultures in biological 
and medical research, because mycoplasma can alter nearly all 
parameters and products of the cell, therefore, all cultures were checked 
for mycoplasma contamination using a mycoplasma kit (Gen probe, 
Biomérieux Inc. St Louis, Missouri, USA).
4.2.3 Dermal substrates
Two different skin-derived dermal substrates were used; unprocessed de- 
epidermised dog dermis (DED), and commercially available processed 
human donor dermis (AlloDerm®, LifeCell Corporation, Branchburg, 
New York, USA).19
DED was produced from full-thickness skin explants, as described 
previously for human skin.26 The explants were obtained from the groin 
of beagle dogs, which is the least hairy region of the animal. Briefly, the 
skin was subjected to at least three freeze-thaw cycles using liquid
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nitrogen. Subsequently, the skin was placed in phosphate-buffered saline 
(PBS) supplemented with 100 U/ml penicillin G and 100 ^g/ml 
streptomycin (Life Technologies, Breda, The Netherlands) at 37°C for 
two weeks to detach the epithelium. The DED was stored in PBS with 
antibiotics at - 20°C until use. Before the experiment, the DED was 
thawed and both skin-derived substrates were washed three times in PBS 
before use.
4.2.4 Composite cultures
The skin-derived substrates (DED and AlloDerm®), were placed on 
stainless steel grids in keratinocyte medium. Subsequently, 
approximately 2x105 third-passage autologous keratinocytes were seeded 
on these substrates within a stainlesssteel ring with an inner diameter of 
10 mm that was placed on the substrate. The cells were cultured 
submerged in keratinocyte medium for three days and then air-exposed 
for another 11 days. Before implantation, a small punch sample from the 
cultures was taken for histological evaluation.
4.2.5 Implantation
The six dogs were randomly assigned to three groups, for evaluation, at 
1, 3, and 12 weeks post-surgery. In each dog, four standardized full­
thickness wounds were created in the medial region of the hard palate 
down to the palatal bone with a 6-mm biopsy punch (Stiefel 
Laboratorium, Offenbach am Main, Germany).
Prior to surgery, the animals were premedicated with 0.5 ml 
Thalamonal® (0.05 mg fentanyl + 2.5 mg/ml droperidol; Janssen 
pharmacuetica, Beerse, Belgium) and 0.5 ml atropine i.m. (0.5 mg/ml 
atropine sulphate). Subsequently, they were anaesthetized with an intra­
venous injection of 30 mg/kg Narcovet® (60 mg/ml sodium pentobarbital; 
Apharmo, Arnhem, The Netherlands). After intubation, anaesthesia was 
maintained with Ethrane® (15 mg/mg enflurane; Abott, Amstelveen, The 
Netherlands). The palatal mucosa was cleaned with Betadine® solution 
(povidoniodine; Dagra-Pharma, Diemen, The Netherlands). In addition, 
approximately 1.5 ml Xylocaine® (0.4 mg/ml lidocaine-hydrocloride + 
0.0125 mg/ml adrenaline; Astra Chemicals, Rijswijk, The Netherlands)
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was injected into the palatal mucosa to avoid excessive bleeding during 
the procedure.
The circular -  non critical size - soft tissue defects were made 
distally to the canines, and they were randomly assigned to one of the 
following treatments: 1: left open (control), 2: filled with an autologous 
mucosal punch biopsy from one of the other wounds (sham), 3: filled 
with DED-based culture, 4: filled with Alloderm-based culture. Every 
implant was fixed gently in place using four stitches (4-0 Vicryl, Ethicon; 
Johnson & Johnson Company, Amersfoort, The Netherlands). A pressure 
dressing was not used, because these materials have been shown to 
induce persisting inflammation and cytotoxic effects, which may result in 
a delay in wound healing.27,28
After surgery, the animals were medicated with 1.5 ml of Albipen®
15 percent (ampicillin anhydrate 150 mg/ml; Mycofarm, de Bilt, The 
Netherlands). All animals received a normal diet after surgery.
4.2.6 Histology
At the time of sacrifice, the animals were brought under general 
anaesthesia using 30 mg/kg Narcovet®. After some minutes, a lethal dose 
of Narcovet® was injected intravenously. A small mucosal biopsy (0  4 
mm) was taken from the margin of each wound. These biopsies, 
containing tissue from the experimental wound and some normal palatal 
mucosa, were fixed for 4 hours in 4 percent paraformaldehyde in 0.1 M 
phosphate buffer at room temperature and embedded in paraffin. The 
samples were used for immunohistochemical staining (see below).
Subsequently, the maxillae were dissected and immersed in 4 
percent paraformaldehyde in 0.1 M phosphate buffer at room 
temperature. After fixation, all biopsy wounds were dissected separately. 
After decalcification, in 20 percent formic acid and 5 percent sodium 
citrate, the tissues were dehydrated through a graded series of ethanol and 
embedded in paraffin. Serial sections of 7 ^m were made through the 
entire wound. Each tenth section was mounted onto a superfrost (Menzel­
Gläser, Braunschweig, Germany) slide and stained with haematoxylin 
and eosin (H&E) for a general tissue survey. For further histological 
analyses, selected sections from the centre of each wound were taken.
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Sirius red staining was used to visualize the collagen fibres, and elastin 
was detected with the Weigert-Van Gieson staining the presence of the 
substrate.29,30 The sections were blindly evaluated by one of the authors 
(RO) for the degree of inflammation (H&E), epithelial regeneration 
(H&E), and the orientation and amount of elastic fibres (Weigert-Van 
Gieson staining). The variables were scored on a scale from 0 (none) to 4 
(abundant). The re-epithelialisation was given a score from 0 to 4 [0=still 
open; 1=closed with a few cell layers (<10); 2=closed with many cell 
layers and no rete pegs; 3=closed with many cell layers and some rete 
pegs; 4=closed with many cell layers and normal rete pegs]. For each 
staining, twelve sections from the centre of each wound were evaluated, 
the median score of these sections for each characteristic was used.
4.2.7 Immunohistochemistry
Paraffin sections of the 4-^m mucosal biopsies were collected on 
Superfrost Plus slides (Menzel-Gläser; Braunschweig, Germany), 
deparaffinated and rehydrated again. Before staining, the slides were 
treated with 0.1 percent trypsin (DIFCO laboratories, Detroit, USA) for 
10 minutes and rinsed with PBS. Thereafter, the slides were treated with 
3 percent H2O2 in PBS for 30 minutes to block endogenous peroxidase 
and rinsed in PBS. All sections were pre-incubated with 5 percent PBSA 
(5 percent Bovine Serum Albumin (BSA, Sigma Chemical Co, St. Louis, 
Missouri, USA) in PBS buffer).
Heparan sulphate. After pre-treatment, the sections were incubated 
with mouse anti-heparan sulphate IgM over night at 4°C. After washing 
with PBS, the sections were incubated with a biotinylated goat anti­
mouse antibody 1:400 (Vector Laboratories, Burlingame, California, 
USA) for 60 minutes at room temperature. After treatment with first and 
second antibodies, all sections were washed with PBS and trated with 
ABC-peroxidase (Vector Laboratories). Peroxidase activity was 
visualised with a standard DAB technique (Sigma). The sections were 
counterstained with Dellafields haematoxylin.
Collagen type III was detected with a rabbit anti-collagen III 
antibody (Chemicon, Temecula, California, USA), and biotinylated goat 
anti-rabbit antibody was used as a secondary antibody(Chemicon).
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a-Smooth muscle actin was detected by a mouse anti-smooth muscle 
actin antibody (1:1600) (Sigma Chemical Co). The staining method was 
the same as described for heparan sulphate, and the secondary antibody 
was biotinylated donkey anti-mouse antibody (1:500) (Jackson Immuno 
Research Laboratories, West Grove, Pennsylvania, USA).
Leucocyte protein L1 was detected with a mouse anti-L1 
macrophage antibody (1:800) (Abcam Limited, Cambridge, UK) with 
biotinylated donkey anti-mouse antibody as secondary antibody (1:500) 
(Jackson Labs).
The scorings system used for the presence of heparan sulphate, 
collagen type III, a-smooth muscle actin, and leucocyte protein L1 was 
on a scale of zero (none) to four (abundant). The general results are 
specified in Table I. Representative sections were photographed on a 
Leitz DMRD Microscope (Leica, Wetzlar, Germany).
Table I  Semiquantative analyses o f the experimental wounds.
control sham DED AlloDerm® control sham DED AlloDerm®
Weeks post-surgery Degree of inflammation Collagen type III
1 1 2 2 2 1 1 1 1
3 1 1 2 1 1 1 2 1
12 0 0 0 0 3 2 2 2
a-sm ooth  muscle actin Leucocyte protein L1
1 4 3 4 4 3 4 4 4
3 2 3 2 3 2 1 2 1
12 1 1 2 1 0 0 0 0
For each group the median is shown after 1, 3, and 12 weeks post surgery. The scoring 
system used for degree o f inflammation, presence o f collagen type III, a-smooth muscle 
actin, and leucocyte protein L1, was on a scale from 0 (none) to 4 (abundant).
4.3 Results
4.3.1 Histology
Normal palatal mucosa
The palatal mucoperiosteum of a beagle dog consists of four layers: 
epithelium, lamina propria, submucosa, and periosteum. The first three 
layers are shown in Figure 1A. The palatal epithelium contains a basal
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layer with cuboidal and columnar cells. Superficial to the basal layer, 
about 15 layers of spherical to flattened cells are present with normal 
epithelial stratification. The parakeratinized layer is composed of flat 
cells in which often pyknotic nuclei are visible. The lamina propria 
contains a relatively loose network of collagen fibres while in the deeper 
mucosa more densely packed collagen fibres are found. The submucosa 
contains the major arteries, veins, and nerves of the palate. Elastin is 
found in the submucosa and in the walls of the blood vessels of normal 
palatal mucosa. The mucoperiosteum is attached to the palatal bone by a 
thin periosteal layer mainly contained some osteoblasts. Only a few 
collagen fibres connect the fibrous layer of the periosteum to the palatal 
bone.
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Figure 1 Histology o f normal palatal mucosa and the cultured substitute.
A; Normal palatal mucosa o f a beagle dog (Haematoxylin and Eosin), 
B; Substitute containing oral keratinocytes on top o f de-epidermised dog 
dermis (DED) cultured for 14 days (H&E). Su=substrate, e=epithelium, 
s=submucosa. The bar represents 50 /um.
Cultured mucosal substitutes in vitro
Oral keratinocytes cultured on both DED and AlloDerm® formed a 
parakeratinized epithelium, which was approximately 10 cell-layers thick 
(Figure 1B). The epithelium contained a basal cell layer with cuboidal 
cells, some intermediate layers with vacuoles within the flattened cells, 
and a thick cornified layer of the parakeratinized type. The epithelium is 
filling up the voids left by hair follicles. All these cultures resembled 
normal palatal epithelium of the beagle dog.
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4.3.2 Experimental wounds
1 week after implantation
At 1 week post-surgery, a fibrin clot and many polymorphonuclear 
leucocytes were present in the untreated wounds (Figure 2A). The 
epithelium had started to proliferate and keratinocytes had migrated from 
the wound edges under part of the clot. The wounds were partly filled 
with granulation tissue. This tissue was rich in fibroblasts, polymorphs, 
and an extracellular matrix without a clear organization. Neither elastin 
nor collagen fibres were observed in the wounds. Superficial osteoclastic 
bone resorption was found on the palatal bone. The semiquantitiative 
analyses are summarized in Table I.
The autologous biopsies could still be recognized in the pertinent 
wounds (Figure 2B). The dermal part of these biopsies were severely 
degraded, although elastin and collagen were clearly present, as patches 
in the outer part of the implant (not shown). The collagen fibres of the 
grafts were thick and resembled that of normal mucoperiosteum. On top 
of the implant, tissue, rich in fibroblasts and granulocytes, was present, 
but no keratinocytes were found. The epithelium of the wound margins 
had started to proliferate and to migrate between the implant and the clot. 
Underneath the implant, the tissue organization was similar to that of the 
untreated wounds at 1 week post-surgery.
The wounds filled with both types of mucosal substitutes showed 
similar histological characteristics as the wounds filled with an 
autologous biopsy (Figure 2C). The cultured keratinocytes on top of the 
substrates were lost from all samples. The dermal part of the substitutes 
showed severe degradation. However, remnants of the substrate were 
always present in the superficial layer of the granulation tissue as shown 
by the presence of elastin (Figure 2D). In addition, thick, mature collagen 
fibres of the substrate were still detected with the Sirius Red staining (not 
shown). Below this superficial layer, tissue was present with many 
fibroblasts, granulocytes, and an extracellular matrix with no clear 
organization. Neither elastin nor collagen fibres were found in this tissue. 
As in the untreated wounds, the epithelium had started to proliferate and
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had migrated from the wound edges under the superficial layer with the 
remnants of the implant.
Figure 2 Histology o f experimental wounds at 1, 3 and 12 weeks post-surgery.
A; Untreated wound at 1 week post-surgery (Haematoxylin and Eosin), B; 
Autologous implant at 1 week post-surgery (H&E), C; Cultured oral 
substitute (AlloDerm®) at 1 week post-surgery (H&E), D; Cultured oral 
substitute (AlloDerm®) at 1 week post-surgery (Elastin staining and elastin 
is stained black), E. Cultured oral substitute (de-epidermised dog dermis) at 
3 weeks post-surgery (H&E), F; Cultured oral substitute (AlloDerm®) at 12 
weeks post-surgery (H&E). The arrow (Î) indicates the wound margin; the 
wound is left o f this arrow. The bar represents 50 ¡j.m.
93
Chapter 4
3 weeks after implantation
At 3 weeks post-surgery, the untreated wounds had closed with an 
epithelium composed of up to nine cell layers with a parakeratinized 
superficial layer (not shown). Rete pegs had not yet developed. The thin 
collagen fibres in the newly formed lamina propria had a mainly 
transverse orientation and between these fibres, some inflammatory cells 
and many regenerating blood vessels were seen. Bone apposition was 
found at sites where the bone probably had been damaged by the biopsy 
punch (not shown). The semiquantitiative analyses are summarized in 
Table I.
The tissue organisation of the wounds filled with an autologous 
biopsy was comparable to that of the untreated wounds at 3 weeks. 
Furthermore, no elastin was found within the wound area. The wounds 
with the mucosal substitutes (Figure 2E) also showed the same 
histological characteristics as the untreated wounds. The substitutes could 
not be identified in any of the samples, as confirmed by a negative elastin 
staining. Between the thin parallel-orientated collagen fibres, some 
inflammatory cells were still present.
12 weeks after implantation
At 12 weeks, the histological findings for all wounds were similar 
(Figure 2F and Table I). The epithelium had become thicker, although it 
had not regained its original thickness, and rete pegs were present. The 
connective tissue showed thinner collagen fibres than the tissue outside 
the wound area. The collagen fibres in the wound area were clearly 
aligned and elastin was absent. Inflammatory cells were no longer found 
in any of the samples. The periosteal layer in the wound area seemed to 
be thicker than outside this area. Collagen fibres were penetrating into the 
newly deposited bone at the palate as Sharpey’s fibres, thus creating an 
attachment of the wound tissue to the lamellar palatal bone (not shown).
4.3.3 Immunohistochemistry
Cultured mucosal substitutes in vitro
Collagen type III was observed throughout the dermal part of the cultures 
and a continuous staining for heparan sulphate was present at the
94
Implantation o f tissue-engineered mucosal substitutes in the dog palate
epithelial-dermal borde r. a-Smooth muscle actin, was not detected in the 
cultures. Leucocyte protein L1 was not expressed in the dermis, but the 
outer layers of the epithelium were always positive (not shown).
4.3.4 Experimental wounds
Heparan sulphate
Heparan sulphate staining was used to evaluate the presence of a basal 
membrane and angiogenesis in the wounds. Continuous staining for 
heparan sulphate was always observed at the epithelial-dermal border of 
the normal mucosa. Within the wounds, heparan sulphate staining of the 
basal membrane was not observed until 12 weeks post-surgery (Figure 
3A). Heparan sulphate positive regenerating blood vessels were observed 
in all wounds from 3 weeks post-surgery on.
Collagen type III
In normal palatal mucosa, an intensely stained network of loose collagen 
type III fibres was present in the lamina propria, and around blood 
sinuses. Staining in the other regions of the submucosa was very weak. 
At one week post-surgery, all experimental wounds showed collagen type 
III staining which was more intense close to the surface than deeper in 
the wounds (Figure 3B). At 3-weeks post-surgery, the intensity of the 
staining in the wound area had decreased and there were no differences 
between the experimental groups (Table I). At 12 weeks post-surgery, the 
staining in the lamina propria and the periosteum in the wound area was 
close to normal, although, the amount of collagen type III in the 
submucosa was still higher than in the normal tissue.
a-Smooth muscle actin
The a-smooth muscle actin staining was used to detect myofibroblasts. In 
normal unwounded palatal mucosa, a-smooth muscle actin was almost 
exclusively found around blood vessels. Myofibroblasts were found in 
considerable numbers in all wounds 1-week post-surgery (Figure 3C). In 
general, there were more myofibroblasts in the deeper layers of the 
submucosa than just below the epithelium. In some samples, the 
myofibroblasts showed a focal clustering. At 3 weeks post-surgery, the 
number of myofibroblasts had decreased in all wounds (Table I), and at 
12 weeks post-surgery, the staining for a-smooth muscle actin was 
comparable with that of normal tissue (Figure 3D).
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Figure 3 Immunohistochemistry o f experimental wounds at 1, 3, and 12 weeks post­
surgery. A; Heparan sulphate in a wound with a cultured oral substitute 
(AlloDerm®) at 12 weeks post-surgery, B; Collagen type III in a wound with 
an autologous implant at 1 week post-surgery, C; a-Smooth muscle actin in 
an untreated wound at 1 week post-surgery, D; a-Smooth muscle actin in an 
untreated wound at 12 weeks post-surgery, E; Leucocyte protein L1 in a 
wound with a cultured oral substitute (de-epidermised dog dermis) at 1 week 
post-surgery, F; Leucocyte protein L1 in a wound with a cultured oral 
substitute (AlloDerm®) at 12 weeks post-surgery. The specific proteins are 
stained brown and indicated by arrowheads (V), the arrow (Î) indicates the 
wound margin; the wound is left o f this arrow. The bar represents 50 ¡j.m.
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Leucocyte protein L1
Leucocyte protein L1 staining was used to detect neutrophils, monocytes,
-5 1
and macrophages, and is also known to stain mucosal epithelium. In 
normal palatal mucosa, L1 was hardly expressed in the dermis. At 1 week 
post-surgery, L1 positive cells were found in considerable numbers in all 
wounds (Figure 3E). At 3 weeks post-surgery, only a few L1 positive 
cells remained in the wounds, and at 12 weeks post-surgery, L1 positive 
cells were not detected in any of the samples within the wounds (Figure 
3F and Table I).
4.4 Discussion
The overall aim of this research is to develop an implantable 
mucosal substitute for CP surgery. The use of an autologous skin graft in 
a surgically created palatal defect by Jonsson and Hallmans showed a 
positive effect. Therefore, the implantation of a cultured substitute 
might reduce wound contraction and scar tissue formation and prevent 
the inhibition of maxillary growth after palatal surgery. The aim of this 
specific study was to investigate the in vivo behaviour of oral mucosal 
substitutes composed of autologous oral keratinocytes cultured on two 
types of skin-derived substrates after implantation in open palatal wounds 
in the beagle dog.
The cultured mucosal substitutes showed histological and 
immunohistochemical characteristics close to normal oral epithelium, 
which was also found in a previous study.25 Therefore, it was 
hypothesized that such substitute may prevent the iatrogenic effects of 
CP repair.
The current study showed, however, that the keratinocytes of the 
implants disappeared within the first week after implantation. Moreover, 
also the epithelium of the autologous biopsy had disappeared at that time. 
Others have reported the clinical survival and even the outgrowth of 
keratinocytes from a sheet.14,33 However, in these studies epithelialisation 
was only examined macroscopically and not histologically. Thus, it is 
difficult to determine whether the epithelium originates from the sheet or 
has proliferated and migrated from the wound margins. In the present 
study, epithelium from the wound margins had started to proliferate and
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migrate at 1-week post-surgery, when the epithelium was lost already 
from the implant.
The observed loss of epithelium is in agreement with previous 
reports on the healing of free gingival grafts placed on periosteum.34,35 
These studies also showed loss of the epithelium and degeneration of the 
graft. When the free gingival grafts were placed directly on bone, 
epithelial coverage was only restored after 14 days by outgrowth from the 
wound margins, which is in agreement with the present study. It has been 
speculated that graft degeneration and delayed epithelialisation is caused 
by the slow revascularisation of the dermal component.36,37 The 
substitutes used in the present study were composed of keratinocytes and 
a cell-free dermal component. They were implanted directly on the 
palatal bone, and therefore, nutrient supply is only possible by diffusion 
from the lateral wound margins until neo-angiogenesis has taken place. 
This process might be stimulated by vascular endothelial growth factor 
(VEGF) and basic fibroblast growth factor (bFGF).38,39
In the present study, all substrates induced an inflammatory response 
and all matrices were quickly degraded or sequestrated. In addition, 
Turnbull et al.40 reported that their porcine skin-derived substrate showed 
no incorporation or vascularisation after implantation in an open wound 
in the hamster cheek pouch. These findings suggest that all substrates 
showed significant degeneration and epithelial migration underneath the 
material if applied in open wounds. Owens et al.,41 however, implanted 
AlloDerm® in the submucosal layer of the palate of beagle dogs. In that 
situation, only a slight degradation of the substrate without signs of 
inflammation was found one month after implantation. This indicates that 
mucosal coverage might be essential for the nutrient supply of the 
implant material and to prevent contamination with bacteria, food, and 
debris.
A basal membrane was present in all cultured substitutes before 
implantation. However, it was not found in any of the wounds before 12 
weeks post-surgery, although these samples exhibited a complete 
epithelial regeneration from 3 weeks on. It is likely that not only the 
epithelium had disappeared after implantation but also the basal 
membrane, and that the formation of a new basal membrane only starts
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when the keratinocytes migrate from the wound margins over the 
granulation tissue. In another study, using the same antibody, it was 
reported that in wounded human skin heparan sulphate was absent for up 
to 2 weeks42. They speculated that the expression of this specific epitope 
was below the detection level in paraffin-embedded tissue.
Cultured autologous epithelium on a skin-derived substrate 
implanted as an oral mucosal substitute in palatal wounds in dogs showed 
serious drawbacks. The epithelium is lost already after 1 week, and the 
dermal part of the substitute shows severe degradation. Since this might 
be related to a slow vascularisation of the dermal substrate, future 
research should aim at the stimulation of revascularisation using growth 
factors such as VEGF or bFGF, which might improve the take and 
survival of the substitute.
4.5 Acknowledgements
The authors gratefully acknowledge to Prof. Dr. J. Berden for providing 
the anti-heparan sulphate JM 403 antibody, and to Dr. L.E. Boerboom 
from LifeCell Corporation for providing AlloDerm®, that were made 
without obligation to facilitate these studies. They also thank R.E.M. van 
Rheden and M.P.A.C. Helmich for their excellent technical assistance. 
This work was supported by a research grant from the European 
Orthodontic Society.
4.6 References
1. Ross RB. Treatment variables affecting facial growth in complete unilateral 
cleft lip and palate. Cleft Palate J  1987;24:5-77.
2. Berkowitz S. Cleft lip and palate. W ith an introduction to other craniofacial 
anomalies. Perspectives in management. 1996;65-101.
3. Ishikawa H, Nakamura S, Misaki K, Kudoh M, Fukuda H, Yoshida S. Scar 
tissue distribution on palates and its relation to maxillary dental arch form. 
Cleft Palate Craniofac J  1998;35:313-9.
99
Chapter 4
4. W ijdeveld MG, M altha JC, Grupping EM, De Jonge J, Kuijpers-Jagtman AM. 
A histological study of tissue response to simulated cleft palate surgery at 
different ages in beagle dogs. Arch Oral Biol 1991;36:837-43.
5. Searls JC, Kremenak CR, Rittman BR. Quantitative characterization of changes 
in cellularity and collagen fiber size in contracting palatal wounds. Cleft Palate 
J  1979;16:373-80.
6. Squier CA, Kremenak CR. M yofibroblasts in healing palatal wounds o f the 
beagle dog. J  Anat 1980;130:585-94.
7. Desmouliere A. Factors influencing myofibroblast differentiation during wound 
healing and fibrosis. Cell Biol Int 1995;19:471-6.
8. Rudolph R. Inhibition o f myofibroblasts by skin grafts. Plast Reconstr Surg 
1979;63:473-80.
9. Simons AM, Darany DG, Giordano JR. The use of free gingival grafts in the 
treatment o f peri-im plant soft tissue complications: clinical report. Implant 
Dent 1993;2:27-30.
10. Hertel RC, Blijdorp PA, Baker DL. A preventive mucosal flap technique for 
use in implantology. Int J  Oral Maxillofac Implants 1993;8:452-8.
11. Sanders B, McKelvy B. Split-thickness skin grafts transplanted over exposed 
maxillary bone in dogs. J  Oral Surg 1976;34:510-3.
12. Endo T, Nakayama Y, Kikuchi M. Oral-cavity hair growth after free-flap 
transfer: case report. J  Reconstr Microsurg 2001;17:37-8.
13. Lauer G. Autografting o f feeder-cell free cultured gingival epithelium. Method 
and clinical application. J  Craniomaxillofac Surg 1994;22:18-22.
14. Lauer G, Schimming R. Tissue-engineered mucosa graft for reconstruction of 
the intraoral lining after freeing of the tongue: a clinical and immunohistologic 
study. J  Oral Maxillofac Surg 2001;59:169-75.
15. Ellis DL, Yannas IV. Recent advances in tissue synthesis in vivo by use of 
collagen-glycosaminoglycan copolymers. Biomaterials 1996;17:291-9.
16. Fujioka M, Fujii T. Maxillary growth following atelocollagen implantation on 
mucoperiosteal denudation of the palatal process in young rabbits: implications 
for clinical cleft palate repair. Cleft Palate Craniofac J  1997;34:297-308.
17. van Zuijlen PP, van Trier AJ, Vloemans JF, Groenevelt F, Kreis RW, 
Middelkoop E. Graft survival and effectiveness of dermal substitution in burns 
and reconstructive surgery in a one-stage grafting model. Plast Reconstr Surg 
2000;106:615-23.
100
Implantation o f tissue-engineered mucosal substitutes in the dog palate
18. Rennekam pff HO, Kiessig V, Griffey S, Greenleaf G, Hansbrough JF. Acellular 
human dermis promotes cultured keratinocyte engraftment. J  Burn Care 
Rehabil 1997;18:535-44.
19. Batista EL, Jr., Batista FC. Managing soft tissue fenestrations in bone grafting 
surgery with an acellular dermal matrix: a case report. Int J  Oral Maxillofac 
Implants 2001;16:875-9.
20. Clark JM, Saffold SH, Israel JM. Decellularized dermal grafting in cleft palate 
repair. Arch Facial Plast Surg 2003;5:40-4.
21. Gustafson CJ, Kratz G. Cultured autologous keratinocytes on a cell-free dermis 
in the treatment of full-thickness wounds. Burns 1999;25:331-5.
22. Kangesu T, Navsaria HA, M anek S, Fryer PR, Leigh IM, Green CJ. Kerato- 
dermal grafts: the importance of dermis for the in vivo growth of cultured 
keratinocytes. Br J  Plast Surg 1993;46:401-9.
23. Clugston PA, Snelling CF, Macdonald IB, Maledy HL, Boyle JC, Germann E, 
Courtemanche AD, Wirtz P, Fitzpatrick DJ, Kester DA, . Cultured epithelial 
autografts: three years of clinical experience with eighteen patients. J  Burn 
Care Rehabil 1991;12:533-9.
24. W alden JL, Garcia H, Hawkins H, Crouchet JR, Traber L, Gore DC. Both 
dermal matrix and epidermis contribute to an inhibition o f wound contraction. 
Ann Plast Surg 2000;45:162-6.
25. Ophof R, van Rheden RE, Von den HJ, Schalkwijk J, Kuijpers-Jagtman AM. 
Oral keratinocytes cultured on dermal matrices form a m ucosa-like tissue. 
Biomaterials 2002;23:3741-8.
26. Ghosh MM, Boyce S, Layton C, Freedlander E, Mac NS. A comparison of 
methodologies for the preparation o f human epidermal-dermal composites. Ann 
Plast Surg 1997;39:390-404.
27. Smeekens JP, M altha JC, Renggli HH. Histological evaluation of surgically 
treated oral tissues after application o f a photocuring periodontal dressing 
material. An animal study. J  Clin Periodontol 1992;19:641-5.
28. Alpar B, Gunay H, Geurtsen W, Leyhausen G. Cytocompatibility o f periodontal 
dressing materials in fibroblast and primary human osteoblast-like cultures. 
Clin OralInvestig 1999;3:41-8.
29. Lillie RD. Histopathologic technique and practical histopathology. 3rd Ed. 
1965;
30. Junqueira LC, Bignolas G, Brentani RR. Picrosirius staining plus polarization 
microscopy, a specific method for collagen detection in tissue sections. 
Histochem J  1979; 11:447-55.
101
Chapter 4
31. Brandtzaeg P, Dale I, Fagerhol MK. Distribution of a formalin-resistant 
myelomonocytic antigen (L1) in human tissues. II. Normal and aberrant 
occurrence in various epithelia. Am J  Clin Pathol 1987;87:700-7.
32. Jonsson G, Hallmans G. Healing of palatal defects with and without skin grafts. 
An intraindividual experimental study on dogs. Int J  Oral Surg 1980;9:128-39.
33. Raghoebar GM, Tomson AM, Scholma J, Blaauw EH, W itjes MJ, Vissink A. 
Use of cultured mucosal grafts to cover defects caused by vestibuloplasty: an in 
vivo study. J  Oral Maxillofac Surg 1995;53:872-8.
34. Brackett RC, Gargiulo AW. Free gingival grafts in humans. J  Periodontol 
1970;41:581-6.
35. Caffesse RG, Burgett FG, Nasjleti CE, Castelli WA. Healing of free gingival 
grafts with and without periosteum. Part I. Histologic evaluation. J  Periodontol 
1979;50:586-94.
36. Boyce ST, Supp AP, Harriger MD, Greenhalgh DG, W arden GD. Topical 
nutrients promote engraftment and inhibit wound contraction o f cultured skin 
substitutes in athymic mice. J  Invest Dermatol 1995;104:345-9.
37. Sumi Y, Hata KI, Sawaki Y, Mizuno H, Ueda M. Clinical application of 
cultured oral epithelium for palatal wounds after palatoplasty: a preliminary 
report. Oral Dis 1999;5:307-12.
38. Nomi M, Atala A, Coppi PD, Soker S. Principals o f neovascularization for 
tissue engineering. Mol Aspects Med 2002;23:463-83.
39. Hojo M, Inokuchi S, Kidokoro M, Fukuyama N, Tanaka E, Tsuji C, Miyasaka 
M, Tanino R, Nakazawa H. Induction of vascular endothelial growth factor by 
fibrin as a dermal substrate for cultured skin substitute. Plast Reconstr Surg 
2003;111:1638-45.
40. Tunbull RS, Stross EE. The healing o f hamster oral mucosal wounds covered 
by porcine grafts. A histologic study. J  Periodontol 1983;54:746-52.
41. Owens KW, Yukna RA. Collagen membrane resorption in dogs: a comparative 
study. Implant Dent 2001;10:49-58.
42. Andriessen MP, van den BJ, Latijnhouwers MA, Bergers M, van de Kerkhof 
PC, Schalkwijk J. Basal membrane heparan sulphate proteoglycan expression 
during wound healing in human skin. J Pathol 1997;183:264-71.
102
C h ap ter  5
Evaluation of a collagen-GAG Dermal 
Substitute in the Dog Palate
Ricardo Ophof 
Jaap C. Maltha
Anne Marie Kuijpers-Jagtman 
Johannes W. Von den H off
Tissue Engineering 2007;13:2689-98.

Evaluation o f a collagen-GAG Dermal Substitute in the Dog Palate
A bstract
Introduction: Tissue shortage complicates the surgery of cleft lip and 
palate. The healing of defects on the palate impairs growth of the dento- 
alveolar complex due to scar tissue formation. Implantation of a matrix 
into the wound might overcome this adverse effect.
Methods: Integra with and without the silicon top layer was 
implanted into standardized full-thickness wounds (0  6 mm) in the 
palatal mucoperiosteum in beagle dogs. In some wounds, the silicone 
layer was removed after 14 days. Control wounds were without an 
implant. At two and four weeks post surgery, the wounds were assessed 
for epithelialisation, inflammation (H&E, leucocyte protein L1), number 
of myofibroblasts (asma) and general histological characteristics.
Results: Wounds filled with Integra without the silicon layer showed 
less myofibroblasts and inflammatory cells than the sham wounds. 
Collagen fibres were more randomly orientated in these wounds than in 
the sham group. Wound closure was found to be delayed and many 
inflammatory cells were present when Integra with silicone was 
implanted. The silicon layer was lost within 4 weeks in these wounds.
Conclusion: In the moist oral environment the silicon of Integra is 
not required. Re-epithelialisation and tissue integration proceed more 
favorably without it. Further research in the dento-alveolair development 
with Integra will take place in a simulated cleft palate repair in the dog 
model.
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5.1 Introduction
Like surgical reconstructions of the skin, reconstructions of the oral 
mucosa are often complicated by a shortage of tissue. During closure of a 
palatal cleft by the Von Langenbeck method for example, there is a lack 
of mucosal tissue which leaves areas of denuded bone on the palate. 
Generally, no autologous grafts are used to cover these wounds. In stead, 
they are left to heal by secondary intention which means that 
proliferation and migration of cells as well as wound contraction occurs. 
This results in extensive scar tissue, which is firmly anchored to the 
palatal bone.1 Intraoral wound contraction and scar tissue formation 
during the growth of the maxillofacial complex, as is the case in cleft 
palate repair, counteracts normal development of the face due to long­
term impairment of skeletal growth and of the development of the
9 Adentition. -
Studies have been performed to prevent the attachment of scar tissue 
to the palatal bone after palatal surgery by modifying the surgical 
techniques. Surgical techniques that reduce the denudation of the palatal 
bone show some beneficial effects,5,6 but the use of biodegradable poly- 
(L-lactic) acid membranes, or tissue expansion did not show any
7 osignificant beneficial long term effect in animal models. , An other 
generation of biodegradable membranes composed of collagen and 
glycosaminoglycans has been described for the reconstruction of large 
surface area burns and neck contraction therapy with promising 
results.9,10 The implantation of such a collagen-glycosaminoglycan matrix 
in burn wounds yields a functionally and aesthetically highly acceptable
11 19scar. , A few animal studies indicate that these materials may also be 
suitable for intraoral surgery.13,14
A collagen-glycosaminoglycan matrix for dermal substitution was 
first described in 1981 by Burke et al.15 They developed an acellular, 
biodegradable collagen-glycosaminoglycan matrix of which the porosity, 
the glycosaminoglycan content, and the cross-link density, were all 
within the normal physiological range.16-18 With slight modifications, this 
material is commercially available (Integra®, Integra Life Sciences 
Corporation, New Jersey). It provides a matrix for cellular invasion and
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undergoes remodelling, while it is replaced with newly synthesized 
extracellular matrix. This process may require 1 to 2 years to complete. 
The matrix has a mean pore size of 70-200 ^m, and a glycosaminoglycan 
content of 8%. It is used to cover large burn wounds. To prevent fluid 
loss, Integra is provided with a top layer of silicone, which is usually 
removed at 7-14 days later in a second operation after the formation of a 
neodermis as described by manufacturer instructions and replaced by a 
thin epidermal autograft.9 It has been shown that the newly formed 
dermis in these grafted areas was indistinguishable from the unwounded 
tissue, and there were no clinical signs of hypertrophic scar tissue or 
keloids. Therefore, it was concluded that Integra substantially minimizes
19long-term postoperative contractures.
As an alternative to the second-stage skin grafting, Integra can be
9 nseeded with autologous keratinocytes before application. However, 
from this study it can not be concluded that the epithelium indeed is 
derived from these seeded keratinocytes or from keratinocyte ingrowth 
from the wound edges. The latter is suggested by an earlier in vitro study
9 1of our group in which we showed that the seeding of keratinocytes on 
top of Integra did not result in the formation of a stratified epithelium in 
vitro. If  Integra is to be used in the oral environment, the application can 
possibly be simpler than in the case of dermal wounds. Firstly, the oral 
cavity is a moist environment and the need to prevent fluid loss from the 
wound bed therefore is far less. This means that the silicon sheet might 
not be required. Secondly, intraoral wound healing generally proceeds 
faster than the healing of skin wounds, and the formation of a continuous 
epithelium can probably occur by the ingrowth of keratinocytes from the
9 9wound edges. Therefore, we hypothesize that the outer layer of silicone 
on top of Integra may not be required for intraoral applications such as 
cleft palate repair. The aim of this study was to investigate the intraoral 
tissue response to Integra with and without the silicon top layer.
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5.2 M aterials and methods
Four beagle dogs (age 2 -  3 years) were used in this study. The animals 
were kept under normal laboratory conditions and were fed standard dog 
chow and water ad libitum. The experiment was approved by the Board 
for Animal Experiments of the Radboud University Nijmegen Medical 
Centre, The Netherlands.
5.2.1 Surgical procedure
Before surgery, the animals were premedicated with 0.5ml Thalamonal 
(0.05 mg fentanyl + 2.5 mg/ml droperidol; Janssen Pharmaceutica, 
Beerse, Belgium) and 0.5ml atropine intramuscular (0.5 mg/ml atropine 
sulphate). Subsequently, they were anesthetized with an intravenous 
injection of 30 mg/kg of 60 mg/ml sodium pentobarbital (Apharmo, 
Arnhem, The Netherlands). After intubation, anesthesia was maintained 
with 15 mg/mg enflurane (Abott, Amstelveen, The Netherlands). The 
palatal mucosa was cleaned with povidone iodine (Dagra-Pharma, 
Diemen, The Netherlands). In addition, approximately 2ml of 0.4 mg/ml 
lidocaine-hydrochloride + 0.0125 mg/ml adrenaline (Astra Chemicals, 
Rijswijk, The Netherlands) was injected into the palatal mucosa to avoid 
excessive bleeding during the procedure.
In each dog, four standardized full-thickness wounds were created in 
the medial region of the palate using a 6-mm biopsy punch (Stiefel 
Laboratorium, Offenbach am Main, Germany). The circular soft tissue 
defects were made distally to the canines. The defects were assigned to 
one of the following treatments according to a Latin square scheme. In 
each dog, one wound was left open and served as a sham wound (C). A 
second wound was filled with Integra with the top layer of silicone (S+), 
a third wound was filled with Integra without the layer of silicone (S -), 
and the last wound again was filled with Integra with the outer layer of 
silicone, but the top layer was gently removed with a forceps after 14 
days (S14). Every matrix was carefully fixed in place using 4 stitches (4­
0 Vicryl, Ethicon; Johnson & Johnson Company, Amersfoort, The 
Netherlands). After surgery, the animals were medicated with 1.5ml of 
ampicillin anhydrate 150 mg/ml(Mycofarm, de Bilt, The Netherlands).
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All animals received a normal diet after surgery. All experimental 
conditions were evaluated clinically and histologically at 2 and 4 weeks 
post-surgery.
5.2.2 Histology
For histological evaluation two animals were killed at two weeks and the 
other two were killed at four weeks post-surgery. At the time of sacrifice, 
the animals were brought under general anaesthesia using 30 mg/kg 
Narcovet®. After some minutes, a lethal dose of Narcovet® was injected 
intravenously. A small mucosal biopsy (0  4 mm) was taken from the 
margin of each wound. These biopsies, containing tissue from the 
experimental wound and some normal palatal mucosa, were fixed for 4 
hours in 4% paraformaldehyde in 0.1 M PBS at room temperature and 
embedded in paraffin. These samples were used for 
immunohistochemical staining.
Subsequently, the maxillae were dissected and immersed in 4% 
paraformaldehyde in 0.1 M phosphate buffer at room temperature. After 
fixation, they were sawn into four smaller blocks, each containing one 
biopsy wound. The tissue blocks were decalcified in 20% formic acid and 
5% sodium citrate. Decalcification was checked radiographically. Then 
the blocks were dehydrated through a graded series of ethanol and 
embedded in paraffin. Serial paraffin sections of 7 ^m were made 
through the entire wound. Each tenth section was mounted onto a 
superfrost (Menzel-Gläser, Braunschweig, Germany) slide and stained 
with haematoxylin and eosin (H&E) for general tissue survey. The wound 
area of each specimen was blindly evaluated by one of the authors (RO) 
for the degree of inflammation, and epithelial regeneration (rete-ridges 
and the number of epithelial cell layers), using an ordinal scale from 0 to 
4, as shown in table I. Twelve consecutive sections from the centre of 
each wound were scored. The mean score and standard error of these 
sections were used for evaluation of the total wound area.
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Table I  Histometric scoring system used to evaluate degree o f inflammation and 
epithelial regeneration
Grade
Degree of 
Inflam m ation Grade
Epithelial
regeneration
0 Absent 0 Open
1 Minimal 1 Closed with a few cellar layers (<10)
2 Mild 2 Closed with many cellar layers and not rete pegs
3 Moderate 3 Closed with many cellar layers and some rete pegs
4 Severe 4 Closed with many cellar layers and normal rete pegs
5.2.3 Immunohistochemistry
Paraffin sections of the 4-mm mucosal biopsies were collected on 
Superfrost Plus slides (Menzel-Gläser; Braunschweig, Germany), 
deparaffinated and rehydrated again. Before staining, the slides were 
treated with 0.1% trypsin 250 (DIFCO laboratories, Detroit, USA) for 10 
minutes and rinsed with PBS. Thereafter, the slides were treated with 3% 
H2O2 in PBS for 30 minutes to block endogenous peroxidase and rinsed 
in PBS.
a-Smooth muscle actin to detect myofibroblasts. The sections were 
pre-incubated with 5% PBSA (5% Bovine Serum Albumin (BSA, Sigma 
Chemical Co, St. Louis, MO, USA) in PBS buffer). After pre-treatment, 
the sections were incubated with a mouse anti-smooth muscle actin 
antibody (1:1600) (Sigma Chemical Co, St. Louis, MO, USA) overnight 
at 4°C. After washing with PBS, the sections were incubated with a 
biotinylated donkey anti-mouse antibody (1:500) (Jackson Labs, West 
Grove, PA, USA) for 60 minutes at room temperature. After washing 
with PBS, the sections were treated with ABC-peroxidase (Vector Lab, 
Burlingame, USA). Peroxidase activity was visualised with a standard 
DAB technique (Sigma). The sections were counterstained with 
Dellafields haematoxylin. For negative controls, the primary antibodies 
were omitted. All negative controls were blank.
Leucocyte protein L1 to detect inflammatory cells was detected with 
a mouse anti-L1 antibody (1:800) (Abcam limited, Cambridge UK). In 
dogs, leucocyte protein L1 is known to be expressed by cells at an early 
stage of monocyte/macrophage differentiation. This protein is also 
present in the epithelium. The staining method was the same as described 
for a-smooth muscle actin. The secondary antibody was a biotinylated
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donkey anti-mouse antibody (1:500) (Jackson Labs, West Grove, PA, 
USA).
Semi quantitative analysis of the distribution of positive leucocyte 
protein L1 cells was done at a magnification of 200 times. The scoring 
system used for the presence of protein L1 was on a scale from zero 
(none) to four (abundant). An random ar ea was chosen for each of the a -  
smooth muscle actin stained sections, and stained cells within each area 
were counted. Representative sections were photographed on a Leitz 
DMRD Microscope (Leica, Wetzlar, Germany).
5.2.4 Statistics analysis
Differences in the means of degree of inflammation (H&E), epithelial 
regeneration, leucocyte protein L1, and the number of myofibroblasts 
between the groups were tested. To investigate the tissue response to 
Integra with and without the silicon top layer the groups were pooled, 
since no differences between the wounds without a silicon top layer (C 
and S-) and those wounds with a silicon top layer (S+ and S14) existed. 
Differences in the number of myofibroblasts, inflammation, epithelial 
regeneration, and leucocyte protein L1 between the wounds without a 
silicon top layer (C and S-) and those wounds with a silicon top layer (S+ 
and S14) were tested by a Mann-Whitney Rank sum test, since all the 
data were normally distributed. A p-value of less than 0.05 was 
considered to be statistically significant.
5.3 Results
5.3.1 Clinical observations
Wound closure was completed uneventful after two weeks both in the 
sham wounds (C) and the wounds filled with Integra without the silicone 
(S-). The wounds with Integra plus the silicone top layer (S+ & S 14), 
however, showed a slower healing and had not completely re- 
epithelialized after two weeks. Parts of the wound surface in the latter 
two groups appeared inflamed and a fibrin clot was still evident. The top 
silicone layer was still visible through the coagulum in all of the S+ and
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S14 wounds. Parts of the silicone layer protruded from the tissue, 
indicating possible ongoing sequestration. The silicon top layer was 
removed intentionally in the S14 wounds. After four weeks, all 
experimental wounds including the wounds with the silicon top layer 
(S+) were closed. None of the wounds without the silicon layer (S- & C) 
showed any signs of inflammation. However, all other experimental 
wounds (S+ & S 14) still showed some mild inflammation; parts of the 
wound surface still appeared inflamed. In none of the experimental 
wounds with the silicone top layer (S+), this layer was visible anymore. 
Although the silicon layer in this group was not removed intentionally, it 
was fallen away spontaneously between 2 and 4 weeks post surgery.
5.3.2 General histology
Unwounded tissue
The superficial layer of the dog’s palatal mucoperiosteum consists of a 
parakeratinized stratified epithelium with many ridges protruding into the 
underlying connective tissue (Figure 1D). This connective tissue layer, 
immediately below the epithelium, consists of a three-dimensional 
network of thick collagen fibres. Throughout the mucoperiosteum, large 
blood vessels and sinuses are present in the deeper layers of the 
connective tissue. Between the sinuses and close to the bone, the major 
palatine arteries and branches of the palatine nerves are organized into 
neurovascular bundles located mainly at the lateral aspect of the bone. 
The palatal bone is of the lamellar type.
Two weeks post-surgery
The sham wounds (C) were covered with up to 10 epithelial cell layers 
and some ridges had started to form (Figure 1A). The wound was 
completely filled with granulation tissue rich in fibroblasts, granulocytes, 
some blood vessels, and thin collagen fibres. The collagen fibres had a 
mainly transverse orientation. Superficial osteoclastic bone resorption 
was found in all samples (not shown).
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Figure 1 Haematoxylin-eosin staining o f the experimental wounds at 2 and 4 weeks 
post-surgery. A: Sham wound at 2 weeks post-surgery, B: Integra (S-) at 2 
weeks post-surgery, C: Integra (S+) at 2 weeks post-surgery, D: Normal 
palatal mucosa o f a beagle dog, E: Sham wound at 4 weeks post-surgery, F: 
Integra (S-) at 4 weeks post-surgery, G: Integra (S+) at 4 weeks post­
surgery, H: Integra (S14) at 4 weeks post-surgery. m=Integra matrix, 
e=epithelium, s=submucosa, p=periosteum, b=bone and the arrow ('[) 
indicates the wound margin; the wound is right to this arrow. The original 
magnification 50*.
The epithelium covering the wounds filled with Integra without silicone 
(S-) was also continuous (Figure 1B). The thickness of the epithelium and 
the ridge formation was similar to that of the control wounds. All the 
matrices were easily recognized in the wounds because of their 
characteristic network structure. The granulation tissue underneath the 
epithelium was still hyperaemic, and some inflammatory cells were 
present. Thin collagen fibres were aligned in transverse direction and 
seemed to enclose the matrices (Figure 1B). The inflammatory response 
(minimal to mild) outside the implant (S-) was comparable to the sham 
wounds (Figure 1A).
The wounds filled with Integra with silicone (S+ and S14) were not 
yet closed, but the epithelium had already migrated from both wound 
edges underneath the matrix (Figure 1C). The silicone layer was still 
present in both groups at this time. Underneath the newly forming 
epithelium, as well as in the wounds, hyperaemic granulation tissue with 
many fibroblasts and granulocytes surrounded the Integra, and moderate
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bone resorption was found. The bone was of the lamellar type. The 
inflammatory response was mild to moderate with many neutrophil 
granulocytes.
The inflammatory response in all the groups (C, S- and S+) seemed 
to be the same at this point in time. No significant differences were found 
between these groups for the inflammatory response at two weeks post 
surgery. After pooling silicone layer presence (S+ and S 14) and absence 
of these top layer groups (C and S-), no significant differences were 
observed for the inflammatory response as well as the epithelial 
regeneration (not shown).
Four weeks post-surgery
The quantitative data are summarized in figure 3 for the inflammatory 
response, and in figure 2 for the epithelial regeneration of the wound 
tissue.
Figure 2 Epithelial regeneration at four weeks. Each bar represents one individual 
wound. The values are means ± SE o f twelve consecutive sections from the 
centre o f each wound. * denotes a significant difference for the pooled data 
(p < 0.05) using the Mann-Whitney Rank sum test.
The epithelium had become thicker in the sham wounds (C), although it 
was still thinner than the normal oral epithelium (Figure 2). A thick 
cornified layer had formed and ridges were protruding into the underlying 
connective tissue. (Figure 1E). The inflammatory reaction had almost
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ceased and only a few inflammatory cells were found (Figure 3). The 
fibroblasts density had also decreased compared to two week post­
surgery. The connective tissue showed thinner collagen fibres than the 
tissue outside the wound area, and the collagen fibres were clearly 
aligned. Bone apposition was found at some sites where the bone 
probably had been damaged by the biopsy punch.
The epithelium covering the wounds filled with Integra without 
silicone (S-) showed many ridges penetrating into the connective tissue 
(Figure 1F). The thickness of the epithelial layer was more or less 
comparable with the epithelial layer of the sham wounds(C) at the same 
stage (Figure 2). The orientation of the collagenous bundles in the 
superficial layer of the dermis was more random with less transverse 
thick bundles. In the deeper layers of the wound, however, they were 
more oriented in a more transverse direction with more dense collagenous 
bundles. The matrices were still easily recognized within the wounds, and 
they contained many fibroblasts. The inflammatory reaction was 
comparable to the control wounds (Figure 3).
The wounds filled with Integra with silicone (S+) showed a 
continuous epithelium of about 8 cell layers. The thin epithelium showed 
some small ridges protruding intro the underling connective tissue at this 
stage (Figure 1G). Although the top layer was not removed in this group, 
it was not present anymore, but the Integra was always easily recognized 
because of its typical structure. The granulation tissue underneath the 
epithelium was still hyperaemic and many inflammatory cells were 
present. The inflammatory response (mild to moderate) outside the 
implant was comparable to the sham wounds after two weeks (Figure 3).
The wounds filled with Integra with the top layer removed after 14 
days (S 14), were closed with a continuous epithelium consisting of a few 
cell layers (Figure 1H and Figure 2). Underneath the epithelium 
hyperaemic granulation tissue with leukocytes, and macrophages were 
found within, and surrounding the matrix. All the matrices were easily 
recognised in all of the wounds. The inflammatory response was mild to 
moderate with many neutrophil granulocytes still present (Figure 3).
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The inflammatory response in the groups with the silicone layer present 
(S+ and S 14) was significantly higher than in the groups without a 
silicone layer (C and S-) (Figure 3). Furthermore, after pooling of the 
data, the epithelial regeneration was significantly higher in the group 
without the silicon layer at four weeks post surgery (Figure 2).
Unwounded Sham Integra - (S-) Integra + (S+) Integra (S14)
Figure 3 Inflammatory response at four weeks. Each bar represents one individual 
wound. The values are means ± SE o f thirteen consecutive sections from the 
centre o f each wound. * denotes a significant difference for the pooled data 
(p < 0.05) using the Mann-Whitney Rank sum test.
5.3.2 Immunohistochemistry
a-Smooth muscle actin.
The quantitative data on the number of myofibroblast in the wound tissue 
are summarized in figure 5.
An a-smooth muscle actin staining was used to detect myofibroblasts. 
There were evident differences between normal, unwounded, and 
wounded mucosa. In normal palatal mucosa, a-smooth muscle actin was 
exclusively found in blood vessel walls (Figure 4 A&D outside the 
wound area, indicated by an arrow head). In contrast, myofibroblasts 
were found in considerable numbers in the granulation tissue in all 
wounds at 2 weeks post-surgery. In general, more myofibroblasts were 
present in the deeper layers of the submucosa than just below the
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epithelium. The sham wounds (C) (Figure 4A) showed myofibroblasts 
with a mainly parallel orientation in contrast to the other wounds (S- & 
S+) (Figure 4B&C). The wound area of the latter wounds (S- & S+) 
contained more randomly orientated myofibroblasts. In some samples, 
the myofibroblasts showed a focal clustering.
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Figure 4 Immunohistochemical staining o f a-smooth muscle actin containing cells in 
2 and 4 week old wounds. A: Sham wound at 2 weeks post-surgery, B: 
Integra (S-) at 2 weeks post-surgery, C: Integra (S+) at 2 weeks post­
surgery, D: Sham wound at 4 weeks post-surgery, E: Integra (S-) at 4 weeks 
post-surgery, F: Integra (S+) at 4 weeks post-surgery, G: Integra (S14) at 4 
weeks post-surgery. The specific protein o f a-smooth muscle actin is stained 
brown and indicated by an arrow head (V), m=Integra matrix, and the 
arrow (Î) indicates the wound margin; the wound is right to this arrow. The 
original magnification 50*, the bar represents 150^m.
At 4 weeks post-surgery, the number of myofibroblasts had 
decreased in the sham wounds(C) (Figure 4D) and in the wounds filled 
with Integra without silicone (S-) (Figure 4E). The staining for a-smooth 
muscle actin in these wounds was less dense with a tendency to a more 
random randomly orientation of these cells compared to the sham 
wounds(C).
The wounds filled with Integra (S+) (Figure 4F), and those where 
the top layer was removed (S 14) (Figure 4G) showed the same 
characteristics. An intense staining for myofibroblasts was found in these
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wounds. The density of myofibroblasts was higher compared to the other 
wounds (S- & C) (Figure 5), and the number of myofibroblasts was 
comparable to the 2-week post-surgery groups. After pooling, the number 
of myofibroblasts in the groups with the silicone layer present (S+ and S 
14) was significantly higher than in the groups without the silicone (C 
and S-) (Figure 5).
Figure 5 Number o f myofibroblasts at four weeks. Each bar represents one individual 
wound. The values are means ± SE o f twelve consecutive sections from the 
centre o f each wound. * denotes a significant difference for the pooled data 
(p < 0.05) using the Mann-Whitney Rank sum test.
Leucocyte protein L-1
The quantitative data are summarized in figure 7 for the leucocyte protein 
L1 reaction of the wound tissue. The L-1 staining was used to detect 
neutrophils, and macrophages, and is also known to stain mucosal
9 4epithelium. In normal palatal mucosa, leucocyte protein L1 localizes to 
the granular layers of the epithelium, but it is not found in the basal or
9 Scornified cell layers.
At 2 week post-surgery, L-1 positive cells were found in large numbers in 
the sham wounds(C) (Figure 6A) and wounds filled with Integra without 
silicone (S-) (Figure 6B). The L-1 positive cells were equally distributed 
throughout the entire wound area. The wounds filled with Integra with
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silicone (Figure 6C) showed numerous leucocyte protein positive cells. 
The staining was not equally distributed but was mainly present close to 
the wound margin.
Figure 6 Immunohistochemical staining o f leucocyte protein L1 containing cells in 2 
and 4 week old wounds. A: Sham wound at 2 weeks post-surgery, B: Integra 
(S-) at 2 weeks post-surgery, C: Integra (S+) at 2 weeks post-surgery, D: 
Sham wound at 4 weeks post-surgery, E: Integra (S-) at 4 weeks post­
surgery, F: Integra (S+) at 4 weeks post-surgery, G: Integra (S14) at 4 
weeks post-surgery. The specific protein is stained brown, m=Integra 
matrix, and the arrow (Î) indicates the wound margin; the wound is right to 
this arrow. In normal unwounded palatal mucosa, leucocyte protein L1 is 
localized to the spinous and subcorneal layers o f the stratum spinosum. The 
original magnification 50*, the bar represents 150^m.
The leucocyte protein L1 response to all the groups (C, S- and S+) 
seemed to be the same at this point in time. Moreover, after pooling 
silicone layer presence (S+ and S 14) and absence of these top layer 
groups (C and S-), no significant differences were observed for this 
reaction at 2 weeks post-surgery (not shown).
At 4 weeks post-surgery, only few L1-positive cells remained in the sham 
wounds (Figure 6D) and the wounds without silicone (S-) (Figure 6E). 
The positive cells were found throughout the whole healing wound and 
their distribution was comparable to the unwounded tissue (Figure 6D, 
outside the wound area). At this point in time, the number of positive 
cells in the wounds filled with Integra with silicone (S+) seemed to be
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higher (Figure 6F), although there was no significant difference 
compared to the groups without this top layer (C and S-). However, the 
wounds with Integra where this top layer was removed after 14 days (S 
14) were filled with numerous L1-positive cells (Figure 6G). The staining 
was not equally distributed but was more pronounced close to the 
epithelium. After pooling, the response in the groups with the silicone 
layer present (S+ and S 14) was significantly higher than in the groups 
without the silicone (C and S-) (Figure 7). Furthermore, this was also 
affirmed by the general histology for the inflammatory response between 
these groups (Figure 3).
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Figure 7 The leucocyte protein L1 staining at four weeks. Each bar represents one 
individual wound. The values are means ± SE o f twelve consecutive sections 
from the centre o f each wound. * denotes a significant difference for the 
pooled data (p < 0.05) using the Mann-Whitney Rank sum test.
5.4 Discussion
The overall aim of our research is to develop a mucosal substitute for 
implantation on the palate after cleft palate surgery. The implantation of a 
suitable graft material into an open wound might reduce wound 
contraction and scarring.26 The aim of this specific study was to
120
Evaluation o f a collagen-GAG Dermal Substitute in the Dog Palate
investigate the in vivo response to Integra with and without the silicon 
top layer after implantation on the palate of beagle dogs. We hypothesize 
that this top layer may not be required for intraoral applications such as 
cleft palate repair because of the moist environment.
A widely accepted method for the primary closure of palatal clefts is 
the Von Langenbeck palatoplasty. In this technique, bilateral palatal 
relaxation incisions are made in the mucoperiosteum adjacent to the 
posterior teeth. The mucoperiosteum is then elevated, mobilized, and 
moved to the midline region of the palate in order to close the cleft. This 
procedure results in two areas of denuded bone in the lateral region of the 
palate. Wijdeveld et al. (1989) created a midpalatal soft tissue cleft in
-5
dogs that was subsequently closed by the Von Langenbeck technique. 
Their results showed similar effects on growth as in the clinical situation. 
In the present study, standardized full-thickness wounds were created in 
the medial region of the palate with a 6-mm biopsy punch. The diameter 
of these wounds is similar to the largest width of the wounds in the Von 
Langenbeck technique. Therefore, we can use the present results as a 
basis for a larger study to evaluate the wound healing process in growing 
beagle dogs after palatal with and without implantation of Integra.
The overall take rate of Integra in this study was 100%. This take 
rate exceeds that reported in burn patients in a large clinical series.19 
However, healthy animals do not show the systemic illness and localised 
infection associated with severe burn injuries, which might contribute to 
the inconsistency of take rates in clinical practice. Grant et al. reported a 
take of about 96% in a histological study of skin wounds in pigs. 
Although their animal model and the implantation site are different from 
ours, their findings on the take rate are similar.
In the present study, wound closure was found to be retarded in all 
wounds filled with Integra with the silicon top layer. Obviously, the 
migration of the epithelium and the connective tissue cells in these 
wounds (S+ and S 14) is more difficult than in the wounds without a 
silicon top layer (C and S-). The present study has further shown that all 
matrices were integrated into the tissue. However, the silicon top layer 
had disappeared spontaneously between 2 and 4 weeks post-surgery from 
all wounds filled with Integra with the silicon top layer. This indicates
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that epithelial migration had occurred between the matrix and the silicon 
top layer. Retarded wound healing after implantation of a silicone-coated 
membrane was also found in a trial in skin wounds of O'Donoghue et
9 »al. Furthermore, the wounds filled with Integra with the silicon top 
layer showed a significant higher inflammatory response than the other 
wounds. A delayed wound healing and a high inflammatory response was
9 Qalso found after subcutaneously implanted silicone. In general, we can 
conclude that wounds filled with Integra with the silicon layer showed a 
significant delay in wound closure and a significant higher and extended 
inflammatory response. The hydrophobic properties o f the silicone and 
therefore the low adhesion of cells might underlie these effects.
The scar tissue was clearly distinguishable from the normal 
mucoperiosteum. The loosely woven matrix of the unwounded 
submucosa was replaced by a matrix with parallel orientated collagen 
fibres and many myofibroblasts. Myofibroblasts are involved in wound 
contraction.30,31 These contractile fibroblasts are found in many types of 
contracting wounds. After contraction, the myofibroblasts disappear
-5 1
probably through apoptosis, and wound contraction cease. Therefore, 
reducing the number of myofibroblasts during palatal wound healing 
might decrease wound contraction. In our study, the density of 
myofibroblasts in all wounds was higher at the level of the mucosa than 
in the periosteum. One might thus expect more contraction in the 
superficial layer of the mucoperiosteum. Indeed, this was shown in 
beagle dogs.1 In this study, collagen fiber orientation was described using 
conventional light microscopy. In this general observation, we did not 
quantitatively asses the morphology and orientation of the scar tissue. 
Several studies have described the orientation of scar tissue by light 
microscopy in combination with Fourier analysis.32,33 The sham wounds 
in this study showed parallel collagen fibers and considerable numbers of 
myofibroblasts at 2 weeks post-surgery, which is in agreement with 
others. The collagen fibers in a healing wound tend to run in the direction 
of the contraction forces.34 Squier and Kremenak30 have shown that 
myofibroblasts are present in healing palatal wounds of the beagle dog 
from 7 days post-surgery, and are most numerous between 10 and 15 
days. The wounds filled with Integra without the top layer showed less
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myofibroblasts than the sham wounds, and the collagen fibres were not 
aligned in a transverse direction, as in the sham group. This indicates that 
wounds filled with Integra without the silicon top layer undergo less 
contraction than a sham wound.
From the results of this study, we can concluded that implantation of 
Integra without the silicon top layer yields a wound with less parallel 
collagen fibres and less myofibroblasts. In addition, wound closure was 
faster without the silicone top layer. Apparently, in the moist oral 
environment, the silicon layer is not required to prevent fluid loss. To 
evaluate the effect of Integra on the maxillary growth, a larger study into 
the implantation of Integra without the silicon top layer after palatal 
repair in beagle dogs is required.
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Dento-alveolar development in beagle dogs after palatal repair with a dermal substitute
Summary
Introduction: The aim was to compare the dento-alveolar development in 
beagle dogs after palatal repair according to the Von Langenbeck 
technique with and without the implantation of a dermal substitute.
Methods: Nineteen beagle dogs (12 weeks of age) were assigned to 
two experimental groups and an untreated control group. Palatal surgery 
was performed by the Von Langenbeck technique. Thereafter, the dermal 
substitute Integra was implanted in one experimental group, while the 
other served as sham group. Dental casts were made prior to surgery, and 
on several time points in all groups to measurement dento-alveolar 
development Transversal distances, arch depth, tipping, and rotation were 
determined. Histology was performed at 3, 7, and 15 weeks after surgery. 
The degree of reepithelialisation and tissue organization were evaluated 
microscopically (H&E).
Results: All wounds healed without complications. Scar tissue 
attached to the bone was found in both experimental groups. Deposition 
of bone within the substitute occurred after implantation indicating its 
osteoconductivity. Transversal dento-alveolar development was similar in 
both experimental groups but in both it was significantly less than in the 
control group.
Conclusion: Implantation of the dermal substitute Integra after the 
Von Langenbeck procedure for palatal repair does not improve dento- 
alveolar development.
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6.1 Introduction
In cleft palate patients, maxillary growth and dento-alveolar development 
are often impaired after surgical closure of the palate. This is caused by 
three main factors: intrinsic developmental deficiencies, functional 
distortions, and surgery itself. The last factor is considered as the main 
factor for midfacial hypoplasia in these patients.1 A strong indication for 
the involvement of surgery is the largely undisturbed growth in untreated 
cleft palate patients. , Specific techniques, timing, the sequence of 
surgical interventions, the use of pre-surgical orthopaedic appliances, and 
the skills of the surgeon may all influence the extent of growth 
impairment.4,5
A widely accepted method for the primary closure of palatal clefts is 
the palatoplasty according to Von Langenbeck or modifications thereof. 
Extensive research in animal models has been carried out to investigate 
the impairment of maxillary growth and dento-alveolar development after 
palatal surgery. These studies show that growth impairment is mainly due 
to the manipulation of the mucoperiosteum. 6,7 Both wound contraction 
and scar tissue formation in the lateral wound areas seem to be 
responsible for the iatrogenic effects. Wijdeveld et al. used dogs in which 
a midpalatal soft tissue cleft was closed by the Von Langenbeck 
technique. Their results showed similar growth disturbances as in the 
clinical situation. Furthermore, they found that the extent of the 
disturbances was related to the age at the time of surgery. Especially 
when surgery was performed before or during the transition of the 
posterior teeth, the deviations in maxillary arch dimensions were most 
prominent. This was caused by a decreased sutural growth, and by palatal 
tipping of the teeth in the lateral areas. Scar fibers were continuous with 
the cervical periodontal ligament, thus forming a mechanical connection
o
between the teeth and the palatal bone. This presumably causes traction 
on the erupting permanent teeth.
Studies have been performed to prevent the attachment of scar tissue 
to the palatal bone.9,10 Surgical techniques that reduce the denudation of 
the palatal bone by means of local turnover flaps, buccal fat pad grafting,
1 1  1 "Kand free flaps show some beneficial effects, - but other attempts using
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Low level laser therapy, biodegradable poli-(L-actic) acid membranes, or 
tissue expansion did not show any significant long term improvements. 14­
16 In the partially-split flap technique described by Leenstra, the palatal 
mucoperiosteum is split parallel to the bony surface. This technique 
induces less scar formation and the growth pattern of the maxilla is more
1 9normal. However, theoretically many of these techniques are hampered 
by the risk of avulsion of the major palatine artery leading to necrosis of 
the palatal flaps. In spite of all efforts, most authors agree that scar tissue 
formation after palatal repair is still one of the main causes of maxillary 
growth inhibition. Another approach is to supplement the tissue shortage 
after palatal repair with a dermal substitute.
Biodegradable collagen membranes, sometimes supplemented with 
other extracellular matrix components like glycosaminoglycans, have 
been used for the reconstruction of large burn wounds with promising 
results.17,18 Animal studies indicate that these materials may also be 
suitable for intraoral surgery.19 It has been reported that they reduce
9 nwound contraction and subsequent scarring. The present study was 
designed to evaluate the dento-alveolair development in beagle dogs after 
palatal repair according to the Von Langenbeck technique combined with 
the implantation of the dermal substitute Integra. This study is one in a 
larger series that aims at the development of a substitute for oral mucosa 
that minimizes the iatrogenic effects of cleft palate closure.
6.2 M aterials and methods
After approval by the Board for Animal Experiments of the Radboud 
University Nijmegen Medical Centre, the experiments were performed 
with 19 male beagle dogs. The animals were kept under normal 
laboratory conditions and were fed standard dog chow and water ad 
libitum. The dogs were divided randomly into three groups: an 
unoperated control group (group 1; n = 5) and two experimental groups 
(group 2 (=Von Langenbeck) and 3 (=Integra); both n = 7). Palatal 
surgery according to Von Langenbeck was performed in both
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experimental groups at 12 weeks of age. At the start of study (t=0 w p.o.), 
the complete deciduous dentition was present in all dogs.
6.2.1 Surgical procedures
Prior to surgery, the animals were premedicated with 0.5 ml Haloperidol 
(0.05 mg/ml fentanyl plus 2.5 mg/ml droperidol; Janssen Pharmaceutica, 
Beerse, Belgium) and 0.5 ml atropine intra-muscular (0.5 mg/ml atropine 
sulphate). Subsequently, they were anesthetized with an intravenous 
injection of 30 mg/kg Narcovet (60 mg/ml sodium pentobarbital; 
Apharmo, Arnhem, The Netherlands). After intubation, anesthesia was 
maintained with Ethrane (15 mg/ml enflurane; Abott, Amstelveen, The 
Netherlands). The palatal mucosa was cleaned with Betadine solution 
(povidoniodine; Dagra-Pharma Diemen, The Netherlands). In addition 
approximately 2.0 ml Xylocaine (0.4 mg/ml lidocaine hydrochloride plus 
0.0125 mg/ml adrenaline; Astra Chemicals, Rijswijk, The Netherlands) 
was injected into the palatal mucosa to avoid excessive bleeding during 
surgery.
In both experimental groups, a standardized soft tissue defect was 
created in the medial region of the palate by incising, elevating, and 
removing an elliptically-shaped mucoperiostal flap of about 3.5 cm long. 
This flap extended distally from the canines to the region distal to the 
deciduous third molars. The maximum width of the flap was about 6 mm, 
which was about one-third of the transverse distance between the 
deciduous first molars. Full thickness relaxation incisions were made in 
the mucoperiosteum on both sides of the palate close to the posterior 
teeth. The remaining palatal mucoperiosteum was elevated from the 
underlying bone with a small raspatory. Special attention was taken not 
to avulse the major palatine neurovascular bundle during this procedure. 
The midpalatal soft tissue defect was closed and sutured (4-0 Vycril, 
Ethicon; Johnson & Johnson Company, Amersfoort, The Netherlands), 
leaving two areas of denuded bone adjacent to the dentition. In the 
experimental group 2 (Von Langenbeck group), the denuded bone areas 
were left untreated. The denuded bone areas in experimental animal 
group 3 were filled with Integra. Prior to use, Integra was rinsed for 30 
seconds in chlorhexidine digluconate 1% in water for disinfection,
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followed by 30 minutes in sterile physiologic saline. Then the top silicon 
cover layer of the Integra matrix was gently removed with tweezers. 
Subsequently, Integra was placed directly on the denuded bone and 
inserted underneath the wound margins for a few millimeters (Figure 1B). 
The matrices were carefully fixed in place using tensionless sutures 
crossing the defect (4-0 Vycril, Ethicon; Johnson & Johnson Company, 
Amersfoort, The Netherlands). Additional protection of the wounds was 
omitted, as this may lead to persisting inflammation and cytotoxic 
effects, which may delay wound healing.21,22 The animals of group 1 
served as unoperated controls. All experimental animals of group 2 and 3 
were medicated preoperatively with 1 ml of Albipen 15% (150 mg/ml 
ampicillin anhydrate; Mycofarm, de Bilt, The Netherlands). All animals 
received a normal diet after surgery.
Figure 1 Schematic drawing o f the palate and the operation in the experimental 
groups. A mucoperiostal flap was removed in the medial region o f the palate 
and two relaxation incisions were made (A). The remaining palatal 
mucoperiosteum was elevated, repositioned and sutured in the middle. The 
Integra (Black colored) was placed on the bone and inserted underneath the 
wound margins (B).
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6.2.2 Dental casts and intraoral photography
Alginate impressions (CA 37; Cavex, Haarlem, The Netherlands) and 
standardized intraoral slides of the palate were taken in all animals at the 
start of the study (group 1) or prior to surgery (group 2 and 3) at 12 
weeks of age (t=0 w p.o.), and at 15, 17, 19, 22, 25, and 27 weeks of age. 
For this purpose, the animals were premedicated with 0.5 ml Haloperidol 
(0.05 mg/ml fentanyl plus 2.5 mg/ml droperidol) and 0.5 ml atropine (0.5 
mg/ml atropine sulplhate). Subsequently, they were anesthetized with an 
intravenous injection of 15 mg/kg Nesdonal (50 mg/ml thiopental 
sodium). The alginate impressions were poured out within 2 hours.
The following measuring points for the deciduous as well as for the 
permanent dentition were defined on the dental casts (Figures 2A&B): 
Midpoint (=mid): point between the central incisors 
Tip points: tips of the right and left canines; deciduous first, second, and 
third molars; permanent first, second, third, and fourth premolars; 
permanent first molars.
Figure 2 Schematic drawing o f maxillary deciduous dentition with measuring points 
(A) and a schematic drawing o f maxillary permanent dentition with 
measuring points (B) (Not drawn to scale).
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Crest points: mesial and distal crests at the gingival margin of the 
right and left deciduous first and second molars; permanent first, second, 
third, and fourth premolars; permanent first molars Standardized 
photographs of the dental casts were taken on the same day. A digital 
Nikon D1x Body and an AF Micro Nikkor fixed focus lens (1:2.8, 105 
mm) with an integrated Nikon Macro lightspeed SB-295 ring flash were 
used. Measuring points were placed on the printed photographs with a 
pencil. The measurements were only made on fully emerged teeth. 
Therefore, it was inevitable that some data were missing at certain ages. 
A digital caliper (MarCal Digital Caliper 16 EX, Carl Mahr Holding 
GmbH, Göttingen, Germany) and protractor were used. Two independent 
observers measured all series of dental casts. One observer performed all 
the measurements twice. The measuring points in the deciduous and 
permanent dentition were used to calculate the following variables:
Transversal distances: The distances between the tips of the 
corresponding left and right teeth, if  present. This was calculated for 
canines; deciduous first, second, and third molars; permanent first, 
second, third, and fourth premolars; and permanent first molars.
Arch depth: The distances between Midpoint, and the midpoint of 
the line between the tips of the left and right deciduous third molars or, if 
available, between the left and right permanent first molars.
Tipping: Tipping was calculated as the distance of the projection of 
the tip of a certain tooth to the line between the mesial and distal crest at 
the same tooth. It was also recorded, whether teeth tipped palatally of 
buccally. Tipping was calculated for deciduous first and second molars; 
permanent first, second, third, and fourth premolars; and permanent first 
molars.
Rotation: Rotation was defined as the angle between the line used 
for the determination of the arch depth and the line through the mesial 
and distal crest of individual teeth. Rotation was calculated for the same 
teeth as for tipping.
For the intra oral photos, a Nikon F body (Nikon Corp, Tokyo, 
Japan) and a Medical Nikon Fixed focus lens (1: 5.6, f=200 mm) with 
close-up lens and integrated ring flash and Kodak Ektachrome film (200 
ASA; Eastman Kodak Rochester, NY) were used. The reproduction ratio
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was 2:3. A plain intraoral mirror was placed behind the tuberosities of the 
maxilla at an angle of 45° to the palate. Optimal sharpness was obtained 
by carefully positioning of the camera and two photos were made at each 
occasion.
6.2.3 Histology
For histological evaluation, two dogs of each group were sacrificed 
respectively at 15 weeks of age (deciduous dentition), 19 weeks of age 
(after eruption of premolars), and 27 weeks of age. At the time of 
sacrifice, the animals were brought under general anesthesia using 30 
mg/kg Narcovet (60 mg/ml sodium pentobarbital; Apharmo, Arnhem, 
The Netherlands). After some minutes, a lethal dose of Narcovet was 
injected intravenously. Subsequently, the maxillae were dissected and 
immersed in 4% formaldehyde in 0.1 M phosphate buffer at room 
temperature. After fixation, they were sawn into five smaller blocks. Two 
blocks contained the left and right second premolars and the adjacent 
lateral palatal tissue. Two other blocks contained the third premolars 
including the palatal tissue. The fifth block contained the midpalatal area 
between the fourth premolars and the first molar. The tissue blocks were 
decalcified in 20% formic acid and 5% sodium citrate. Decalcification 
was checked radiographically. Then the blocks were dehydrated through 
a graded series of ethanol and embedded in paraffin. Serial paraffin 
sections of 7 ^m were made throughout the entire wound. Each tenth 
section was mounted onto a superfrost (Menzel-Gläser, Braunschweig, 
Germany) slide and stained with haematoxylin and eosin (H&E) for 
general tissue survey. Polarized light microscopy was utilized to evaluate 
the collagen fiber orientation.
6.2.4 Statistical procedures
Prior to surgery, the anterior-posterior distance and four transversal 
distances in the deciduous dentition of all dogs were used for 
standardization to compensate for size and shape differences between 
individual dogs. The mean value of each of the distances of all dogs was 
calculated. Subsequently, a standardization factor was determined for 
each individual dog. This was calculated as the quotient of the mean
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value and the initial value. This individual standardization factor was 
used during the entire experimental period for each distance. To assess 
the inter-observer error of the method, all dental casts were measured by 
two independent observers. Furthermore, to analyze the intraobserver 
agreement one observer did all the measurements twice. Paired t-tests 
were applied to assess differences between the two independent observers 
for each variable. The reliability coefficients between the measurements 
of the two observers were calculated for each variable as Pearson’s 
correlation coefficients. For the assessment of the intra-observer 
agreement, the duplicate measurement error was calculated using 
Dahlberg’s formula.
6.3 Results
6.3.1 Clinical observations
Wound closure was completed without complications after two weeks in 
both experimental groups. None of the wounds showed signs of 
inflammation after 5 weeks. Palatal rugae had not regenerated in the 
wound area in either of the groups at 15 weeks after surgery (Figure 3).
Figure 3 Photographs o f the maxilla o f an adult dog at 15 weeks after surgery (27 
weeks o f age) o f the control group (Figure 3A) and o f experimental group 3 
(Integra group, Figure 3B).
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6.3.2 Reproducibility
The mean difference between the two observers for most variables was 
smaller than the duplicate measurement error. However, the duplicate 
measurement error for arch depth in the deciduous dentition, and rotation 
of deciduous second molars on both left and right side was larger than the 
standard deviation of this variable. Statistically significant differences 
(p < 0.05) between the two observers were found for the following four 
variables: arch depth in the deciduous dentition, rotation of deciduous 
second molars on both left and right side, and rotation of permanent 
fourth premolars on the left side. The overall differences for these 
variables between the observers were 0.41 mm, 1.32 degrees, 1.12 
degrees, and 1.15 degrees respectively. The accuracy of the method was 
considered to be acceptable.
6.3.3 Dental cast measurements
At the start of the study (12 weeks of age= 0 w p.o.), no statistically 
significant differences between the groups were present. All transverse 
and anterior-posterior distances increased in time in all groups. At 3, 5, 7, 
10, and 13 weeks after the start, no statistically significant differences in 
all these distances were found in all three groups except for the 
transversal tip distances at the P1(which has no predecessor), m1(P2), 
and m2(P3). All groups were comparable for the parameters tipping and 
rotation.
The transversal distance P1 tip width of the three groups across time. 
The only significant differences between the groups was found for the 
transversal distance P1 tip at 10 weeks after surgery (Control group > 
experimental group 2 and 3). The transversal distance P1 tip width in the 
unoperated control group was 3.18 ± 0.08 cm; in the Von Langenbeck 
group 2.89 ± 0.16 cm; and in the Integra group 2.91 ± 0.03 cm (Figure 4).
The transversal distance between the tips of the deciduous m1 
increased across time in all the three groups. At 7 weeks after surgery, 
the transversal distance m1 tip for the deciduous dentition in the Integra 
group (3.05 ± 0.09 cm) was significantly smaller compared to the control 
group (3.24 ± 0.05 cm).
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Figure 4 Transversal distances P1 tip.
Curve for all groups o f the transversal distance P1 tip from 7 to 15 weeks 
after start o f the study. As the P1 has no predecessor only data for the 
permanent dentition are given. Data are presented as mean ± SEM. 
*Denotes significantly different (P < 0.05), brackets denote one 
measurement.
Figure 5 Transversal distances m1 and P2 tip.
Curve for all groups o f the transversal distance m1 tip from 0 to 13 weeks 
after start o f the study and the distance P2 tip at 15 weeks p.o.. Data are 
presented as mean ± SEM. * Denotes significantly different (P < 0.05), 
brackets denote one measurement. Dotted line represents the transition 
period.
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After shedding, the transversal distance for the permanent dentition was 
smaller than the deciduous distance due to more palatal positioned second 
premolars. In the permanent dentition (P2), the transversal distance was 
not significant different between the three groups (figure 5).
The transversal distance m2(P3) was smaller in the permanent 
dentition than in the deciduous dentition. This difference in the 
transversal distance between the tips was due to more palatal erupting 
third premolars. At 15 weeks after surgery, the transversal distance of the 
third premolar (P3) was significantly smaller in the Integra group 
compared to the control group, 3.4 ± 0.04 cm, and 3.8 cm respectively 
(Figure 6).
Figure 6 Transversal distances m2 and P3 tip.
Curve for all groups o f the transversal distance m2 from 0 to 13 weeks after 
start o f the study and the distance P3 tip at 15 weeks p.o. Data are presented 
as mean ± SEM. * Denotes significantly different (P < 0.05), brackets 
denote one measurement. Dotted line represents the transition period.
6.3.4 Histology
The histological characteristics in the two experimental groups were 
similar after three and 7 weeks post surgery. Therefore, these groups will 
be pooled for these two time points.
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Von Langenbeck group and Integra group (3 and 7 weeks post surgery) 
After 3 weeks post surgery, the thickness of the closed epithelium in both 
groups was up to 10 cell layers, and the ridge formation was similar. The 
granulation tissue underneath the epithelium was hyperaemic, and the 
wounds were completely filled with granulation tissue rich in fibroblasts, 
granulocytes, and some blood vessels. The implanted Integra was easily 
recognized in the wounds because of its characteristic network structure. 
Superficial osteoclastic bone resorption was found in all samples (not 
shown). After 7 weeks post surgery, the epithelium had become thicker in 
both groups, although it was still thinner than the normal oral epithelium 
outside the wounds. The Integra matrices were still easily recognized in 
the wounds. The inflammatory reaction had almost ceased and only a few 
inflammatory cells were found (not shown).
Unoperated control group (15 weeks after the start)
The superficial layer of the palatal mucoperiosteum consists of a 
parakeratinized stratified epithelium with many ridges protruding into the 
underlying connective tissue (Figure 7A). This connective tissue layer 
consists of a three-dimensional network of thick collagen fibers. 
Throughout the mucoperiosteum, large blood vessels and sinuses are 
present in the deeper layers. Between the sinuses and close to the bone, 
the major palatine arteries and branches of the palatine nerves are 
organized into neurovascular bundles located mainly at the lateral aspect 
of the bone. The periosteal part of the mucoperiosteum consisted of a thin 
layer with some osteoblasts. The palatal bone is of the lamellar type and 
some Sharpey’s fibers are c learly visible. (Figure 7 B&C).
Von Langenbeck group (15 weeks after the start)
The epithelium is continuous and regenerated to a thickness comparable 
to the control group (Figure 7D). The underlying connective tissue layer 
contained mainly parallelorientated collagen fibers. Attachment to the 
palatal bone by Sharpey’s fibers was present throughout the former 
denuded bone areas (Figure 7E&F). The bone was of the woven type and 
a layer of active osteoblasts covered its surface. No oseoclasts were 
found.
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Integra group (15 weeks after start of the study)
The histological characteristics closely resembled the characteristics of 
the Von Langenbeck group. The wounds filled with Integra showed a 
continuous epithelium (Figure 7G). The connective tissue layer contained 
mainly parallel oriented collagen fibers. Integra was always easily 
recognized because of its typical structure. Deposition of bone was 
observed also into the Integra in all wounds. Attachment of the scar 
tissue to the palatal bone in the region of the denuded bone areas by 
means of Sharpey’s fibers was observed in most regions of the former 
denuded bony areas. The palatal bone resembled coarse woven bone laid 
down around the Integra structures. Some bone deposition and local 
resorption was found. Only resting osteoblasts were present (Figure 
7H&I).
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Figure 7 Transversal sections o f the palate at 15 weeks after start o f the study (H&E).
A,B,C: Unoperated control group, A=Overview, B=Detail showing the 
border between the palatal bone and the mucoperiosteum, C=polarization 
microscopy o f area 7B. D,E,F: Von Langenbeck group, D=Overview, 
E=Detail showing the border between the palatal bone and the 
mucoperiosteum, F=polarization microscopy o f area 7E. G,H,I: Integra 
group, G=Overview, H=Detail showing the border between the palatal bone 
and the mucoperiosteum and the bone ingrowth into the matrix, 
I=polarization microscopy o f area 7H.
Arrows indicate the Integra matrix, e=epithelium, b=bone and 
nvb=neurovascular bundle. The bar represents 100^m.
6.4 Discussion
Dento-alveolar development in beagle dogs after palatal repair according 
to the Von Langenbeck technique was compared with and without the 
implantation of the dermal substitute Integra. The goal was to reduce 
wound contraction and subsequent scar tissue formation, and thereby 
minimize the growth disturbances due to surgery.
Similar to the human situation, palatal closure in the dogs was 
performed when the deciduous dentition was still present. Surgery 
performed after completion of the permanent dentition has no effect on 
final maxillary arch dimensions in dogs. The dental transition in beagle 
dogs is completed at the age of 25 weeks, and after that the dental arch
o
width hardly increases anymore. Therefore, the dogs were followed until 
the age of 27 weeks (15 weeks after surgery).
During the experimental period, the transversal distances in all 
groups increased. However, in both experimental groups they were 
smaller than in the control group. No statistically significant differences 
were found if the experimental groups were mutually compared. It can be 
concluded that the implantation of Integra showed no statistically 
significant effect on the transversal distances compared to the Von 
Langenbeck technique alone. On the other hand, there were no 
statistically significant differences in arch depth, tipping, and rotation 
between both experimental groups and the control group. This means that 
surgery itself, with or without Integra implantation, has no effect on these 
parameters. This is in agreement with other studies.15,23
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In both experimental groups, wound healing was completed without 
complications such as sequestration of the material or a delayed wound 
closure. This supports result of earlier studies.24,25 The histology in the 
present study showed attachment of scar tissue to the palatal bone by 
means of Sharpey’s fibers in the region of the formerly denuded bony 
areas in both experimental groups. However, in this study, there were less 
Sharpey’s fibers present compared to other studies, possibly due to 
individual variations in the dogs. The collagen fibers of the scar tissue 
showed a mainly parallel transverse orientation. This is in agreement with 
the findings of Wijdeveld et al., and Leenstra et al. , The scar tissue and 
its continuity to the underlying palatal bone is held responsible for the 
growth disturbances of the dento-alveolar complex.15,24,26 There was no 
difference in scar tissue and its attachment in both experimental groups. 
These findings explain the similar growth data in the two experimental 
groups.
Deposition of bone within the Integra occurred after implantation. 
Osteoblasts recognize the collagen I matrix, and are triggered to form 
new bone as is also observed by others.27 Type I collagen plays a role in 
osteoblastic differentiation.28,29 Hanagata et al. demonstrated that type-I 
collagen stimulates proliferation and bone deposition by osteoblast-like 
cells.30 The present study indicates that also Integra (a collagen I matrix) 
promotes bone-like formation under physiological condition.
Wound healing is a dynamic process and involves interactions of 
many cells, extracellular matrix molecules, and soluble mediators. It 
involves four phases that overlap in time and space: inflammation, 
proliferation, tissue formation with contraction, and tissue remodeling.32 
Evidence from several studies show that cytokines are involved in wound 
contraction and scarring.31,32 From these studies, it was concluded that 
certain cytokines are able to reduce the numbers of myofibroblasts and 
the collagen content of scar tissue after palatal wound healing. In future 
studies, a matrix loaded with cytokines might reduce wound contraction 
and scarring after cleft palate surgery, and thereby minimize growth 
disturbances.
From the results of this study, it was concluded that palatal surgery 
according to Von Langenbeck followed by implantation of the dermal
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substitute Integra has no statistically significant effect on the dento- 
alveolar development compared to the Von Langenbeck procedure only. 
Future research should aim at improving the performance of the dermal 
substitutes by loading with pharmaceutical agents such as cytokines.
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7.1 Introduction
Patients with a repaired orofacial cleft palate often have a facial and 
maxillary dento-alveolar morphology that differs from individuals 
without this disorder. The etiology of this deformation is still not 
completely known. Factors such as intrinsic developmental deficiencies 
and functional distortions are initially involved but palatal repair seems 
to be the main cause.1 A strong indication for this is the near normal 
growth and dental development in unoperated cleft palate patients. 
Wound contraction and formation of scar tissue after surgery are 
considered major factors in the disturbance of maxillary dento-alveolar 
growth.3,4 Especially the scar tissue attached to the palatal bone shows a 
long-term influence on growth.5,6
Developments within the field of tissue engineering allow the in 
vitro construction of skin and mucosal substitutes to improve wound
7 8healing, , and it has been shown that certain substitutes indeed are able 
to reduce wound contraction and scar formation in skin wounds after 
implantation.9,10 The present study focuses on the development and the in 
vivo evaluation of mucosal substitutes for cleft palate repair, and the long 
term effects on maxillary growth in dogs. In the following sections, the 
results are discussed in the light of more general issues in tissue 
engineering of skin and oral mucosa. Specifically, attention is paid to the 
requirement of cells and a dermal substrate, and the reduction of scarring. 
Finally, conclusions are drawn on the suitability of mucosal substitutes 
for the prevention of growth disturbances after cleft palate repair.
7.2 Requirements of a mucosal equivalent; need for cells?
The objective of many studies using tissue engineering techniques is to 
culture a multilayered epithelium on top of a substrate with or without 
cultured fibroblasts to obtain a construct that resembles normal skin or 
oral mucosa.11 However, the culture period of several weeks necessary to 
yield enough autologous cells may not be clinically acceptable. In 
addition, cells may not always be essential for a functional substitute.
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There are two main applications for tissue engineered skin and oral 
mucosa: in vitro test systems to study biological and pharmacologic 
processes in which cells are essential, and clinical applications to 
improve wound healing or supply tissue defects in which the necessity 
for cells might be questionable.
The complexity of an in vitro test system depends on the aim of the
study. If a study focuses on structural components of cells or cell-cell
12interactions multilayered keratinocyte sheets can be used. However, for 
the evaluation of the biological effects of materials on skin or mucosa, or
13cell-matrix interactions supporting scaffolds should be added. A full­
thickness human oral mucosal substitute composed of keratinocytes on a 
substrate with fibroblasts can be used to investigate the response of oral 
mucosa to dental materials, UV irradiation, and to investigate cell-matrix 
interactions. In addition, aspects of wound healing, angiogenesis, and 
wound contraction can be investigated in such constructs.11,14 The general 
opinion is that in vitro tests will be more convincing when performed 
with cells that are homologous with the human tissue concerned. For 
example, appropriate cell lines for the use in cytotoxicity and tolerance 
tests concerning the skin should be dermal fibroblasts and epidermal 
keratinocytes, as they take an active part in the immune response, 
inflammatory processes, and wound healing.
The clinical purpose of tissue-engineered substitutes is to restore
barrier function of the skin and mucosa and to initiate and improve
11 12wound healing. , Skin defects may be of partial thickness including 
only the epidermis, or full-thickness when the dermis is involved. For 
partial thickness defects, various types of biological dressings including
cultured keratinocytes sheets are employed to support re-
11 12epithelialization. , These sheets have been successfully used worldwide 
to treat burn wounds.15,16 They serve as biologically active dressings that 
enhance wound healing by the secretion of growth factors and cytokines. 
Despite early reported benefits of this technique, including improved 
patient survival rates and better cosmetic results when compared with 
meshed autograft, more recent reports have consistently reported poor
15 17clinical results. , It is currently believed that keratinocytes sheets are
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valuable as a life saving measure for early closure but that they are not
18suitable as permanent coverage.
Full-thickness skin wounds have been treated with a full thickness 
skin substitute composed of a multilayered keratinocyte sheet on top of a 
dermal substrate. These methods represent the common standard in 
clinically applied tissue-engineered skin substitutes. However, up till now 
only case studies have been reported.19,20 Other studies show that the full­
thickness engineered mucosa results in faster wound healing of oral 
tissues compared with the transplantation of autologous keratinocytes 
sheets. The presence of cultured epithelium appeared to influence the
revascularization of the underlying dermis by the synthesis and release of
21 22cytokines, enzymes, and growth factors. , In the present study, we 
attempted to construct an oral mucosal substitute composed of 
keratinocytes and a substrate for clinical application in cleft palate
23 24repair. , The results, as described in chapter 2, show that by seeding 
oral keratinocytes onto a skin-derived substrate, a full-thickness oral 
mucosal substitute can be established. However, such a tissue-engineered 
oral mucosa failed in the in vivo situation, probably due to delayed 
vascularization (Chapter 4). Also others have speculated that graft 
degeneration is probably caused by the slow revascularization of the
25 27relatively thick dermal avascular component. - The maximum thickness
of dermal substitutes that show a sufficient revascularization to survive is
28about 0.2 mm. Consequently, a cultured skin or oral mucosal substitute 
thicker than 0.2 mm will only function as a temporary coverage.
A rather new approach is the use of genetically modified 
keratinocytes that over-express VEGF. If these cells are combined with 
autologous fibroblasts in cultured skin substitutes, graft vascularization
27was faster, leading to a more stable engraftment. The complex cell 
signaling interactions which occur between keratinocytes and fibroblasts
29 30during wound healing have been reviewed recently. , Another 
promising approach is the development of human endothelialized skin 
substitute, in which keratinocytes, fibroblasts, and endothelial cells are 
combined within a collagenous sponge. This combination leads to the in 
vitro formation of tube-like endothelial structures in the construct that
31inosculate with the host’s capillary network after grafting. The use of
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endothelial cells, however, is complicated by their slow growth in
32primary culture compared to fibroblasts and keratinocytes. In addition, 
it has been shown that only a small proportion of endothelial cells persist
3 3during the culture of engineered skin grafts. Thus, although the addition 
of endothelial cells to cultured skin or mucosa for in vitro stimulation of 
angiogenesis is theoretically possible, technical problems still need to be 
overcome.
In summary, for in vitro models, cultured keratinocytes and other 
cells are suitable. In clinical applications, however, cultured equivalents 
will mostly function only as a temporary coverage. However, the 
application for tissue engineered skin or oral mucosa, combining 
keratinocytes, fibroblasts and endothelial cells, may in the near future 
result in superior wound repair in terms of functional and esthetic result. 
But until then, tissue-engineered oral mucosa for clinical applications 
might only be marketed as a service with temporary profitability.
7.3 Requirements of a mucosal equivalent; need for dermal 
substrates?
As mentioned before, there are two types of skin wounds, partial­
thickness and full-thickness, and the healing of each follows a distinct 
pattern. For partial thickness defects, a dermal substrate is not required as 
re-epithelialisation is generally rapid. Full-thickness skin wounds heal by 
second intention, which is characterized by extensive granulation tissue 
formation followed by wound contraction and scar formation.34 The 
mechanical effect of scar tissue in children is one of the factors that can
3 5restrict growth, apart from the functional and esthetical consequences.
Full-thickness equivalents may provide improved coverage and 
decreased wound contraction.36 However, their efficacy depends on the 
dermal replacement material. A dermal replacement material should have 
acceptable low (preferably no) immunogenicity, be slowly biodegradable, 
and support the reconstruction of normal tissue. In addition, it should 
reduce the differentiation of myofibroblasts and scarring and should have 
similar mechanical and physiological properties of the tissue it
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37 39replaces. - Substrates used for skin and mucosa reconstruction include 
synthetic scaffolds, biological materials (such as acellular skin-derived 
substrates and collagen-based scaffolds) and hybrid substrates of both 
biological and synthetic materials. An extensive review of these 
substrates and their use has recently been published elsewhere.11
Several currently available dermal substrates do not allow proper 
differentiation of a multilayered keratinocyte epithelium on top. To 
address these issues, investigators are working to optimize the substrates. 
Aliphatic polyesters such as polyglycol acid, polylactic acid, and 
polycaprolactone are the most commonly used synthetic scaffolds for 
tissue engineering.40,41 However, the degradation of these synthetic 
polymers both in vitro and in vivo, leads to the release of acidic side
42products which negatively influence the microenvironment.
Skin-derived substrates have been extensively studied in tissue
37engineering. Advantages of these substrates are: a good durability and 
reduced antigenicity, ability to retain its structural properties, even after 
freezing, lyophilization, or preservation in glycerol. We have shown that 
oral mucosal substitutes composed of oral keratinocytes cultured on skin- 
derived substrates (DED or AlloDerm) show histological and 
immunohistochemical characteristics very close to normal oral mucosa 
(Chapter 2). The effects of implantation of these dermal substitutes on 
palatal wound healing was studied in our dog model (Chapter 3 and 4). 
Chapter 4 shows that an oral mucosal substitute based on these skin- 
derived substrates (DED or AlloDerm) had serious drawbacks after 
implantation in dogs. The epithelium was lost after one week, and the 
dermal part of the substitute showed rapid degradation. Contradictory 
results are reported on the take rates and the outcome of skin-derived
27 3 8substrates. , This may be due to immunogenic properties of the 
material or possible hypersensitivity of the immune system. A major 
problem might be that slow revascularization causes graft
25 27degeneration. , Within the body, most cells are found no more than 
100-200 ^m from the nearest capillaries, providing sufficient diffusion of 
oxygen, nutrients, and waste products in order to support and maintain 
viable tissue.43 Therefore, it appears to be critical that a cell-populated 
substrate is pre-vascularized prior to implantation.
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37Collagen has long been used in the design of skin substitutes. 
Collagens in the skin are mainly synthesized by fibroblasts. Type I 
collagen is a major component of the dermis, fasciae and tendons and 
also of scar tissue. Many, mainly clinical, positive reports have been 
published over the recent years concerning the use of the collagen-based 
scaffold Integra. The long-term results are positive, in terms of the 
structure of the skin and a low tendency to form hypertrophic scars.44,45 
However, in a full-thickness animal skin wound model, it was shown that 
Integra reduced the rate of contraction only temporary until the silicone 
outer layer was removed. Wound contraction rates were then found to 
increase thereafter to a greater rate than in wounds treated with only skin 
grafts.46,47 We investigated the in vivo response to Integra after 
implantation on the palate of beagle dogs (Chapter 5). The implantation 
of Integra produced a wound with less parallel collagen fibers and less 
myofibroblasts. However, we also found that the implantation of Integra 
during palatal surgery has no positive effect on the dento-alveolar 
development in dogs (Chapter 6). Scar tissue had still attached to the 
palatal bone by means of Sharpey’s fibers. As mentioned before, 
substrates including cultured keratinocytes are employed to support re- 
epithelialization and to provide growth factors and cytokines that enhance
13wound healing. Growth factors and cytokines might also be 
incorporated into the substrate but their effect seems to be dependent on 
location and timing.48,49 Although substrates loaded with growth factors 
may reduce the myofibroblast differentiation and subsequent wound 
contraction and scarring, the interaction between these factors, the cells, 
and the extracellular matrix has not yet sorted out properly.50
In summary, for partial thickness defects, a dermal substrate is not 
required. In full-thickness skin wounds, however, a dermal component is 
required to replenish the dermal defect in order to prevent myofibroblast 
differentiation and subsequent wound contraction and scarring. It is 
reasonable to assume that the incorporation of suitable growth factors or 
cytokines in the substrate may further decrease the rate of wound 
contraction and subsequent scarring.
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7.4 Reduction of wound contraction and scarring; clinical 
consequences?
Clinical studies show that not the surgical technique itself but the 
surgeons skill probably is the most important variable which determines 
the outcome of cleft palate surgery.1 Therefore, it is reasonable to also 
focus on the skills and case load of the surgeons. Although, this may 
reduce unfavourable outcomes of surgery to a great extent, scar formation 
will always take place whatever the experience of the surgeon.
In general, no particular surgical technique has an advantage with 
respect to dental arch form, speech outcome, feeding, or any other 
functional variable. Surgery always leads to growth disturbances in the
51 52midface. , A strong indication for these iatrogenic effects is the near 
normal growth and dental development in non-operated CLP patients. 
Therefore, CLP repair by itself is considered to be the main cause of 
growth inhibition of the maxillofacial complex.
Growth inhibition might be reduced by prevention of scar tissue 
formation and attachment to the palatal bone. Wound contraction and scar 
tissue formation might be decreased by preventing myofibroblasts 
differentiation. Studies have also been performed to prevent attachment
53-55of scar tissue to the bone, but without much success. -
Studies in full-thickness skin wounds in animal models show a 
reduction in the number of myofibroblasts by the use of full-thickness 
skin grafts which may result in decreased wound contraction and scar 
tissue formation.56 The implantation of Integra in palatal wounds yields a 
wound with less parallel collagen fibers and less myofibroblasts (Chapter 
5). However, this positive effect on the structure of the scar tissue was 
counteracted by its attachment to the palatal bone (Chapter 6). Therefore, 
it was not surprising that palatal surgery combined with implantation of 
the dermal substitute had no positive effect on dento-alveolar 
development. Growth factors and cytokines may be incorporated in the 
substrate to further reduce myofibroblast differentiation. Therefore, the 
question whether implantation of a suitable substrate produces more 
favorable dento-alveolar development than CLP repair alone has still not 
been answered.
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There is a large variability in craniofacial morphology and in tissue 
response to treatment, even in children with the same type of cleft. At the 
same time, we should keep an open eye for other promising approaches 
such as fetal surgery repair or gene therapy. Several studies on fetal
57 58surgical for cleft lip and palate have been performed on animals. , 
Nevertheless, for now still too many unsolved problems are associated 
with intrauterine surgery, which make this approach for cleft lip palate 
surgery in humans ethically unjustifiable. In the future, we may be able to 
manipulate gene expression in children and adults to simulate fetal 
wound healing that proceeds without scar formation. However, both 
syndromic and nonsyndromic cleft lip and palate have a multifactoral 
inheritance that involves not only genetic factors but also environmental 
influences.59 Therefore, continuing research is needed to elucidate the 
many factors that contribute to the etiology of cleft lip and palate.
7.5 Conclusion and future perspectives
Tissue engineering of skin and oral mucosa is either performed to 
develop in vitro test systems, or to provide graft material to improve 
wound healing. The former application requires that the construct 
resembles the tissue as much as possible, while for the latter only the 
clinical outcome is decisive. Thus for clinical applications the inclusion 
of cells is not critical. Moreover, the culture time required to obtain 
enough cells may not be clinically and practically acceptable. Cellular 
tissue substitutes are also limited in thickness because of the required 
nutrient supply from nearby blood vessels. The inclusion of suitable 
growth factors to attract the proper cells and to guide their differentiation 
might overcome the need for cells.
Research is also ongoing into the development of suitable substrates 
for tissue engineering of skin and mucosa. Biological substrates such as 
dermis or collagen-based scaffolds seem to be the most promising. 
Synthetic polymers are still hampered by poor cell attachment and the 
resulting toxic degradation products.
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In the studies described here, some of these issues have been 
addressed for the purpose of improving wound healing after cleft palate 
repair. Dog oral keratinocytes cultured on a skin-derived substrate 
formed a multi-layered oral mucosal substitute in vitro, but it did not 
survive after implantation on the palate. This was probably due to the 
lack of nutrient supply through the relatively thick dermal component. 
Therefore we switched to an acellular collagen-based substrate without 
cells.
The implantation of this substrate in experimental wounds on the 
palate resulted in regenerated tissue with less parallel collagen fibers and 
less myofibroblasts. However, simulated cleft palate surgery in dogs 
combined with the implantation of the substrate had no positive effect on 
the dento-alveolar development. Loading of the substrate with growth 
factors may promote angiogenesis and further reduce contraction and scar 
formation. This should be investigated in future research.
Advances have been made toward a better understanding of different 
aspects of CLP, but there is still a long way to go to reach consensus on 
the optimal treatment. This is due to the large variability in morphology, 
and the complex etiology involving interacting genetic and environmental 
factors. Tissue engineering may contribute to the improvement of 
surgical treatment of cleft palate.
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Summary

Summary
The aim of the present study was to develop a substitute for oral mucosa, 
which can prevent the iatrogenic effects of surgical cleft palate closure.
C hapter 1 describes the background of the study and reviews the 
literature on orofacial clefts, cleft palate surgery, and tissue engineering 
of oral mucosa. After cleft palate surgery in young patients, maxillary 
growth and dento-alveolar development are severely impaired. Two 
events during the wound healing process, contraction and scar formation, 
are responsible for these adverse effects of surgery. Scar tissue formation 
is still one of the main causes of maxillary growth inhibition. A possible 
solution is to supplement the tissue shortage after palatal repair with a 
cellular or acellular mucosal substitute using tissue engineering 
techniques. To investigate this, several approaches have been taken. 
Firstly, a cellular substitute was constructed and evaluated in vitro. 
Secondly, the biocompatibility of this substitute and several dermal 
substrates was tested in an animal model. Finally, the effects of an 
acellular implanted substitute on the development of the dento-maxillary 
complex were evaluated in a dog model.
C hapter 2 describes an in vitro study on the culture and 
characterization of substitutes containing dog keratinocytes. Epidermal 
and oral keratinocytes were cultured on several skin-derived and 
collagen-based substrates. The results show that oral keratinocytes 
cultured on the skin-derived substrates closely resemble normal oral 
epithelium. Epidermal keratinocytes cultured on skin-derived substrates 
form an epithelium that is similar to dog epidermis. In contrast, 
keratinocytes cultured on the collagen-based substrates invade the 
substrate without the formation of a multi-layered epithelium. It is 
concluded that dog oral keratinocytes cultured on skin-derived substrates 
exhibit a tissue organization that resembles normal dog oral mucosa.
C hapter 3 describes a study on the in vivo behavior of five different 
dermal substrates. This study was performed in order to obtain a suitable 
material for implantation on the palate of the beagle dog. Three collagen- 
based substrates and two skin-derived substrates were implanted in open 
wounds on the palate. Histology was performed at 3, 10, and 20 days 
post-surgery. It was concluded that all collagen-based substrates were
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well-tolerated. However, it was unclear whether AlloDerm was rapidly 
degraded or that it was sequestrated and lost.
In C hapter 4 it was investigated whether cultured mucosal 
substitutes composed of skin-derived substrates and dog oral 
keratinocytes can be used as a graft material. Two different types of 
cultured mucosal substitutes composed of skin-derived substrates (DED 
and AlloDerm) and autologous oral keratinocytes were implanted in 
palatal wounds in six beagle dogs. The cultured substitutes were 
compared with a sham and a control group. The animals were sacrificed 
in pairs up to 12 weeks after surgery. It was shown that before 
implantation all cultured substitutes possessed a multilayered epithelium, 
closely resembling normal oral epithelium. After implantation however, 
the epithelium was rapidly lost and an inflammatory response was 
observed in the first week. After 3 and 12 weeks, the implanted 
substitutes had completely disappeared and epithelial migration had 
occurred from the wound margins. This in vivo study further 
demonstrated that the substitutes did not improve the healing of palatal 
wounds. It was suggested that the revascularization of the substitutes is 
too slow to allow survival and integration of the substitutes.
In C hapter 5 the influence of the silicon top layer of Integra on 
palatal wound healing was investigated. Wounds were made in the palate 
of four beagle dogs. Integra with and without the silicon layer was 
implanted into the full-thickness wounds. In some of the wounds, the 
silicone layer was removed after 14 days. No implants were placed in the 
control wounds. At two and four weeks post-surgery, the wounds were 
assessed for epithelialisation, inflammation, number of myofibroblasts, 
and general histological characteristics. It was concluded that wounds 
implanted with Integra without the silicon layer showed less 
myofibroblasts and inflammatory cells than the control wounds. In 
addition, collagen fibres were more randomly oriented than in the sham 
group. Wound closure was found to be retarded and many inflammatory 
cells were present when Integra with silicone was implanted. Moreover, 
the silicon layer was lost within 4 weeks from the wounds. It was 
concluded that in the moist oral environment the silicon layer of Integra 
is not required.
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C hapter 6 compared the dento-alveolar development in beagle dogs 
after palatal repair with and without the implantation of Integra without 
the silicon layer. Nineteen young beagle dogs were assigned to two 
experimental groups and a control group. Palatal surgery was performed 
by the Von Langenbeck technique. Thereafter, a substitute was implanted 
in one experimental group, while the other served as sham group. Dental 
casts were made prior to surgery, and at several time-points in all groups. 
Dento-alveolar development was measured on the dental casts. These 
were used to determine the transversal distances, arch depth, tipping, and 
rotation. Histology was performed at 3, 7, and 15 weeks after surgery. It 
was found that the scar tissue in both experimental groups was firmly 
attached to the palatal bone by means of Sharpey’s fibers. Moreover, it 
was shown that bone was deposited inside the Integra substrate after 
implantation. Transversal dento-alveolar development was similar in both 
experimental groups but significantly smaller than in the control group at 
some time-points. Therefore, it was concluded that the implantation of 
the dermal substrate does not improve the dento-alveolar development 
after the Von Langenbeck procedure for palatal repair.
Finally, in chapter 7 the results of the previous chapters are 
discussed and suggestions are made for further research. In spite of the 
disappointing results of the implanted substrates found in this thesis, 
these materials still might be useful in cleft palate surgery. Loading of a 
substrate with growth factors may promote angiogenesis and further 
reduce contraction and scar formation. Therefore, future research both in 
vitro and in vivo is needed to better understand material characteristics, 
and cell-tissue interactions to the materials before using these materials 
in human cleft palate surgery.
In summary, the following conclusions are drawn from the studies: 
o Seeding oral keratinocytes onto a skin-derived substrate, a full­
thickness oral mucosal substitute can be established. However, 
these substitutes containing autologous keratinocytes were lost 
after implantation. It was suggested that the revascularization of 
the substitutes is too slow.
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o The implantation of Integra in palatal wounds yields a wound with 
less parallel collagen fibers and less myofibroblasts. However, this 
positive effect on the structure of the scar tissue was counteracted 
by its attachment to the palatal bone. Therefore, it was not 
surprising that palatal surgery combined with implantation of the 
dermal substitute had no positive effect on dento-alveolar 
development.
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Samenvatting

Samenvatting
Het doel van dit proefschrift was het ontwikkelen van een nieuw soort 
kunst slijmvlies (mucosaal substituut), dat de nadelig invloeden door het 
chirurgisch sluiten van de bovenkaak bij een schisis kan voorkomen.
Hoofdstuk 1 beschrijft de achtergrond van dit onderzoek en geeft 
een overzicht over het onderzoek op het gebied van schisis en 
schisischirurgie en de gekweekte mucosale substituten. Het chirurgisch 
sluiten van een schisisspleet op jonge leeftijd zal de groei van de 
bovenkaak en de gebitsontwikkeling nadelig beïnvloeden. Twee aspecten 
van het wondgenezingsproces, namelijk contractie en littekenvorming, 
zijn verantwoordelijk voor de nadelige gevolgen van de chirurgie. 
Littekenvorming en de hechting daarvan aan het gehemeltebot worden 
beschouwd als de belangrijkste oorzaken van de verstoorde groei van de 
bovenkaak. Een mogelijkheid zou zijn het slijmvliestekort na de 
schisischirurgie aan te vullen met een mucosaal substituut met of zonder 
cellen. Hiervoor zullen een aantal mogelijkheden onderzocht worden. Ten 
eerste zal een mucosaal met cellen substituut in het laboratorium ( in 
vitro) gekweekt en bestudeerd worden. Vervolgens wordt de 
biocompatibiliteit van dit substituut en een aantal celvrije substraten in 
het proefdiermodel getest. Tenslotte zal het effect van het geïmplanteerde 
celvrije substraat op de ontwikkeling van de bovenkaak en het gebit 
worden onderzocht in het hondenmodel.
Hoofdstuk 2 behandelt het in vitro onderzoek naar de kweek en 
karakterisatie van substituten die epitheelcellen (keratinocytes) van 
honden bevatten. Huid- en slijmvlieskeratinocyten werden gekweekt op 
verschillende uit huid verkregen (skin-derived) en kunstmatige 
(collageen) dermale substraten. Slijmvlies keratinocyten gekweekt op een 
skin-derived substraat vormen een gelijkend aan normaal mondslijmvlies. 
Huid keratinocyten gekweekt op een skin-derived substraat vormen 
een epitheel wat lijkt op een huidepitheel. Echter keratinocyten gekweekt 
op een collageen substraat groeien in het substraat zelf waarbij geen 
meerlagig epitheel ontstaat. Geconcludeerd werd dat 
slijmvlieskeratinocyten van honden gekweekt op een skin-derived 
substraat een epitheel vormen gelijk aan een hondenslijmvlies.
Hoofdstuk 3 beschrijft het in vivo gedrag van vijf verschillende 
dermale substituten. Doel van het onderzoek was een geschikt materiaal
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te vinden om te implanteren in het gehemelte van de beagle hond. Drie 
collageen-en twee skin-derived substraten werden geïmplanteerd in open 
wonden op het gehemelte. Histologisch onderzoek vond plaats drie, tien 
en twintig dagen na chirurgie. Geconcludeerd werd dat de collageen 
substraten goed getolereerd werden. Echter onduidelijk was het of 
AlloDerm snel werd afgebroken of werd uitgestoten.
In hoofdstuk 4 wordt onderzocht of een gekweekt mucosaal 
substituut bestaande uit slijmvlieskeratinocyten van honden gekweekt op 
een skin-derived substraat als transplantaat gebruikt kunnen worden. 
Twee soorten gekweekte mucosale substituten bestaande uit 
slijmvlieskeratinocyten van honden gekweekt op een skin-derived 
substraat werden in wonden op het palatum van zes honden 
geïmplanteerd. De gekweekte substituten werden vergeleken met twee 
controle groepen. De proefdieren werden geofferd in paren tot aan 12 
weken na de ingreep. De gekweekt mucosaal substituten bestonden voor 
de implantatie uit een epitheel met meerdere cellagen. Echter na 
implantatie was dit epitheel verloren gegaan en een ontstekingsreactie 
was waarneembaar vanaf de eerste week na implantatie. Het 
geïmplanteerde substituut was drie en 12 weken na de ingreep niet meer 
aanwezig en re-epithelialisatie was zichtbaar vanaf de wondranden. 
Verder werd aangetoond dat er geen sprake was van een betere 
wondgenezing wanneer deze substituten werden geïmplanteerd. Het 
verlies van de substituten zou mogelijk veroorzaakt kunnen zijn door een 
te trage bloedvatvorming in de wonden.
In hoofdstuk 5 werd het effect van de buitenste siliconen laag van 
Integra onderzocht. Gestandaardiseerde diepe wonden werden gemaakt in 
het palatum van vier beagle honden. Integra met en zonder de siliconen 
laag werd geïmplanteerd in deze wonden. De silicone laag werd 
verwijderd in een aantal van deze wonden na 14 dagen. De controle groep 
bestond uit wonden zonder Integra. Vervolgens werden de wonden 
histologisch onderzocht op een aantal weefselkarakteristieken twee en 
vier weken na de ingreep. Er werd geconcludeerd dat er minder 
myofibroblasten en ontstekingscellen aanwezig waren in de wonden 
waarbij Integra zonder de silicone laag werd geïmplanteerd. De collageen 
vezels in deze wonden waren meer willekeurig georiënteerd vergeleken
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met de controle groep. Vertraagde wondgenezing en aanwezigheid van 
vele ontstekingscellen werd aangetoond in de groep waarbij Integra met 
de silicone laag werd geïmplanteerd. Echter de siliconenlaag was in geen 
enkele wond meer aanwezig na vier weken. Deze studie suggereert dat in 
de vochtige mondholte de siliconenlaag van Integra niet noodzakelijk is.
Hoofdstuk 6 vergelijkt de ontwikkeling van de bovenkaak en het 
gebit bij beagle honden na gehemeltechirurgie zonder en met implantatie 
van een dermaal substraat. Negentien honden (leeftijd 12 weken) werden 
verdeeld over twee experimentele en een controle groep. 
Gehemeltechirurgie volgens de Von Langenbeck methode werd toegepast 
hierna werd in één experimentele groep het dermaal substraat 
geïmplanteerd. Gebitsmodellen werden gemaakt voor de chirurgische 
ingreep en op enkele tijdstippen hierna. Bovenkaak- en 
tandboogontwikkeling werden onderzocht aan de hand van de 
gebitsmodellen. Op drie verschillende tijdstippen werden histologische 
preparaten vervaardigd. In beide onderzoeksgroepen bleek het 
littekenweefsel star verbonden te zijn met het gehemeltebot door middel 
van vezels van Sharpey. Verder bleek er nieuw botvorming aanwezig te 
zijn in het dermale substraat. De kaakbreedte in beide experimentele 
groepen vertoonde grote gelijkenis maar was significant kleiner dan de 
controle groep. Daarom werd geconcludeerd dat chirurgie samen met de 
implantatie van een collageen substraat geen verbetering geeft van de 
ontwikkeling van de bovenkaak en het gebit.
In hoofdstuk 7 worden de resultaten van de vorige hoofdstukken 
bediscussieerd en zijn suggesties gedaan voor vervolgonderzoek. 
Ondanks de negatieve resultaten na implantatie van het substraat in dit 
proefschrift, lijken deze materialen in schisischirurgie mogelijk toch 
nuttig te zijn. Het toevoegen van groeifactoren aan het substraat zou 
versnelling van bloedvatvorming kunnen geven en vermindering van 
wondcontractie en littekenvorming. Daarom zal in de toekomst meer in 
vitro en in vivo onderzoek naar materiaaleigenschappen en 
weefselreacties tegen deze materialen gedaan moeten worden.
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Samenvattend kunnen de volgende conclusies uit dit onderzoek worden 
getrokken:
o Slijmvlies keratinocyten gekweekt op een skin-derived substraat 
vormen een gelijkend op dat van normaal mondslijmvlies. Echter, 
deze substituten met autologe cellen waren na de ingreep niet meer 
aanwezig. Het verlies van de substituten zou mogelijk veroorzaakt 
kunnen zijn door een te trage bloedvatvorming in de wonden. 
o De wonden waarin Integra werd geïmplanteerd vertoonde zowel 
minder parallelle vezels als minder myofibroblasten. Echter dit 
positieve effect op het litteken werd teniet gedaan door de hechting 
aan het gehemeltebot. Daarom is het niet verwonderlijk dat 
schisischirurgie samen met het implanteren van een dermaal 
substraat geen verbetering geeft van de ontwikkeling van de 
bovenkaak en het gebit.
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werken. We gaan nu weer van ons leven genieten.
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